The URL can be used to link to this page

Home My WebLink About24-1835ORD[NANCE NO. 24- 1835 AN ORDINANCE OF THE CITY OF DENTON, A TEXAS HOME-RULE MUNICIPAL CORPORATION, AUTHORIZING THE CITY MANAGER TO EXECUTE A CONTRACT WITH UNITED HEALTHCARE SERVICES, INC., TO PROVIDE MEDICAL NETWORK, CLAIMS ADMINISTRATIVE SERVICES, AND PHARMACY BENEFIT MANAGEMENT SERVICES FOR THE CITY OF DENTON’S SELF-FUNDED HEALTH PLANS; PROVIDING FOR THE EXPENDITURE OF FUNDS THEREFOR; AND PROVIDING AN EFFECTIVE DATE OF JANUARY 1, 2025 (RFP 8577 – AWARDED TO UNITED HEALTHCARE SERVICES, INC., FOR THREE (3) YEARS, WITH THE OPTION FOR TWO (2) ADDITIONAL ONE (1) YEAR EXTENSIONS, IN THE TOTAL FIVE (5) YEAR NOT-TO-EXCEED AMOUNT OF $4,787,000.00). WHEREAS, the City has solicited, received, and evaluated competitive proposals to provide Medical Network, Claims Administrative Services, and Pharmacy Benefit Management Services for the City of Denton’s self-funded health plans; and WHEREAS, the City Manager, or a designated employee, has received, reviewed, and recommended that the herein described proposals are the most advantageous to the City considering the relative importance of price and the other evaluation factors included in the request for proposals; and WHEREAS, this procurement was undertaken as part of the City’s governmental function; and WHEREAS, the City Council has provided in the City Budget for the appropriation of funds to be used for the purchase of the materials, equipment, supplies, or services approved and accepted herein; NOW, THEREFORE, THE COUNCIL OF THE CITY OF DENTON HEREBY ORDAINS: SECTION 1. The items in the following numbered request for proposal for materials, equipment, supplies, or services shown in the “Request Proposals” on file in the office of the Purchasing Agent, are hereby accepted and approved as being the most advantageous to the City considering the relative importance of price and the other evaluation factors included in the request for proposals. RFP NUMBER CONTRACTOR AMOUNT 8577 United Healthcare Services, Inc. $4,787,000.00 SECTION 2. That by the acceptance and approval of the above numbered items of the submitted proposals, the City accepts the offer of the persons submitting the proposals for such items and agrees to purchase the materials, equipment, supplies, or services in accordance with the terms, specifications, standards, quantities, and for the specified sums contained in the Proposal Invitations, Proposals, and related documents. SECTION 3. That should the City and person submitting approved and accepted items wish to enter into a formal written agreement as a result of the acceptance, approval, and awarding of the proposals, the City Manager, or their designated representative, is hereby authorized to execute the written contract which shall be attached hereto; provided that the written contract is in accordance with the terms, conditions, specifications, standards, quantities, and specified sums contained in the Proposal and related documents herein approved and accepted. SECTION 4. The City Council of the City of Denton hereby expressly delegates the authority to take any actions that may be required or permitted to be performed by the City of Denton under this ordinance to the City Manager of the City of Denton, or their designee. SECTION 5. By the acceptance and approval of the above enumerated bids, the City Council hereby authorizes the expenditure of funds therefor in the amount and in accordance with the approved bids. SECTION 6. This ordinance shall become effective immediately upon its passage and approval. „„ndJhb',"“it! %pST.“:J'h:= ''di"-"'' "”= TIlldi,e,'=d,':=#?,),„„,,db,T: following vote U - A : Aye Nay Abstain Absent Mayor Gerard Hudspeth:,/ y IZ Z b/ L/ / Vicki Byrd, District 1 : Brian Beck, District 2 : Paul Meltzer, District 3 : Joe Holland, District 4: Brandon Chase McGee, At Large Place 5 : Jill Jester, At Large Place 6: PASSED AND APPROVED thi, th, Ilt" d,y ,f Ser +t-.U/, 2024. GERARD HUDSPETH, MAYOR ATTEST: LAUREN THODEN, CITY SECRETARY Will reI B Y : APPROVED AS TO LEGAL FORM: MACK REINWAND, CITY ATTORNEY BY:IEaboc@aLL£PDP& Docusign Envelope ID: ACAEC6EE-63CA4F3B-BA7C-3AA036880961 DENTON Docusign City Council Transmittal Coversheet 8577RFP FileName B=:!};iIM ESH::5 & c 1 Purchasing Contact GInnY Brummett City Council Target Date SEPTEMBER 17’ 2024 Piggy Back Option SEPTEMBERContract Expiration Ordinance Adml nlstrators/Pharmacya1 ms 17 ,2029 NO ChI -103 ) ££S8 # }OB4uO) SI AlID 'apoD }uatuuraAOf) sexal aq) JO I//.ZZ ia)dell) q IF/n aou€piooo€ ur lull sa8pajA\ouIOZ lolaerIUO) salueduro) £Br3ua UIepa) Eu IDol,Cos salueduroD rl JIM s+3er)uo) uo uo FIlqIHold 'qoeaJq lejJajUU e paraplsu03 aq ITjA uorsrAord sup iapun s]uaruannbaJ aq) U18}urBur io )aaur ol aJnlrey tuawaarBD atl) jo lula I all 1 8uynp laDrsI n034oq lou 111 at (z) pIm 1laDasI Hoodoq lou saop (1) :ropDxjuo) loRI dJ!) aHI ol UOPD3dlaa a ual)}IM saplaoxd axn}DUEls s,rol3vrluo) pq i say}Naa ao}3DijUO) '}uatuaarBo HIjl ButuB is ifa 'apoD }uaurw3Aor) sexal atp JO loo'808 uor)oas ur sttua} asotII o) paq}msr s8u}ueaur a1it a,'\eq IInis 6,£U€dUI03„ pIle G6laeisI nooKoq?7 gunn atII 'loer}uoo atp JO ULm) aq) guLmp la2isl uooKoq lou IIIM (z) pUB 1laeisI uooKoq lou saop (1) :1} }eq) Kurdtuoo atp trio g uor}€oyua,'\ ualjUM e sule]uoo )oerlu03 atp ssalun sao Thlas lo spoo8 roJ Ku€druoo v tIlj& IOBrjUOO z olur 8uu3}ua tuo4 patrqn{old ST &!) 'apoD }uatuuIaAOf) sexal aq) JO IZ.ZZ ia)dell) qI IM a3uepioo08 UT IZtli sa8pajMOUXoe ro]3ei}uoD laersI 8uFUoa£o8 salueduro) q+rw s)aBI luo) uo uop Iqlgold c6'sluaurnoo(J }3er)uoO„ se £laAp9aljOO ol pauajar aq lleqs sluaum30p asatiJa 'aAoqr pals IT aJe KaRI gOjqM u! iapro atp UT s}Tqlqxa aq) o+ Iraq) +uauIaai8r as8q atp o+ +sly aouapaoaJd guTAT8 Aq paAjOsai aq IIens }o}IJuoo ro £3ua}srsuoour aq) 'sluaum30p }oer}uoD aq) JO SUO}S}AOJd aq) JO £ue UT P}IJuoo JO £ouatsTsu03uT ug JO }uaAa aq) ul 'lle Aq ioJ pall80 Jl se BuTpuTq s€ aq IIens auo Aq JOJ palleo s} }FIjM pIle Ion)troD aq) dn aJretu sluaum30p asar{JJ SasuodsaJ s,paljun 8urpnlour (+ua8v SIrlseq3ind aq) JO a3UJO aq) )B alld uo „d„ )!qlqxU.) ££98 dIn s,uo)UKI JO Ajl,) S(11l11 ]!qlqXa) aJTeuuoT}sanj') +saJa}ul JO }3lIJUOD – i)ID UUOJ :(I1(III )!qIqXa) SUOI}IPUO) pUB SUUaI JO}OBJ+UOO („)„ Hq IIIxa) s+uaruannbau. uor}€suadUIOD ,sra]rorw pUF s}uauraimbaH aouernsuI :(„8„ )!qIqxa) suo!)TPuoD pIle suual prepue iS no Iua(.I JO KIIO S(„V„ ]!qlqxa.) suo!+}PuoD pIle suuaJJ leIoadS ()) (a) (P) (3) (q) (e) :a3uaiajar Aq UTaJay pa]eJOctr03ul pu€ o+aiaq paIjOR IIe aJe HoltIM sura II 8urMOljOJ aq) pIle +uauIaaJ8e ual)}IM STIjl JO s;s}suoo }ornuoD aHI 'sasodIInd 118 roJ UIang pa+=ioclr03u} pue }ua8v 8ursFqund JO aoyJO arp Ie alg IIO SI HoltIM JO £doo e '3Ba37\TJ ) mcMun–dTIR }uamnoop scA)to atp IIIIM a3uepi039e ul saoi/nas ro/pIle s}3npoid apIAord IIens ro}oe4uoo saDIAHas JO adODS :s/holly se aai8e saIlred atl) '£qaraq paujR+qo aq ol s}yauaq len+nuI aq) roJ pu€ 'u}aiaq pau}€}uoo s}uauIaai8e pu€ s}uuuaAOO atp JO uo}+£rap}suoo ur pu€ rod 'aau8}sap paz blog+ne £lnp SIg JO ra8eue IN All) uo+uaCI aq) Aq }oe4uoD snp JO uor}n3axa }uanbasqns pu8 IrounoD KIjo IIO)ua(I atp JO IZAOJdde uodn „'Ajl)„ se o+ panajai raVru}araq 'uoprrochoo ledlo}unur alnr auror{ e 'svxaJ. 'NOJJNa(i dO AllO atp pur llcJO+3PJ+UODll se 03 paHajaJ JaUeu}aJatI ' IT Sl ssaJppB asoq/w 'uopuo doo e]osauu}W r IUF=MV®® W uaa,WIaq pue Aq (c6a)eCI aAqoaJJa„ aHI) -97az-TCnaUtT aiep sly) o IUI para)ua pIle apeur sr JJ)VHJ.NO) SIH JJ (££S8 rovurN03) DNI 'saDIAxas TUV)H11VaH aaIINn al(v svxal 'NOINaa dO All) Naa7Kla8 aNY Ag 1)VUINO) L960g99£ow€-ozvg-a€JFvo€9-=3903vov :al adOjOAu3 u61snooa Docusign Envelope ID: ACAEC6EE-63CA-+F3B-BA7C-3AA036880961 prohibited from entering into a contract with a company for goods or services unless the contract contains written verification from the company that it ( 1 ) does not boycott energy companies; and (2) will not boycott energy companies during the term of the contract. The terms “boycott energy company” and “company shall have the meanings ascribed to those terms in Section 809.001 of the Texas Government Code. By signing this agreement, Contractor certifies that Contractor’s signature provides written veripcation to the City that Contractor: (1) does not boycott energy companies; and (2) will not boycott energy companies during the term of the agreement Failure to meet or maintain the requirements under this provision will be considered a material breach. Prohibition on Contracts with Companies Boycotting Certain Firearm Entities and Firearm Trade Associations Contractor acknowledges that in accordance with Chapter 2274 of the Texas Government Code, City is prohibited from entering into a contract with a company for goods or services unless the contract contains written verification from the company that it ( 1) does not have a practice, policy, guidance, or directive that discriminates against a firearm entity or firearm trade association; and (2) will not discriminate during the term of the contract against a firearm entity or firearm trade association. The terms “discriminate against a firearm entity or firearm trade association,” “firearm entity” and “firearm trade association” shall have the meanings ascribed to those terms in Chapter 2274 of the Texas Government Code. By signing this agreement, Contractor certiDes that Contractor’s signatute provides written yeti$cation to the City that Contractor: (1) does not have a practice, policy, guidance, or directive that discriminates against a fIrearm entity or fIrearm trade association; and (2) will not discriminate during the term of the contract against a fIrearm entity or frrearm trade association. Failure to meet or maintain the requirements under this provision will be considered a material breach. Prohibition on Contracts with Companies Doing Business with Iran, Sudan, or a Foreign Terrorist Organization Sections 2252 and 2270 of the Texas Government Code restricts CITY from contracting with companies that do business with Iran, Sudan, or a foreign terrorist organization. By signing this agreement, Contractor cenifies that Contractor’s signature provides written verifcation to the City that Contractor, pursuant to Chapters 2252 and 2270, is not ineligible to enter into this agreement and will not become ineligible to receive payments under this agreement by doing business with Iran, Sudan, or a foreign terrorist organization . Failure to meet or maintain the requirements under this provision will be considered a material breach. Termination Right for Contracts with Companies Doing Business with Certain Foreign-Owned Companies The City of Denton may terminate this Contract immediately without any further liability if the City of Denton determines, in its sole judgment, that this Contract meets the requirements under Chapter 2274, and Contractor is, or will be in the future, (i) owned by or the majority of stock or other ownership interest of the company is held or controlled by individuals who are citizens of China, Iran, North Korea, Russia, or other designated country (ii) directly controlled by the Government of China, Iran, North Korea, Russia, or other designated country, or (iii) is headquartered in China, Iran, North Korea, Russia, or other designated country The parties agree to transact business electronically. Any statutory requirements that certain terms be in writing will be satisfied using electronic documents and signing. Electronic signing of this document will be deemed an original for all legal purposes. Contract # 8577 ££S8 # )oeJ}uo) INaPVIUVdaa sa)Jnosau ueLurIH alIII JO 33aJ La UH aPWN aaINIHd yleauql PD ue6aw stELla) ssaulsnq pUB stroll£8}lqo IFUor]Frado pUF ler9ueuy ol sz aaAOXddv aNV aa7WaIATH HI08 Naag SVH iNHPVaTHDV SIHI uagPVfIN alVDIJIluaD S6Z I NOISSIPVPVOD SDIHIa svxal AaMHOllv AllO 'aNV7WNITU HDVW :WdOJ lv9al OI SV aaAouddv OZS611-tZOZ ssTHa(rv IIVyVU u03 - 3ynOseLunp–J aJ Fuua F xag}vfLN aNOHd AUVIaE Das AllO 'NaaoHI NTUnVI:lsallv 99Z9–ZS6–£9Z Ja6eue1/u t3ei luo) LeuoF6au 'apTI sauna JaJ}uua[ 'auIBN papIPd xa9vNVW XIID 'AHISN8H,Ml I :*’ Hq pauDlsnooa svxal 'NOINaa dO AIID THfIIVNDIS HOI)VUINO) 'ua}}}iM aAoqF +sly Aup pu£ rga£ aq) ul +uauIaar8e sup pa+n3axa aAeq s}uasaid asaHI JO salpFd aq) 'do IHaHA\ ssaN]JiA\ NI L960g99£OW£-OZV8-8€JFVO€9-33903VOV :al OdOjOAU3 u61sn90a Docusign Envelope ID: ACAEC6EE-63CAdtF3B-BA7C-3AA036880961 Exhibit A Special Terms and Conditions 1. Total Contract Amount The contract total for services shall not exceed $4,787,000 Pricing shall be per Attachment D, Attachment D-5 – Fees. 2. Contract Terms This contract shall be effective for three (3) years from the Effective Date (“Initial Term“). City and the Contractor shall have the option to renew this contract for an additional two (2) one-year periods. Each service period under this contract will begin January 1 st and end December 3 1 st. The Contract shall commence on the Effective Date and shall automatically renew each year, from the Effective Date. At the sole option of the City of Denton, the Contract may be further extended as needed, not to exceed a total of six (6) months. 3. Price Escalation and De-escalation Contractor may change the fees on the latter of the expiration of: • A Renewal Term, or • Any applicable multi-year fee term as set forth in Attachment D-5 - Fees. Contractor will provide City with 30 days prior written notice of the revised Fees for each Renewal Term, and such Fees will be effective the first day of such Renewal Term. Contractor will provide City with a new Attachment D-5 – Fees that will replace the existing Attachment D-5 – Fees. Contractor may also change the Fees: •any time there are changes made to this Agreement or the Plan which affect the Fees, • any time there are changes in Law which affect the Services Contractor is providing, or will be required to provide, under this Agreement, • if the number of Employees covered by the Plan or any Plan option changes (i) by 10% or more, or (ii) the enrollment band, or • (4)if the total number of enrolled Participants divided by the total number of enrolled Employees (“Average Contract Size”), varies by 10% or more from the assumed average contract srze. Any new Fee will be effective as of the date the change is applicable, even if that date is retroactive. If City does not agree to any change in Fees, City may terminate this Agreement after City receives written notice of the new Fees. City must still pay any amounts due for the periods during which the Agreement is in effect. 4. The City of Denton will interview and select the assigned account management teams dedicated to service the medical and pharmacy accounts from United Healthcare and Optum Rx’s recommended service teams. Contract # 8577 ££98 # )OBJIuo) UOI}IPUOO qIIpaq oyroads IraqI 8ulwaouoo }u€d}o}pedrelno}Ned e o) }uas aiF )etp suo}+go}untutuoo pnp}AjpIll apnlou} lou saop suIJJ 'sJaqurauI iTaq) o) uo}]nqp lsTP o) JObrd suo}leolunwtuoo aAOJdde pu€ /hajAar IIIM uo]uac1 JO Ajl) 's+uauras}uaAp€ 10 'sao} lou 's8u}l}etu }ued loINed ssetu Kue gulpn louT 'saa£oIdtua IraqI o+ paprAord suopeo}tmunu03 lle IIO j€Aoidd€aJd sai}nbar uo+ua(J JO KIlo aHI 's L960g99€OW€-OZV8-8€JhVO€9-33903V9V :al OdOjOAU3 u61sn90a Docusign Envelope ID: ACAEC6EE-63CA-4F3B-BA7C-3AA036880961 Exhibit B City of Denton Standard Purchase Terms and Conditions These standard Terms and Conditions are applicable to contracts/purchase orders issued by the City of Denton hereinafter referred to as the City or Buyer and the Seller or respondent herein after referred to as Contractor or Supplier. Any deviations must be in writing and signed by a representative of the City’s Procurement Department and the Supplier. No Terms and Conditions contained in the seller’s proposal response, invoice or statement shall serve to modify the terms set forth herein. If there is a conflict between the provisions on the face of the Contract/purchase order these written provisions will take precedence. The Contractor agrees that the contract shall be governed by the following terms and conditions, unless exceptions are duly noted and fully negotiated. 1. CONTRACTOR’S OBLIGATIONS. The Contractor shall fully and timely provide all services/deliverables described in this Contract and the Solicitation in the Contractor’s Offer in strict accordance with the terms, covenants, and conditions of the Contract and all applicable Federal, State, and local laws, rules, and regulations. 2. EFFECTIVE DATE/TERM. This Contract shall be effective as of the Effective Date (date service begins) and shall continue in effect until the is terminated pursuant to the terms herein. 3. INTENTIONALLY DELETED 4. WORKFORCE A. The Contractor shall employ only orderly and competent workers, skilled in the performance of the services which they will perform under the Contract. B. The Contractor, its employees, subcontractors, and subcontractor’s employees may not while engaged in participating or responding to a solicitation or while in the course and scope of delivering goods or services under a City contract or on the City's property. i. use or possess a firearm, including a concealed handgun that is licensed under state law, except as required by the terms of the contract; or ii. use or possess alcoholic or other intoxicating beverages, illegal drugs or controlled substances, nor may such workers be intoxicated, or under the influence of alcohol or drugs, on the job. C. If the City or the City’s representative notifies the Contractor that any worker is incompetent, disorderly or disobedient, has knowingly or repeatedly violated safety regulations, has possessed any firearms, or has possessed or was under the influence of alcohol or drugs on the job, the Contractor shall immediately remove such worker from Contract services, and may not employ such worker again on Contract services without the City's prior written consent. Immigration: The Contractor represents and warrants that it shall comply with the requirements Contract # 8577 LLS8 # )on+ilo) pIamssassE S,JO)OPJ+UOD UO pasBq Sl 1)OFlad aoBJr) alIJJ 'SIunOUIB asaHI }3alt03 Ol SJn3ui JO+OBJIUO) let{} s)soo £u€ JOJ ro}or4uo) asrnquI Ial 1181is All) '(„aleU )solo luI„) saad – g-CI +uaun{oeBV UT guy )as aler }sara luT atp lz s}unouie asatl+ uo tsaia luT Jo}oer}uo) Xed IInn Ajl) '(GCpouad aoeJr)„) ale(I an(I ITallI rayF S£8p OE U TIP TM PIed IOU ar€ pa/no s}unoui€ Jl ')uaur£ed O)Za 'a}ucl an(I alq€orlddF arp Aq aaa all) JO p£d paIndslpun aq) Aed IIIM All) '}3an03u} sun Itlq s,lo lorI+uo) )ualxa aq) o) passassz aq 11+rw lsara luT ON 'sa}ouudai9s TP aaa Kuv aA[osar o) HIjq poo8 UT io]oRr}uoD ql1,w paul o) saar8u All) 'ro}oe4uoD OIIou Ajldword III,w & ID 'ro}3er}uoD anp aa I £ue sa}ndsrp KIIO JI •salnds1(1 aaa :INa}vAVd '£ +sanbaJ uodn a+€3u}yao uor]dUIaxa XF) v qsuuru III,u K)to aHI )urIOUR paojOAUI alp ul paprljouT aq )OU )snlii saxB+ sales KW) JO csaxB} ale IS 'saxe) as Taxa IBJapaJ 'a3}oAUI S,JO+OBqUOD alp UO payloads ssaJppe a9ue}}}maJ all) uo £lai Kew All) atp 'BuT in/n ur palonDsur asl,may lo ssalun '£FD all) in IM uo TIeris TSar s,JopuaA atp UT uoT+£uuoju} aHl qol8tu £l}08xa +sntu a3jOAu! aHI uo raqurnu uo!}=3y}luapT x€} aq) 'alqgolldd2 JT 'pu€ ssaJppe a3ugnTurar 'aurgu sGro)oe4uoD aHI -a3roAur aq) o) patIoe IIe aq lleqs 'aIqeo}ldde ualIM 'lITq£e/w )qB Tag atp pug SIrlpeT JO lITq arp JO Kdoo v -Kla}eredas palsTI aq news '£ur JT 'sa8rrq3 uo}}epodSUFr+ pIle pazTura}} aq Il€qs sa3roAUI ')uaur+reda(I aq) roJ +3e)u03 JO }ulod all) JO ourBU aq) pug 'aru€N- s,}uour)ieda(I all) 'oIqz3lldd8 Jl raqurnu )uauraarBe ra+suuI aq) pug 'iaqurnu a3jOAUl anblun B apnl3u! )silla sa3jOAUI radord 'g '(IIInom-pIur 'q+UOUI atp JO Iep is 1 ''8'a) sarlddr aaJ aHI you{m o) q}uou aq) iOJ poq+auI UD!)word plos alp go paseq painseauI aq TIgrIS +uaurljOIua £!q}UOUI 'llrq-Jlas ol pa}oala srq AIT) JI 'iawo IsrI) Aq pap I/told }uaullorua KIlj+uoru 8ursn pa}eiaua8 are saoIOAUI '(6Ga lga an(.I„) q}UOUI iepualeo }xau aq) JO AFP )sly aljI no ST s+unourr paoTOAu} aq) JO +uaurK8d roJ app HIP alIJJ 'tPUOtII tIaRa JO ISIg atp JO a31iB APE UT aolaAU I auTl-HO up }Tuqrls IIFtis JO+OBJ+UOD altI 'V :saDioANI -9 '('bas Ja IgZt§ ')'s'n EE) cpapuauIe SB c+oV IonuoD uo!}nllod JaIBA TeJapaJ arp pIle Cbas Ja IOP£§ ')'s'n Z}) IOV iTV ueaID aHl JO sa+epu8ur aHI ol }uensind panssr suor}8lnSaJ lo 'sJapio 'spi€pue is aIqe3}ldde Tlr qITM £ldUI09 Il€qs Ja}lddns :uo IDa)Old le}uouruor IAU'a 'qderg€red slq+ rapun suopr811qo s,io}3eI}uoD arp JO qo€arq atp UIorJ guTS liu puN Alam JO £)11}q€ 11 pu2 sapleuad 'sauy 's)uauI8pnf 'suopoe 's)Tns 'spueuIap 'suITrIO 118 Isu legg pIle UIO4 ssajULrer{ KIT) atp p[OIl pur ©}utuapu I IIFtis lojorr}uoD atII 'uraAo8 news +uamarTnbai K]aj€s }ua8ujJis )soul allI '}oluuoo JO asr3 UI '(VHSO) uop€4sTulmpV qljeaH pue £}ajeS leuopednoo(.) all) Aq puu KIjo aq) Aq pa}e81ntuoJd asor{} ol pa)null lou +nq 8urpnlour 'saormas aq) JO a3ueuuojrad al{} ul suoprln8ai pIle salru 'sa3u€ulpro 's/heI lr+uaumoi}Aua pu8 'K+ajes 'qIteari Ie30l pUF 'aIr is 'j€JapaJ alq80lldde lte q JIM Klduroo llrqs 'ro}oeiluo) alII :SNOiJ.vln')'ax wiNg}vNOHiANa alw 'AladVS 'H11vaH HUM a)NVIld}gOD 'S '9661 'oc iaqura+das no pa}oeua (VUIU.ii„) 966 1 JO )ov ,qrlrqrsuodsau. +uer8runuI pIle uuojaU uo}+Fr81tutul Te8alII aq) pIle }3F4UOD aq) rapun saolmas lo JOqFl Kue uuojrad III/w OHm '9861 '9 raqwaAON iaUe IO rio puTq sl€npjATpuT £ue roJ suuoJ uo}}eaU}IaA JO uor)ua)m pIle uo}+€oupaA }uaurKoldtua 8ulpre8ar 066 1 pIn 9861 JO DV Ior}uoD pIle uuojaU uor+er8uutul atp JO L960g99eow€-ozv8-8€]Fvo£9-33903vov :al adOjaAu3 u61snooa Docusign Envelope ID: ACAEC6EE-63CA-4F3B-BA7C-3AA036880961 of Customer’s financial condition. If Contractor reasonably determines that Customer’s financial condition has deteriorated, or City fails to comply with the funding and financial obligations specified in this Agreement, Contractor may: (a) remove the Grace Period upon notice to Customer, and (b) either charge interest on payments not received after the Due Date or terminate the Agreement if payments are not received by the Due Date. A. If payment is not timely made, (per the above); interest shall accrue on the unpaid balance at the lesser of the rate specified in Texas Government Code Section 2251.025 or the maximum lawful rate; except, if payment is not timely made for a reason for which the City may withhold payment hereunder, interest shall not accrue until ten (10) calendar days after the grounds for withholding payment have been resolved. B. Payment will be made by check unless the parties mutually agree to payment by credit card or electronic transfer of funds. C. The awarding or continuation of this contract is dependent upon the availability of funding. The City’s payment obligations are payable only and solely from funds Appropriated and available for this contract. The absence of Appropriated or other lawfully available funds shall constitute grounds for termination to the extent funds are not Appropriated or available. The City shall provide the Contractor written notice of the failure of the City to make an adequate Appropriation for any fiscal year to pay the amounts due under the Contract, or the reduction of any Appropriation to an amount insufficient to permit the City to pay its obligations under the Contract. In the event of none or inadequate appropriation of funds, there will be no penalty nor removal fees charged to the City 8-14. INTENTIONALLY DELETED 15. FINAL PAYMENT AND CLOSE-OUT: A. If a DBE/MBE/WBE Program Plan is agreed to and the Contractor has identified Subcontractors, the Contractor is required to submit a Contract Close-Out MBE/WBE Compliance Report to the Purchasing Manager no later than the 15th calendar day after completion of all work under the contract. Final payment, retainage, or both may be withheld if the Contractor is not in compliance with the requirements as accepted by the City. 16. INTENTIONALLY DELETED 17. RIGHT TO AUDIT: A. On each calendar year during the term of the Contract or any applicable runout period, the City, or a mutually agreeable entity on Customer’s behalf, shall have the right to conduct a medical claims audit for the purposes of determining if Contractor is administering its claims transactional Services in accordance with Plan provisions. Prior to the commencement of this audit, a signed, mutually agreeable confidentiality agreement with Contractor is required. The Contractor shall retain such books, records, documents and other evidence pertaining to the Contract for period of time as required by law. Further, the Contractor shall also require all Subcontractors, material Contract # 8577 LL$8 # pBJ)uoD payloads aint) aq) UTqITM aaA IS ST a9uzJnsse ou Ierp )ua Aa aq) UI 'uuoJJad OI )ua)ul arp JO aouernsse ualIUM roJ AIred ray lo aq) o) apeuI aq Keur pueuIap 'uuojrad OI )ua luI s,AIred raIjlo arp uopsanb o) uosFaJ seq guy poo8 ur }oer}uoD atp o) £ued auo iaAauaqlw :a3NVHnssv OJ. J.Hr)IH ' tz aalalaa lwNoiINaINI -EZ -SUOI)rln8ar ro salm 's/weT leool pw a+z iS 'l8rapa J a[q€orldde lle pug '}oer}uoD arp JO s}ueuaAOO pue 'suoplpuoo 'suua] all) 'tIll/w a9ueproooe ul pue sa3ue}sum3r}a reITur TS Japun asn plno/w sianrur Hons in TM reTTlu12J pug £]!oedr3 aaH e ur Bultor £rer3npy/ro}8r}sru}urpz surlel3 }uaprud e )erp 8u![!eAard uali) saouR]surnoJ TO all) rapun a3ua8rlrp puc aouaprud 'TIP{s 'aieo arp 8uTsn paunojnd aq 11 TM )aerluo) arp iaptm ApD atp papTAOJd aq ol saor,was Tlr +zq} stuasardar pw s}uene,w io+3€4uo) alIJJ :sa)]AHas – AINVWVA& 'ZZ aalalaa AiwNoiiNaiNI 'I Z -salqeiaArlap arp o) srmel3 ajI II asIa/\pr IIe lsu lege pu8 uro# ssaluu€q KIIO aq) ploy pIle q}utnapu} news iO+OFJ+UO9 aIn 'saou8Jqumoua pIle SIsara lu! £+jJn3as 'StIljFjO 'suall IIB JO Jeal3 puB aaJJ ale salqeJaA}lap all) )etp puB 6}oeJ}uoD aq) lap IIn parIsjtHrU salqeJaA}lap IIe o) apr) alqrseajapur pue poo8 s€t{ 1} }etp s]ueue/w iOjOFi}UOD aHI :811.It – AJJNVUHVAA 'OZ aalalaa AITVNOiiNaINI '6 1 '/nut Aq pannbaJ aq asrRratjlo Ketu se 3daoxa ro+oFr+uooqns Hons £uz anp s£auotu Kue JO +uaurK€d all I o) aas o) lo Aed ol KIIO all) JO Hed all) IIO uo}}e8}lqo £ue algala IT TIeris lou 'ro}3e4uooqns Hons £ue pur XII) arp uaa4tIaq dlqsuo}}elaJ l8n}oei}uoo £ue io}oer}uooqns IIons Aug JO )yauaq aq) roJ a+zara Ipris ]3e4uoD aq) UT BuTyloN 'SUOjSS}UIO pue sloe UMO s,JO}384UOD aHl roJ a[qlsuodsar ST iO}ORqUOD aq) s8 +snf sro+oei}uooqnS arp JO SUOjSSjUIO pur s+38 ITV JOJ XII) aq) o) alqjSUOdsaJ KIlrU aq 1181is lo}3eJ}uoD aHI 'ro]oe4uoD aq) JOJ payloads s}unour€ pIn adA) aq) u! aouernsu! '}oequ03 naH) JO una+ aq) +noq8norq+ 'uTe+uleuI pUF UTe+qo SJo}3eJ+uooqnS Tl€ +8111 UTnbar 'TT :}o€r}uoD aq) JO suua} pue suopeoy Toads 'suo}sTAoid aHl qIpw aoueprooog ul paprAoid aq io low+u03qns aq) Aq papjAOJd aq o) salq8ia Allap IIe tellI aJjnbaJ 'I :+eq) suorsr AOJd ure}uoo IIUis pue '+084uoD aq 1 JO suua I alj] HIIM lorIJuoo lou Arm }oer}uooqns atp JO sulla+ aHI 'ro}o€r+uooqnS pue io}oei+uoD aq) uaa nlaq }3€r}uoo ualjuM e o) }uensind aq TFtis ro+oe4u03qns e Aq ro}oerluo) aq) roJ pauuojrad )FolK 'v :SHOI)VUINO)8flS -81 ']uatun90p pa lurId leuy r arFdard ro a}gJauaB o) pasn £l+uanbasqns are saly o}uon3ala io SUmp ljons JI uaAa 'saly oluor+oala pue SUrrp apnl3u! o) paTu}suoo aq lleqs 'aAoqe pasn SB '6Gaouap IAa Jay lo„ pUB „s}uauInoop„ '„spJOoaJ„ '„s}looq„ suLla) aHI JO Hoe]- ]oaiaql uo}puTuna) roJ spunor8 'uolprosTP alos stAllO atp u! 'alnl}lsu03 lleqs pug ]981luo) aq) JO q38arq leFn)etu e aq IIFtis rio IIoas STIll JO suo}s}Aord aq) in IM KldUIOO OI unITgd '8 A3 TO aljI Aq atuoq aq III/w +!pnu arp JO ]soo arE 'K}}) atp JO snlprI aT}ul-OS e UTqI}/w alqgl}2Ae apetu aq 11}/u spJOoaJ pUB s]ooq IIV 's}uaumoop asoljl o) ssa33e JPI TUI is AITO aq) /KatIe 01 pUB '}oeBuo) all I 01 8ururz Ind aouaprAa raIl lo pIn s}uaumoop 'sprooai 's]ooq lle u TrIal ol saa£ed JaIlio pUR 'srallddns L960889£OW€-OZV8-8€JFVO£9-33903VOV :at odoIOAU I u61snooa Docusign Envelope ID: ACAEC6EE-63CA-4F3B-BA7C-3AA036880961 after demand is made, the demanding party may terminate this Contract with thirty (30) days WIItten notIce. . 25. INTENTIONALLY DELETED 26. DEFAULT: The Contractor shall be in default under the Contract if the Contractor (a) fails to fully, timely and faithfully perform any of its material obligations under the Contract, (b) fails to provide adequate assurance of performance under Paragraph 24, (c) becomes insolvent or seeks relief under the bankruptcy laws of the United States or (d) makes a material misrepresentation in Contractor’s Offer, or in any report or deliverable required to be submitted by the Contractor to the City 27. TERMINATION FOR CAUSE: in the event of a default by the Contractor, the City shall have the right to terminate the Contract for cause, by written notice effective thirty (30) calendar days, unless otherwise specified, after the date of such notice, unless the Contractor, within such thirty (30) day period, cures such default, or provides evidence sufficient to prove to the City’s reasonable satisfaction that such default does not, in fact, exist. In addition to any other remedy available under law or in equity, the City shall be entitled to recover all actual damages, costs, losses and expenses, incurred by the City as a result of the Contractor’s default, including, without limitation, cost of cover, reasonable attorneys’ fees, court costs, and prejudgment and post- judgment interest at the maximum lawful rate as outlined in Section 15, Indemnification. Additionally, in the event of a default by the Contractor, the City may remove the Contractor from the City’s vendor list for three (3) years and any Offer submitted by the Contractor may be disqualified for up to three (3) years. All rights and remedies under the Contract are cumulative and are not exclusive of any other right or remedy provided by law. 28. TERMINATION WITHOUT CAUSE: Either party shall have the right to terminate the Contract, in whole or in part, without cause any time upon thirty ( 120) calendar days ’ prior written notice following the Initial Term. This Contract may also terminate under the following circumstances: ( 1) The Plan terminates, (2) Both Parties agree in writing to terminate this Agreement, (4) Contractor gives City notice of termination because City did not pay the fees or other amounts City owed Contractor when due under the terms of this Agreement, (5) Contractor gives City notice of termination because City failed to provide the required funds for payment of benefits under the terms of this Agreement, (6) Either Party is in material breach of this Agreement, other than by non-payment or late payment of fees owed by City or the funding of Plan benefits, and does not correct the breach within 30 days after being notified in writing by the other Party, (7) Contractor gives City notice of termination in the event of a filing by or against the City of a petition for relief under the Federal Bankruptcy Code, or (8) As otherwise specified in this Agreement. Contract # 8577 L LgB # +3u)uoD aq ll£qs suQ}}ualor parnsu}-Jlas ro salqponpap IIV 'sa}orlod UI pale is '£ue Jr 'suor IIra laI parnsuT-Jlas pIle salq1}3npap 'sumTUIard JOJ alqTsuodsar aq ll8qs ro}oerluo) alIJ. 'n! ]OFi}UOD aq) UT par}nbaJ sz ro }ori}uoD aq) JO una+ aq) 8uurtp asdel ol aouuJnsu} Aug }Tuuad JOU paTa3w3 aq ol aoueinsu} £ue asnRO lou lleqs io+3Fr}uoD aHI 'nT +sanbar uodn XII) allI o) aou€rnsuI JO a+raUl Ira) € pJUwroJ osI€ }snui lojon+noD aHI '&T) arp UOiJ }sanbai ual) Fun raUr sKzp JepuajF3 ( Pl) uaajInoJ unDm par uo}}noaxa }32r}uoo OI robId a8eiaAOO JO uo}+€oy bIa A se KIT) aq) o) pannbaJ s}uauIasJopua pIle s,a8eiaA03 aq1 qlyu a9uzJnsuI JO saIgoUTpaD apl/\old IIeqs io}9er}troD anI -IT pouad £}uerreM Aug Su}mp pur 'gpo brad la/to ploy pIle suo IIdo Ilo}stm)xa 8uTpnlou} ' Iaer)troD atp JO uo}}vrnp aq) roJ 's+uauIai}nbau uo}+FSuadUIOD 6sraaroAA pIle s+uauIar}nbau. aouernsuI – ) +rqrqxg ul paleolpuT s)unorne pIle sad& aq} ul aoueJnsu} Ku€o umuI}ujUI e )e TIeris loj981)noD anI ' I :s}uauIannbaU lerauar) 'V AITD aW o) alqqda30F s+rmoure umtuTUTUI atp UT pug sad& aq) JO aouernsuT ulquFU pIle amooJd TIeris io+3er}uo) :a)NIVHnSNI 'Z£ saaJ pue sasuadxa und raylo JO s+yauaq u€1d JO +uauIKed a+n+4su03 }£r{} sasuadxa io 's}uatu8pnF'sa8FmFP 's)soo 'sauD 'sapl£uad 'sapIITqe IT 'sassol 'suITelo Kue roJ uvld aq) lo KIT) £J}utuapu} lou saop ro}oeJ]uoD pue s]yauaq lle JO }uaur£gd JOJ alqrsuodsaJ surRuiar KIIO '}uauIaar8v sly) Japun gaoj&las uuojiad OI saItwd png) q+IM olur SJa}ua Jo+3ei}troD s}uauIaar8e £uz JO &led pITy) € Aq qo€aiq e (p) pIle :+uauaar8v STIjl JO qouaJq scJo}3rJ}noD (!) :8ujMOljOJ aq) JO q+oq JO auo JO )no 8uTs}i€ }ualxa anl ol 's)soo pu€ saaJ ,s£auronr alqFUOSFai SIr}pnjOu} 'srnou} AITO sasuadxa pu£ 's+uaur8pnF 'sa8eurep 'sls03 'sauy 'sa}}T€uad 'sarUjrq2H 'sassoT 'suITelo IIe pu8 Auc JOJ KW) 4lutuapu} TIeris JO}O€i luo) 'rauro)snD JO uo!+e3UluuropuI uo}}n+TlsuoD sexaJ_ alj! JO L 110lpaS 'IX atojjIV puB 'apoD salpatuaU. pUF ao!+o€id ITAIO sexal aq) JO IOT ia+d€qD '£+}unuIurI u8TaJaAOS 8u}pnlouT 'SM€1 pue salru IgJapq pIle a+ets 'leool aTqeo}ldde Kue JO Ja APM £ a+n+psu03 lou op qderg€wd SjIP JO suo}s}Aord anl iO+UJ+SFU}UIp€ SUIT8l3 aq+ s€ ro+ozi+uoD isu lege }q8noiq stuTUT3 pIle u€1d atp JO uor+Fiado pIle u8rsap s,nuro+snD (I1) pIle :+uauraar8V SKI) JO q3eaJq s,iauIo+snD (1) :8U}MOIjOJ aHl JO aroui JO allo JO )no guTsjJe )ualxa aq) ol 'sIsoo pue saaJ ,s£auIone alq€uosgai 8u}pnIouT 'srn3u} iO}O€J}UOD sasuadxa pur 's]uaur8pnF 'sa8ewep 's+soo 'sauD 'sa!}l8uad 'sa}}}llqe Tt 'sassol 'suITelo IIe pue £ue ioJ io}oFr}uo3 £J}utuapul lleqs ApD 'Mel sexal Aq paMOlle IIra)xa arp ol 'io+3er)uoO JO uo!)eaUIuuIapuI :AliNlvaaNI 'I [ 0813130 A11vNoiINaINI 'O£ 'uo} Ioe legal ul }tnsar £FtU pu€ AH) all) Aq asngo roJ )3e4uoD arp JO uo}}€u Tuna) aq) iOJ spunoJg aq lluqs ApD aq) o) JOHn luo) aHI Aq pauluqns aq ol paJTnbaJ podaJ AuF ul io)oer}uoD aq) Aq s}uauia Ie is ]ualnpn€rJ :anvHd '6z 'Joaiat{ suLla) aq) qIIM aou€proooe III 'pouad }no uni uodn paar8e Aug Su}mp pue uo}+8u Tuna) JO a Iep aq) o) JObId parm9uT suo}}e8}lqo pIle pauuojrad sao}hias IIZ roJ 'sasodmd ljons roJ a[qel}rAg £llr8al asImay lo lo pa}epdorddv spuq JO )ua)xa all I o) 'io}oe4uoD arp Xed tIeris All) aVI 'suopdaoxa mourn Hons tIljM '+3er}uoD alp ol +uensmd NOM raIIHIV Tlr as€ao £l+dUIord Ileqs io}oe4uoD aq) 'uop€u luna) JO aol lou F JO +draoar uodn L960899€ow£-ozv8-8€JFvoe9-33933vov :al odOjaAU I u61sn30a Docusign Envelope ID: ACAEC6EE-63CAJ+F3B-BA7C-3AA036880961 disclosed on the Certificate of Insurance iv. The Contractor shall endeavor to provide the City thirty (30) calendar days’ written notice of erosion of the aggregate limits below occurrence limits for all applicable coverage’s indicated within the Contract. 33. INTENTIONALLY DELETED 34. NOTICES: Unless otherwise specified, all notices, requests, or other communications required or appropriate to be given under the Contract shall be in writing and shall be deemed delivered three (3) business days after postmarked if sent by U.S. Postal Service Certified or Registered Mail, Return Receipt Requested. Notices delivered by other means shall be deemed delivered upon receipt by the addressee. Routine communications may be made by first class mail, telefax, or other commercially accepted means. Notices to the Contractor shall be sent to the address specified in the Contractor’s Offer, or at such other address as a party may notify the other in writing. Notices to the City shall be addressed to the City at 901B Texas Street, Denton, Texas 76209 and marked to the attention of the Purchasing Manager. 35. RIGHTS TO BID, PROPOSAL AND CONTRACTUAL MATERIAL: All material submitted by the Contractor to the City shall become property of the City upon receipt. Any portions of such material claimed by the Contractor to be proprietary must be clearly marked as such. Determination of the public nature of the material is subject to the Texas Public Information Act, Chapter 552, and Texas Government Code. 36. INTENTIONALLY DELETED 37. CONFIDENTIALITY: Definition : Confidential Information: Information disclosed or made available by a Party in connection with this Agreement, including without limitation the following, regardless of form or the manner in which it is furnished: (a) pricing, discounts, reimbursement terms, payment methodologies and payment processes, compensation arrangements, and any similar commercial information, (b) data, information, statistics, trade secrets, and any information about business, costs, operations, techniques, know-how, or intellectual property. (c) inventions, employee information, trade secrets, confidential know-how, confidential business information, and other information which the City or its licensors consider confidential. Any material that is derived from or developed from Confidential Information will be deemed Confidential Information for purposes of this Agreement, regardless of the person creating, disclosing, or making available such material. Any Confidential Information included in preparations, proposals, scope documents, discussions, findings, summaries, reports, and conclusions remain Confidential Information. Confidential Information does not include: (a) information that is or becomes generally available to the public other than as a result of a disclosure by a receiving Party in violation of this Agreement or other agreement between the Parties, (b) information either obtained from a third party or already in a receiving Party’s possession before receipt from the other Party, if the receiving Party can demonstrate such information was lawfully obtained and not subject to another obligation of confidentiality, and (c) information independently developed without reference to Confidential Contract # 8577 L LgB # )onIuo) 'uoP€uuojul l€}}uapyuo) aq) JO K}}le}}uapyu09 panu!}uoo aq) arnsua ol saJnseatu alqeuosrar }s8al lg aq sa3ug}sumorFO IIZ Japan llrqs sarns8aui aAt)oaIold qoui/w 'uor+guuoju} alqenleA }soul uf'no SIr loa lord o) ssau}snq liMO SII ultIljM sasn io Ioe BUDD AIred leyI uetil }ua8ur4s ssal ou samseaui aATpajOld agn o) saar8e Kped qoea 'iapro aAT)oa lord a}eudordd€ ue ]aas o) arun alqeuos8ar AIred laylo aq) +}uuad o) sg os uo!}euuojuT ljons SuIsolos}P arojaq K}red Jaylo aq) saul lou £l)dUIord KInd 8u}sol3sTP aq) papTAord 'uoT+olpsTm[ radoid qpa K)}JOy)ne le}uaunuaAo8 laIHO lo )moo £ue JO rapio ur io /url Aq pasolos TP aq o) pai}nbaJ ST UO4FUUOJUI lrQuapyuo) allI ssaIun 'u}araq paz}log)ne asIaray lo ssaltm 'X TIed raIllo atp JO }uasuoo ualIUM JOUd atI I +noHIT a £+r€d ial{}o all) JO uo!+ruuojuI IF!+uapyuo) aHI agn as I&laylo JO 'a+eaJoai 'aBIn/\IP '£doo 'apu}uIass TP 'asoIosTP Iou IIFtis pUB aouapyu09 IOPis UT uoT+BuuojuI IBl}uapyuo9 alp UIB}UIBUI IIIM )} Pq) aarSF (saA}}e}uasaidaJ ro 's}ua8F 'srolo£4uooqns 'soaKoIdura slr 8urpnlour) saru£d all 'sJOSuaoTI SH ro/pUF Awed laylo aHl amFu! £lle!+uz)sqns £eui uopruuojul lg}+uapyuoo aq) JO asealar Iag)o lo 'uo!}gu}urass}p 'ainsolos ip 'asn pazlroq}neun Xu€ pue srosuaoII slr JO/pur AIred qo£a JO KHadord alqunl8A aq) ST uo!}guuojuI l€}}uapuuoo atl) ]2t{} saarg8 pue sa8pal,wou]or Kurd q08a 'aaJ R o) +3afqns uoT+euuoju} q3ns apTAoid 'uorlaJOsrp SIl ur 'KRur JotmrInoD IraqI 'par}dxa s=q pojlad )no urn aIq€311dde £u€ pIle sa+€uruua} +uaunar8v aq) rage uorssassod s,ro+oF4uoD UT ST leg I urld atl) }noqR uo}+euuojuT ap}Aord ro}ozx}troD Ierp s+sanbar KIIO JI 'parlnbar £IjF8al sl )etp uo}}€uuojul le!}uapuuoD aq I JO troTpod IRq3 £luo HSTwry ll8qs £Hud Hons 'pau}8)qo lou ST £pamaJ raqlo io rapro aAr+oa}oJd F JI +uaurar}nbar ro )sanbar ainsoIos}p +erp JO adoos arp MOU€U ro a8uall€rIO as I&raIl lo lo Kpaunr ray)o JO JapJO aATpajOld a}ejJdOJdde ue ]aas ot KInd Jaylo all) Aq SHOJJa Aug ur a}€rado03 KIq8uoseai Ipris KInd HonS '+uauarlnbar ro +sanbar leyI JO aol lou uaIHIM a+elpaurtur tijI/w ATred raIl lo aq) apTAoid (M€1 Aq pan}uuad IIla+xa aq) o)) IIrris Awed Hons 's toe sprooai OIjqnd 8uIpnjOUI 'Me1 io 'ssaooid legal '€uaodqns Aq uo}+€uuojuI lepuapyuo) asolos TP o) pairnbar ro pa+sanbaJ sl A}rzd € JI S]JOJWIau JO SUOnIIBOO 'slap}Amd £3FUuer{d lo areu{+jRar{ agzu€uI lo Hi Im }o€4uoo o) uo}+€uuojul l£r}uapyuoD scAtnd Jaylo aq) asn (a JO 'agn IRjOJaurm03 JO letna+xa JOJ aseqe+DP JO a3rhias '}onpoJd Aug JO }uatuaAoidm! JO uopeiado 'uoT]earo aq) JOJ UOjIRUUOJul le!]uapyuoD s,KpFd raylo atp asn (q) 'uoI}euuoJUl le}+uapuuoD s,&led Jar{+o aq) o) slgBp laylo £ue lung io 'asua3rl 'llas &m &red law)IaN 'Me1 qlrM }ualsrsu03 }uatuaaigu £}}lg}}uapuu03 uodn paai8D KljFn}nuI e aimbar £gUI JO}094uOD 'pasolos TP aq uea uo})euuojul le!)uapUuo) s,io}98i)uoD aJOJaq (AI) pu8 'sasocIInd uor+8J}sIuruIpe ueld ioJ uoT+gunojul le}luapyuo) s,ro}oe4uoD asn £luo £zur XII) ( II1) 'mel Aq parmbar }ualxa aq) o) 'ueld aq) JO s}u€dlo}}rrd aurooaq ol aIqlgIla slrnp}AIpur ro 's}uedror}r€d 'iosuods ueld aq) 'srap}Aord 8u}uajar ol 'sueaur raHlo £ue IO Tool }uauIa888ua ramnsuoo 8 q8nonl} 'elep io uo}+€uuoju! aJeo JO £]}lenb ro )soo oy}oads-JapjAOJd gulp}Aord moa pa+rqu{oJd aq lou TIm A IID (n) '}uatuaa:lgV STIjl rapun sao}xraS ap}Aord OI sap}}ua asot{} roJ papaau se sro+o€qu03qns pIle sa+urlyJe SIT o) UO!+FUUOJUl le!+uapyuoD Atl) asol3sTP KFUI Jo+oerluo) ( 1) '8ulo8aioJ arp 8urpue Isg)Im)ON '}uauIaaJSV StIjl iapun panruuad asialaiilo se io '+uatuaarBv SjIP rapun uuojrad ol 'u8ld atp ra]s}u}uIpe ol uor}FUUOJur Hons ol ssaooe 8urpaau sa}2r30ssv ssaursn8 pIle saa£oldUIa s,KInd 8urAra3aJ atl) o) well) ratIlo KIljua lo uosrad Kue ol UO})euuojul IFr)uapUuo) s,layIO aq) asol3s TP TIll'h AIred laW)IaN 'uopeurrojul lepuapUuo) JO asn spJOoaJ uanLLN\ snoau€rodura+uoo q8norq+ aouapuadapu! ljons a+z4suouap uea £}rgd 8u}A}a3ar arp Jr 'uor+ruuojuI L960889eow€-o£v8-8£JP-vo£9-33903vov :al OdOjOAU3 u61sn30a Docusign Envelope ID: ACAEC6EE-63CA4F3B-BA7C-3AA036880961 38. INTENTIONALLY DELETED 39. INTENTIONALLY DELETED 40. ADVERTISING: The Contractor shall not advertise or publish, without the City’s prior consent, the fact that the City has entered into the Contract, except to the extent required by law. 41. NO CONTINGENT FEES: The Contractor warrants that no person or selling agency has been employed or retained to solicit or secure the Contract upon any agreement or understanding for commission, percentage, brokerage, or contingent fee, excepting bona fide employees of bona fide established commercial or selling agencies maintained by the Contractor for the purpose of securing business. For breach or violation of this warranty, the City shall have the right, in addition to any other remedy available, to cancel the Contract without liability and to deduct from any amounts owed to the Contractor, or otherwise recover, the full amount of such commission, percentage, brokerage or contingent fee. 42. GRATUITIES: The City may, by written notice to the Contractor, cancel the Contract without liability if it is determined by the City that gratuities were offered or given by the Contractor or any agent or representative of the Contractor to any officer or employee of the City of Denton with a view toward securing the Contract or securing favorable treatment with respect to the awarding or amending or the making of any determinations with respect to the performing of such contract. In the event the Contract is canceled by the City pursuant to this provision, the City shall be entitled, in addition to any other rights and remedies, to recover or withhold the amount of the cost incurred by the Contractor in providing such gratuities. 43. PROHIBITION AGAINST PERSONAL INTEREST IN CONTRACTS: No officer, employee, independent consultant, or elected official of the City who is involved in the development, evaluation, or decision-making process of the performance of any solicitation shall have a financial interest, direct or indirect, in the Contract resulting from that solicitation as defined in the City’s Ethic Ordinance 18-757 and in the City Charter chapter 2 article XI(Ethics). Any willful violation of this section shall constitute impropriety in office, and any officer or employee guilty thereof shall be subject to disciplinary action up to and including dismissal. Any violation of this provision, with the knowledge, expressed or implied, of the Contractor shall render the Contract voidable by the City. The Contractor shall complete and submit the City’s Conflict of Interest Questionnaire. 44. INDEPENDENT CONTRACTOR: The Contract shall not be construed as creating an employer/employee relationship, a partnership, or a joint venture. The Contractor’s services shall be those of an independent contractor. The Contractor agrees and understands that the Contract does not grant any rights or privileges established for employees of the City of Denton, Texas for the purposes of income tax, withholding, social security taxes, vacation or sick leave benefits, worker’s compensation, or any other City employee benefit. The City shall not have supervision and control of the Contractor or any employee of the Contractor, and it is expressly understood that Contractor shall perform the services hereunder according to the attached specifications at the general Contract # 8577 LLS8 # +ou+uo) aq) Aq pauyap una+ e raAauaqJw ranio all) io AIred auo }sur£SF Kl largs aioui suorsrAord ou 8urpTaJ 'gaiNed q}oq OI neJ aq o) rauueru e UT patu}su03 aq suorsTAord [F )eqI saIjled aID JO )ualur aq) ST IT 'AIred auD Aq paueJP KIlz}+u€+sqns uaaq aArr{ Agm +oer}uoD aq) q8nor{}IV '}9€r}uoD aq) ul pasn tILia) £ur urFldxa ro +uaunlddns ol }ueAalar aq lleqs ap€r} aq) JO a8€sn ro aoueuuojrad JO asrnoo ro salwFd atl) uaa alaq 8u}l€ap lobrd JO asJn03 ON 'tuauaar8e IIar{} JO sulla) atp JO +uauia+€ is aA}snI3xa pur a}alduroo 'Buy u SF saruFd aq) Aq papua IUI sr laFI)troD alIJJ :NOiJJVJJ’aHdMaJJNI '61/ }OBJ}UOD aq) JO suonrpuoo pIle 's}ueuaAOO 'suua} aq) a8ueqo ol }3aJJa lo aoioJ Awe aA8q TIeris +uaumoop law+o lo Japro 'aoroAu} ro)oe4uoD aq) £ue no suLla) let tUI is lo pa lund-aId ON 'sar IIed q)OR Aq pau8rs Bultn/w F Aq XIao papuauIF io pauII)ow aq uro }3FqUOD aHI :SNOIJJV)IJ-Iao]/v '8} Ja+oeJBtio +uaJaJJlp JO Jelmls z JO raIl)agM 's}ln€jap ro }lnzjap amIty lo 8ur}srxa raIlio Xu8 JO aou€}daoo£ parldtur io ssardxa u€ io ' log Duo) aq) Japun suol}r8Tlqo IO SIriSp Ku€ JO JaAjeM }uaueuuad u 'aq ol paultsuoo aq io 's€ a+erado IIrris KInd rolj+o alj! Aq }lnrjap JO s}uaAa arour ro auo £u8 JO AnD aq) io ro}o£r}uoo atp iagIra Aq raAIFzn ON '&red paAalr88€ aq) Aq panS is BuT in/h ul SI pIle uor+8iaprsu09 Aq pa}IOddns sr uoi+grounuar io la ArRM aq) ssalun IrISH io ur}£lo aq) JO uopelounuar io mAle/u r Aq HFd UI lo alotlyn ur pa8ieqosrp aq neo +aer)troD arp JO qoeaiq e JO )no 8msuF uBu lo urrglo ON :Ha-AIVA\ '£l/ ' ImJluo) aVI ol sau€royauaq K}IZd-pJnjl ou an aiar{} }eq) saruFd atl) JO uo}}uajII! aq) BuTaq IT 5o}arar{ Qd F lou KIjlua io tIny 'uosJad £ue uo s}yauaq IO s+HSu JaJU03 ol papualul +ou ST }38r}uoD aHI 'SqIWI JIa’iNaH AJJU.Vd aHiHI '91/ 's}uauI£ed a3jOAu} antItv }oedm} £lasra Ape Kern os op ol unITed ']uatuaar88 uop}sTnb32 ro Ja8ratu pa+noaxa UF JO 'rIOT Ioe aq) SIrjAOJdd€ uoT+nlosai s,lojoar IP JO pJeoq aq) JO £doo 'a8ueqo Hons 8urleorpur alms aq) q+ T/h palO s+uaumooT) '6-A\ paizI)dn ug sr Hons uor}8}uaum90p legal 8urHoddns qpa\ palu€dmo03e aq )smu aureu Kuuduroo e ur sa8ueqo 8uI+Forpur ia}}aT v naIlaT atp IIStS )smu loj38DnoD JO aAI]€}uasardar pazuorIIne uv 'spJ09ar AuD pa}epdn Suture+ureur JO asocimd aq) JOJ a8ueqo ssaJpp8 ro 'aueu £u€duroo R JO 'SUp}IM aT 'Ja8Rue}\[ Su}s€tlund s,All) aq) ©I lou IIUis io+oequoD alII '+uauIu8rsse aq) JO ADD ol ao4ou aprAord III/h Jo}oertuo) pcIe 's}assr s,ro}oerluo) JO IIe £lle!}ue}sqns JO IIe JO laserlund e lo 'sa}erlUJe s,JO}084uOD ol }uauraar8v SjIP uS}sse £rui ro+3eI}troD '8ulo8aioJ atl) Su}pue Isg) TaloN 'qd8J88red SIIP qIIM £}ULUOJUOO ur aperu ssalun proA aq IIrris lolaerItroD aq) Aq uone8alap ro +uatuuSrsse pa}dura++8 £uv -KIt) atp JO }uasuoo ual)}m loud aq) Inot{}}M ro}3zr+uoD arp Aq pa+e8alap aq ljFqS uor}r8rlqo ou puv paug}ssF aq tIeris )oeJ}uoD aq) ur +sara IUI lo )HSu ou Irq) 'roAaMoq papIAord 'SU8ISSB pIle srossaoons aApoadsai aarp pIle JO)oeJ)uoD aq) puu ApD all) JO +yauaq atp o) aJnsua pUB uodn SuIPUTq aq IIeqs +oeDuoD aql :NoilvDalaa-iNHivNDissv 'St ' AjlO alj! lol saoIAlas 8uruuojmd aInIm sarpRd ial{}o JOJ sao}mas uuo;lad pIle as4nApz OI aaa £lssaidxa sr ro+oei+uoD alIJJ '}3£4uoD SIll) iaprm aau8rsap sul lo 'sexal 'uo}uaC1 JO KIIO atp JO ra8rue IV K)rD aq) JO uor}oanp L960899€OW£-OZV8-8€JPVO€9-33903V3V :al adOjOAu3 u61sn30a Docusign Envelope ID: ACAEC6EE-63CA-4F3B-BA7C-3AA036880961 Uniform Commercial Code, as enacted by the State of Texas, is used in the Contract, the UCC definition shall control, unless otherwise defined in the Contract. 50. DISPUTE RESOLUTION: In the event of any dispute, claim, or controversy of any kind or nature between the Parties arising out of this Agreement or the Services (“Dispute“), a Party may provide written notification of the Dispute to the other Party. After such notice, a representative from each Party shall meet in person or telephonically and make a good faith effort to resolve the Dispute. If the Dispute is not resolved within 30 days after the Parties first meet to discuss it, and either Party wishes to pursue the Dispute further, that Party will refer the Dispute to arbitration. Any Dispute that has not been resolved pursuant to the above may be submitted to arbitration. Either Party may initiate arbitration by filing a claim with the American Arbitration Association (“AAA“) in accordance with the then-current Commercial Arbitration Rules of the AAA (“Arbitration Rules”). The arbitration will be conducted in accordance with the Arbitration Rules. In no event may the arbitration be initiated more than one year after the date a Party first gave written notification of the Dispute to the other Party. The Parties will treat the Dispute, the existence of the arbitration, and the outcome of the arbitration as confidential. Each Party hereby waives any right to a class action arbitration. Any arbitration proceeding will be conducted at a mutually agreeable location. Any arbitrator may construe or interpret but must not vary or ignore the terms of this Agreement and will be bound by controlling law. No arbitrator has the authority to award punitive, exemplary, indirect, or special damages. Nothing in this Section 50 will be interpreted to limit, waive, or nullify any other rights under this Agreement. 51. JURISDICTION AND VENUE: The Contract is made under and shall be governed by the laws of the State of Texas, including, when applicable, the Uniform Commercial Code as adopted in Texas, V. T.C. A., Bus. & Comm. Code, Chapter 1, excluding any rule or principle that would refer to and apply the substantive law of another state or jurisdiction. All issues arising from this Contract shall be resolved in the courts of Denton County, Texas and the parties agree to submit to the exclusive personal jurisdiction of such courts. The foregoing, however, shall not be construed or interpreted to limit or restrict the right or ability of the City to seek and secure injunctive relief from any competent authority as contemplated herein. 52. INVALIDITY: The invalidity, illegality, or unenforceability of any provision of the Contract shall in no way affect the validity or enforceability of any other portion or provision of the Contract. Any void provision shall be deemed severed from the Contract and the balance of the Contract shall be construed and enforced as if the Contract did not contain the particular portion or provision held to be void. The parties further agree to reform the Contract to replace any stricken provision with a valid provision that comes as close as possible to the intent of the stricken provision. The provisions of this section shall not prevent this entire Contract from being void should a provision which is the essence of the Contract be determined to be void. 53. HOLIDAYS: The following holidays are observed by the City: Contract # 8577 ££98 # +3u+uo) – su8aui „s+uauoduroo JO )soD„ 'I I +onpoJd pIn IIe o luT AjlouTP pa+€rodioouT KTddns ro 'lepa}euI 'aIorH8 ue sueaur „+uauodUIOD„ -T – qdFr8rJrd STl{} ul pasn sv 'suoTljuyaa 'v alqeoTldde ale s+uauarlnbar papuru £ll=rapaJ 8urMOljOJ aHI (s)uaurarlnbar pap11nJ XII'J;P;J 111'+Ja3 o+ alq', IIddy) sailddns-lov w)ruarvv xna '£S vav alp UT pauuap su sa})}l}qes}p tppw sjFnp TATPUT lsu}28e a3p3erd +uauIKOIdUIa £ro}eunrrLrosrp Aug ur a8r8ua tFtis '}ua8e s,lolagO lo 'roraJJO ON :a3ueIIduro) (V(IV) )aV sapIIlqes!(I q JIM suerlr3urV 'g OdH STIjl trIO a 8uplnsar sap TAjl92 Kw raptm uo}}eu}ur}nsTP OI pa}3afqns asI/maw aq lo 'JO s}uauaq aq) pastvai aq 'uIS bIO RUDI)eu lo 'BujlsaI o!}aua8 'JOjOO 'paan ',q}l}qrsrp 'a8€ 'uorp}uauo lenxas 'xas 'a08r JO spunoI8 aq) uo 'lleqs uosrad ON 'a3T}39rd +uaur£oldtua Aro}uujuI}msrp Kue UT a8e8ua ltetis '}ua8r s,JoiaJJO ro 'roraJJO ON : Allun)roddo +uour£oIdur’I lenb’I 'v xriNnrHOddo lvni)a '9g 'uo}Iraq JO KIIO arp lo 'srxal JO a luIS aq) 'stu€r8oJd }uaruarnoord-uoN pu€ }uatuarn30rd lerapad luo a papn[oxa sarLred JO ISIl uopei+sju}uIPV saolmaS lrJauar) atl) Aq pa]eoTpu} se '}uaurruaAor) leJapa J atl) q II/W ssaursnq 8urop trio a panrqap ro papuadsns £l}uanno lou alg slrdl3upd sIT puu cluB siT )21{} ' Jallaq pcIe a8pal&ou>I alqguos2aJ SII ol 'saylpao loj321+troD arp 'All) aq) q+In }oer luo.) F SUI+da03e Kg 's)OFrluo) AnD lo 'ale is 'lerapa J urorJ paneqap ro papuadsns ar£ sl€dl3uud asoq/w io paneqap JO papuadsns air )81{} saIjled ol spieMu-qns JO aurpd Surlem io rpIM 8u1}3ei}u09 moo pauqu{old st XP) aHI :NOiiV)idiIHa) INalVHv8aa HO NoisNadsns-NON 'SS - Iaer}troD all) JO uo}+€u Tuna Ilo uo!+eiTdxa atjl aATArns llrqs 'saIlred atp JO suor}F8rlqo K+rler}uapuu03 pu€ '£+!utuapu} '£}u€ue/w aq) o) pat}tun lou )nq Su}pnl3u! 'sar+r€d aq) uo suouR8rlqo SurnuI+uoo asodtu} }EtP }3eJ]uoO aq) JO suoTs}AOJd IIV :SNOIIV01180 dO AII118VAIAHns ' PS 'aau8}sap paz}lorDnR STH lo s€xal 'uo}ua(I JO ra8rue IN A IID allI Aq paAoidde aq +snur uop8rado JO smog leuuou atl) UTqlyn lou aouFUUOJiad qJOM ro sauaArlap palnpaqos £uv 'S£FpljOH uo+ua(I JO All) BuTpnloxa '&ppd q8norq} K€puo]/\[ 'Ind 00:t/ pcIe ur8 oo:8 uaa,WIaq aq TIeRS uopeJado JO smog leuuoN '£RpuO]/V SU}MOljOJ aq) uo pa/uasqo aq TIm it 'KFptms uo sITeJ KrplloH lr8al e JI KepTIJ Su}paoaJd aq) uo pamasqo aq III,w A '£eprn}€s IIO SITq £eprloH l€8al F JI pa,uasqo) ArCI sgurISInD (paMasqo) aAa SBUI}SUqD Su}A}8s4uet{I rayv KFPUJ 8UIAI8S4UFql MCI suzra laA Aea roqul Ar(.1 aouapuad9puI tpuaa+amr & C1 l€uoura}\[ £€CI rf '8uFX iatjlnl UIjmIA[ (pamasqo) Kg(I s,reaA /waN L960B99eow€-ozv8-8£JP-vo£9-3390]vov :at OdOjOAU3 u61sn90a Docusign Envelope ID: ACAEC6EE-63CAd+F3B-BA7C-3AA036880961 (1) For components purchased by the Contractor, the acquisition cost, including transportation costs to the place of incorporation into the end product (whether or not such costs are paid to a domestic firm), and any applicable duty (whether or not a duty-free entry certificate is issued); or (2) For components manufactured by the Contractor, all costs associated with the manufacture of the component, including transportation costs as described in paragraph (1) of this definition, plus allocable overhead costs, but excluding profit. Cost of components does not include any costs associated with the manufacture of the end product. iii. "Domestic end product" means- ( 1) An unmanufactured end product mined or produced in the United States; or (2) An end product manufactured in the United States, if the cost of its components mined, produced, or manufactured in the United States exceeds 50 percent of the cost of all its components. Components of foreign origin of the same class or kind as those that the agency determines are not mined, produced, or manufactured in sufficient and reasonably available commercial quantities of a satisfactory quality are treated as domestic. Scrap generated, collected, and prepared for processing in the United States is considered domestic. iv. "End product" means those articles, materials, and supplies to be acquired under the contract for public use. v. "Foreign end product" means an end product other than a domestic end product. vi. "United States" means the 50 States, the District of Columbia, and outlying areas. B. The Buy American Act (41 U.S.C. 10a - 10d) provides a preference for domestic end products for supplies acquired for use in the United States. C. The City does not maintain a list of foreign articles that will be treated as domestic for this Contract; but will consider for approval foreign articles as domestic for this product if the articles are on a list approved by another Governmental Agency. The Offeror shall submit documentation with their Offer demonstrating that the article is on an approved Governmental list. D. The Contractor shall deliver only domestic end products except to the extent that it specified delivery of foreign end products in the provision of the Solicitation entitled "Buy American Act Certificate" . 58.INTENTIONALLY DELETED 59.INTENTIONALL DELETED 60. PREVAILING WAGE RATES: The contractor shall comply with prevailing wage rates as defined by the United States Department of Labor Davis-Bacon Wage Determination at http://www.doI. gov/whd/contracts/dbra.htm and at the Wage Determinations website www.wdol. gov for Denton County, Texas (WD-2509). Contract # 8577 ££98 # )3eJjUOD II{gp Hons +oaJJF asTMratjlo JO aATeM 'laawo 'apnl3aid '4edruT 'HulII o) a}uado IIFtis }08J}noD aVI iapun £pauraJ JO itIS Ii Kue JO asToiaxa leIprd io as}maxa s6Kp8d jaIn la JO JaA TeM JO 'amITq 'K8lap ON 'arnItu at{} ul aoueuuojrad arlnbar ol K}r2d Vans JO itIS}1 aq) }oaJJF lou juM +oer}uoD aq) rapun £PFd raq}ouv Aq aourunoJJad aJ TIIbal o) AIred r JO untIed :SJJHr)IH do u-aAlvAA-NON '99 'aoueuuoJJad ul Kelap ro aoueuuo}lad-uou aq) Su}sneo saoue}suInup aq) IIe lap JO laAal alq€uosear r jF aqn3sap pIle (aouarm900 Hons JO uo}ldaou} aq) JO s£8p repual80 (g) aAU UTqijM BuTKIM ul pauuyuoo aq ol) auot{data) Aq (ra8€uF IN }uamarnooJd uolua CI JO KIjo aq) 'ABD atl) JO aseo aq1 UI) AIred raylo aq) KJT lou £Ia}eTpauIul} lleqs £ped pa+oaJJe aKI '£€1ap +notIWM alqlssod IIra+xa JaAa+£q/h o) pIle raAauarIM aouemasqo JO a9uFUUOJrad aouaurtu03ar ol spoJJa alq8uos2aJ KljZIoiaurtu03 agn o) sanu}+u03 Awed pa+oaJJe alp pIle He Amd saou8+sumoi lo qons s€ 8uoT s€ JOJ pa+3aJJe os s+uaurarInbaJ atp JO aowmasqo ro aoueuuoJJad iaqprV AuF UIOg pasnoxa aq 11 TM jo lorIIIIO) £}r8d pa]3aJJe atp 'rio IIoaS SjIP rapun aouaunooo ur JO +uaAa arp ul '£ued pa)oaJJe atp JO aoua8T18au io }lneJ arp o) alqe+nq TJIIg lou asne3 alqepjOArun ialIlo lo 'pOr) JO +or 'KIpotTIng I=SaT JO Japro 'r£JW JO ioe ue Aq aouFUUOJiad UIO# pa)ua Amd aq )! PInotis +og4uoD aq) Japan aou€uuojrad JOJ alqISUOdsaJ aq )ou TIeris £Hed e ')aerluo) STIjl rapun suo}}u8}lqo guTPUN scAITD JOJ ldaoxH :Hxnarwv a)HOd '$9 aalalaa AITVNoiiNaiNI 'P9 parlss! act iauRarar{ Kern letit alru leuu arp o) s+uatupuatu€ AuF Su}pnlou} 'Joaratp suo TSI /\old +uFAalaJ atl) tl)IM £ldru03 lleqs io}oe4u03 ajl pug aouaraju Aq pa}rrodIOOu} ST 8861 JO IOV aould >[loA aarJ-8ruCI atp JO suojs}Aord arp }uamaldtu I o+ (a lwdqns '08z p€d HdD ZE) asuaja(.1 JO }uamprdaa atp pUF +a8pn8 pIle ]uauIa8€ue IN JO aoyJO aq) Aq panss} '(s+ueJ8) a9eTd >pOM aaa-Bmp JOJ s}uaunJrnbaJ ap}&-+uaunuaAo8 'alru leuy aq) pIle f+uauIUoijAua lroM aaiJ-8rup r UjR luteIn pIle ('e)as la IO£ 'o-s'n it :a ajljIqnS 'AatIll '069-OOI '"'I '1lq''d) 8861 JQ I'va''IdaJOA a;'I-Sma atl+ JO suolsl Amd alqF3}ldd€ aq) q+ Tm £ldUI03 IFris ro+or4uoo aHI :a)VldH-HOAA amd ')nu-a '£9 uopoaS STH) JO q3eaJq JO ualssjluo SIJO+3BJ+UOD UIOq 8u}+lnsaJ saSSOT JO csaI]leuad 's)soo IIe Xed TIeris pIle uo}ua(.I JO ABD al{} XJTmuapuT TIeris ro}oei+uo) 's}uamulnbaJ SulploW)IM a+qs JO leiapaJ io 'a8ria Aoa uo!+esuaduro.) ,sia]JOAA io +uaur£oldUIaun £ue joJ saa£oldUIa SH lo io louluo.-) ol alqe II aq )ou ll€qs uo]ua(.I JO AND aHI 's+uawaJ}nbaJ SulPloWHM pIle s/w€[ xvI a+€ 1S pIle leJapaJ lle q+yu aoue}ldtuoo arnsua TIeris Jo+o€rluo) 'a8£JaAOO a9u€rnsu} uoI;gsuadtuoD ,SJa]lOA\ piFpue is puu a8zJa Aoa a3uernsuT }uaur£oldtuaun al8 is pu8 lejapaJ tl}oq joJ aIqlsuodsar sl ro}3er}uoD 'saa£oldura M€1 uornm03 ol s,z-7w uuoJ JO aouenss} q)}/h guIleap '8£6 1 JO DV anuaAaX aq) JO Ogg rIo}}oaS 8ulpuam€ '90£l trollgaS '9861 JO PV uuojaU- xel luapaJ aq+ lnIM £ld=110' tIeqs '0+'-J+'100 :srNarvxuInt)xu rv301 aEV 'arvrs 'TVuaaad 'Z9 '}o€i}uoD arp JO a3uFUUOJrad pu€ BuTqslmtv o) alqeo}Idde suo}+eln8ar pIle s/h€1 11g in IM £ldUIOO pug sao IIon IIe aA IS 1121is JO lorIluo) aHI 's)ue/nas 3ltqnd ot s}uauaq JO 8u}uajuoo io BupaDO aq) siTqlVOId q3}qM 'apoD leuad sexal aHI JO 60'9£§ (I1) :AIaq}Iq SITqIHold HOTqm 'apoD leuad sexal arp JO ZO'9£§ (1) :SuIMolly aq) 'uo}}FITmIt )not{}}/w '8u}pnl3u! 'saul}} IIe }€ SMFt alqeollddr ip qI Im £lduroo +sntu lojorI+moD alIJJ -s+uatuaJ}nbar pug SMFT Fool pIle 'lzrapa I 'a ins aIqeo}ldde lle IDIM £ldru03 IInis raIlddns ro Jo}oeJ}uoo aHI :S/KVI IVDOI aNY 'wHaaaa 'alvls 11V HII,M a)NV11d IVO) '19 L960g99eowe-ozv8-8£JFvo£9-33903vov :al adOjOAu3 u61snooa Docusign Envelope ID: ACAEC6EE-63CA-4F3B-BA7C-3AA036880961 or remedy. A waiver by a Party of any breach of any term of the Contract will not be construed as a waiver of any continuing or succeeding breach. 67. NO WAIVER OF SOVEREIGN IMMUNITY: The Parties expressly agree that no provision of the Contract is in any way intended to constitute a waiver by the City of Denton of any irnmunities from suit or from liability that the City of Denton may have by operation of law. 68. RECORDS RETENTION: The Contractor shall retain all financial records, supporting documents, statistical records, and any other records or books relating to the performances called for in the Contract. The Contractor shall retain all such records for a period requested by law. The Contractor shall grant access to all books, records and documents pertinent to the Contract to the CPA, the State Auditor of Texas, and any federal governmental entity that has authority to review records due to federal funds being spent under the Contract. Contract # 8577 LLSg # )OBJ+HOO 'pu€ }321luDa STIll JO urn) aq) ]noq8noJr{} £lsnonu}}u03 a88JaAOO IIons up IUjgUI 1121is Jo+oerluo) 'uuoJ ap8tu stuT8lo r iaprm papTAord aq a3uginsuT paJ}nbaJ arp JO Kuu PInotIS , 'ajDP uopv4dxa aq I arofaq pa8uDt Ia &ljDjaa}©w ro palla3uD3 aq a}D3dTHa3 aq) no paqlr3sap sapllod aq) jo AIm plnoqs a3pou ualn.IM iCDP og sar trIbal /Ov :uopvlla3uD.) , 'sJaa}unjOA pu2 'saaKoldura 's}ua8e 'SjFjOUJO SH 'uo)uaa JO AITO aq) JO rOAFJ ul uoTle8oiqnS JO JaA IeA r apIAoid o XHjlqBII JO ]ltult s,rarnsu! aq) aszaioul ol a}eJado lou ll2qs parnsu} allo url{+ arour JO uolsnlour aHI }q8norq ST ljns lo apeur sl tu leto motjM lsu lege painsu} qoea ol £la+eredas sarldd8 aouernsuT STIjl IgIjl pug KoIlod allI rapun paiaAOO suITeto o) +oadsaJ ql1/h parnsul l8uo}}}ppv aq) o) alq€1}cAe aoueinsu I laylo Kue ol £rFm IId s} aouFJnsu} Hons )891 0 SJaa+tmjOA pUB saaKoldtua. 'slua8v 'SjFj3uJO SII 'uo]uaa JO ,C)to all) parnsuI leuoqrppv sg ameN o :BuTMolly alj1 ap}AOJd ol pasIopua aq lleqs saTollod £3}ITq€ 11 1eJauar) leruaunuoD • raIlaq lo IIA -v ]seal Ie JO Super £U€dUIOD }sag - 1/v'v ue tIjIn SFxal JO ale IS at{} ul ssau}snq op o) pazlioq+n£ Ku=dtuoo € Aq pangs} aq TIeris K31jOd qoea , pa Iou os JI 'ra8uol ro ')aei+uo) all) JO uopernp aq) }noq8norq+ suope3u loads leroua8 asoq} II) IM a3ueIIdur03 UI paul8)UIeuI aq IIrqs pu€ 'suop83ul3ads l8raua8 8u},uoIIOJ arl) qH,w £ldur03 ll8qs s)uauIarlnbor asaHI JO uoT+3ejs IIzs ul paIrle+qo io paso(lord sapIIod a3uernsuI IIV •uo}ua(I JO /hI) aq) ,Cq pauBls pUB 'paAordde 'pa+daaoe uaaq seq )3er)u03 arl) +eq) uo!)e3unou 8ujAja3ar IIlun leIla)eur £ue iaAllap lo Ilo,u ,Cue 03uaurtu03 lou llrqs io+3er)uoD •'aurp AIre le s)uatuarInbor a3urrnsu! £UB JO uo!+e3UjleIa roJ rIse ')uatu+redo(1 8ulsrq3rnd grp o) }sanbar ual) IIM uodn 'Kern ro)3ei luo) lao jord aq) JO allp pue raqwnu +3er+u03 arp BIljule+u03 's)uourasropua lo UInpuappe alqe3Hdde AIre gIrlpnl3u! a3uernsu! JO sa)e3upr03 apIAOJd Heljs roped+uoD 'ra)Jeularaq paIealpuT se a8eraA03 a3uernsu! urnur luIur aq) 'sa)8ujUIra} puljuor all) II)un 'llje+ulrur pIle apjAord ll8qs roper luo) all) 'ro+38r)uo) aq) JO sap IIIqeII dO suo!+eBllqo raIl JO aq) JO /Cue BuIlturII )noH)UK :SNOISIAOHd auvaNVls srNarvTaInt)lu aoxwnsNI a Hqlqx I L960989eow£-ozv8-8£JFvoe9-33903vov :al adOjOAu3 u61snooa Docusign Envelope ID: ACAEC6EE-63CA-}F3B-BA7C-3AA036880961 without lapse, for a period of three years beyond the contract expiration, such that occurrences arising during the contract term which give rise to claims made after expiration of the contract shall be covered. • Should any of the required insurance be provided under a form of coverage that includes a general annual aggregate limit providing for claims investigation or legal defense costs to be included in the general annual aggregate limit, the Contractor shall either double the occurrence limits or obtain Owners and Contractors Protective Liability Insurance. •Should any required insurance lapse during the contract term, requests for payments originating after such lapse shall not be processed until the City receives satisfactory evidence of reinstated coverage as required by this contract, effective as of the lapse date. If insurance is not reinstated, City may, at its sole option, terminate this agreement effective on the date of the lapse. SPECIFIC ADDITIONAL REQUIREMENTS: INSURANCE All insurance policies proposed or obtained in satisfaction of this Contract shall additionally comply with the following specifications, and shall be maintained in compliance with these additional specifIcations throughout the duration of the Contract, or longer, if so noted: A.COMMERCIAL GENERAL LIABILITY INSURANCE Commercial General Liability Insurance including, but not limited to, Premises/Operations, Personal & Advertising Injury, Products/Completed Operations, Independent Contractors, and Contractual Liability with minimum combined bodily injury (including death) and property damage limits of $1,000,000.00 per occurrence and $2,000,000.00 general aggregate. B.Errors & Omissions Insurance to provide coverage against claims for any loss on accounts assigned to the CONTRACTOR due to negligent act, error or omission on the part of the CONTRACTOR or its employees with minimum limits of $1,000,000 per claim, 82,000,000 annual aggregate. C.Cyber Insurance coverage to provides protection for business liability for a data breach, cyber extortion, business interruption due to malicious cyber-attacks or malware infections. A Cyber policy is required any time a system interfaces with the City of Denton’s servers or houses sensitive information such as employee data with limits of not less than $10,000,000 unless other limits are individually approved by the City. SUBCONTRACTING LIABILITY (1) Without limiting any of the other obligations or liabilities of the CONTRACTOR, the CONTRACTOR shall require each Subcontractor performing work under the contract, at the Subcontractor's own expense, to maintain during the engagement with the CITY, types and limits of insurance that are appropriate for the services/work being performed, comply with all applicable Contract # 8577 ££98 # +oeJ)uo) SPJBPU€ is A4snpu} tP+M }ua}slsuoo aJB pUB SArI L960g99eow€-ozv8-8€Jhvo£9-33903v9v :al OdOjOAU3 u61sn90a Docusign Envelope ID: ACAEC6EE-63CA4F3B-BA7C-3AA036880961 Exhibit D Contractor Terms and Conditions Section 1 Definitions The following terms have the meanings set forth below. The words may be singular or plural. Bank Account: Bank Account maintained for the payment of Plan benefits, expenses, fees, and other Customer financial obligations. Employee: A current or former employee of Customer or its affiliated employer. ERISA: Employee Retirement Income Security Act of 1974, as amended from time to time. Fee: Any fee or other compensation Customer pays to United for Services provided under this Agreement. Law: Any applicable federal, state or local statute, law, rule, regulation, code, or ordinance of a governmental entity that regulates a Party’s activities or operations. Medical Benefit Drug Rebate: Any discount, price concession, or other direct or indirect remuneration United receives from a drug manufacturer under a rebate agreement that is contingent upon and related directly to Participant use of a prescription drug under the Plan's medical benefit during the Term. Medical Benefit Drug Rebate does not include any discount, price concession, administration fees, or other direct or indirect remuneration United receives from a drug manufacturer for direct purchase of a prescription drug. Network: The group of Network Providers United makes available to the Plan who have entered into or are governed by contractual arrangements under which they agree to provide health care services to Participants and accept negotiated fees for these services. Network Provider: Physician, medical professional, or facility which participates in a Network. A provider is only a Network Provider if they are participating in a Network at the time services are rendered to the Plan Participant. Overpayments: Payments that exceed the amount payable under the Plan. This term does not include overpayments caused by untimely or inaccurate eligibility information. Participant: Employee or dependent of Employee who is covered by the Plan. Plan: The plan to which this Agreement applies, but only with respect to those provisions of the plan relating to the self-funded health benefits for which United is providing Services, as described in the Summary Plan Description. Plan Administrator: The current or succeeding person, committee, partnership, or other entity designated the Plan Administrator, as defined by ERISA or other applicable Law, who is generally responsible for the Plan’s operation. Summary Plan Description or SPD: The document(s) Customer provides to Plan Participants describing the terms and conditions of coverage offered under the Plan. Systems: The systems United owns and makes available to Customer to facilitate the transfer of information in connection with this Agreement. Contract # 8577 ££98 # puWOD JO a Iep aA1}3aJJa aq) ot JObId amI) JO pojIad alqzuosear e UIl{}IM uoT idlrosa(1 arId £reununs ro/pur u€1d aq) o3 sa8u£qo Kur JO aol lou q)uw pajlun apIAOJd Il£qs rarno}snD 'so8ueq) ueld £•s uop3as '8uIprAOJd sl pairun saoImas aq) lo +uauIaar8v SIg) qjIM }ua}srsuoo lou SI uo}s}Aord u8ld AuF lo 'a}Trnooe lou air pallurl o) saouarajaJ +€t{} souruua lop KlqBUOsror pa)itin Jl ttlaID puauB IIFtis Jauo)STIO -saojAlaS SIT JO pa)itin o+ JajaJ IIonINk suoqeoIunuuI03 IIons q+IM patrun aprAord II€qs ratuo}snD 'saI}rFd pru{} lo s}u€droI}I£d ol suorsr,told lo s+yauaq UFld 8urqu3sap suor}=9runurmoo AIre BuT}nqu}sIP aioja8- '}uauIaar8v sup q+rM }ua+srsuoo arz suorsnloxa puc s+uauaq ueld JO £ieurums aq) ro/pu€ uor+duosaCI ueld Kretuums aq) 8urpnlou} 'sluaum30p URld leg) saaJ8e Jatuo}sn) ')uauraar8V SjIP II) I,u +ua+slsuo) ueld Z'S uop33S '}uauraar8V stl{} iapun anp saaJ IIe s+ass8 acId trio# Ard o+ £+!ioq+nr aHI seq UBld alp )erp SaaJ8F JauIo}snD atiJ. 'ro}eJ;s}uTmpv ueld aq1 SR K}r8d rawoue salruSTsap mmolsn) lo ro}er}s}uTupV rIgId atl) sl Jauro+sn) iaqtat{/w 'ueld aq) JO iauIo}sno ol £lddF l21{+ s/nFl £ur qH/w a3uglldUIOO pue 's+uaunoop ueld JO uoI}nqu+sIP pug £oualoyJns legal aq) 'uBTsap }yauaq SII Su}pnlou} 'ueld aq+ roJ aTq}suodsar sr iauro}snD 'uraJat{ IITroJ )as saT)np uo1+84sluTupe tu}€1o aq) puo£aq saIlnp io sa}+}l}qTsuodsar AuF paljun uodn iaju03 lou op pug £Iuo aATldp3sap arg ,GuRld aq) Bupa}sTu}upR„ paljurl ol +uatuaai8v STIjl UT sa3uarajai Kuv 'u€td aHI JO io+€r+sruIrupv ueld aq) lou st palrufl 'ueld aq) lol £+111qlsuodsoH l•s uop3as ( Mr wanr©T53B 'K+un9a S ira }uawrIoe}}V UT guy )as }uauraai8v STg) rapun uo}}euuojur JO £+unoas o) )oadsar qIIM suo!+e8rlqo s,pajlun pIle }uamaar8v a}8roossv ssaursn8 - c-ci +uauIq08 liv ur HUg las ]uauIaar8v SjIP Japun uor}8uuojur JO £oeAud o) }oadsar qH,w suo}}eSrlqo ,saIjnd at{} o) pajlull[ lou )nq 8uTpnlou} olmay paq08++€ +Tqlqxa aApo€ naea ul qUOJ las ramo+snD OI sao ThlaS ap}Aoid IIens pa)Ian ( a Im) mr DmR53B 'alqruos€ar alg }uauraar8V sup rapun paprAord saor&laS roJ pled saad atl) IetF sa8palx\ou>pe KqaJaq JauIo}snD •saod. JO ssau3IqBuosuaH £•c uop33s 'pagreq3 aq £€ur aaa leuoIFppe ue 'sao}mas ljons apjAOJd ot saar88 pa)!url JI pUF +uamaar8v STH) ul qIIq las asoq+ o) uor)IppC UT saolmas apIAmd palrun )gq) }sanbar £euI iauro}snD •saaJ pIle saa I,bras IBUOpjppv z•c uopaas o}aJat{ )uaWoe IIV aAi}o€ 11aea ur HUg las saad ljB pal Tun Xed TIgrIS iauIo}snD •saad. JO )uaur£ed I•C uopaas I 'asT&IaqIO pa lou Kll93y loads laa)xa aq) o) ]da9xa opraH pat{32 IIe s}uaun{oepv lle o) Kldde }uauIaar8v SjIP JO suol}!PuoD pur surIal aRI '}uatuaai8v slyI o luI PUuo&oou} £qaiar{ ST 'laIJe io ale(.I aA}joaJJa aq) uo inTlaljM 'o+araq patlog JIg }uatml02 IIV qoeH s+uatulj3e++V Z uop3aS 'Klr}ua l£luaunnaAOS lai{+o lo 'lrool 'a)z is 'lgrapaJ £u€ Aq paInt lo 'passasse 'pasodun a8r£qo v :saxeJ. lo xeJ. L960g99eow€-ozv8-8£JFvo£9-33903vov :al OdOjOAU3 u61snooa Docusign Envelope ID: ACAEC6EE-63CA-4F3B-BA7C-3AA036880961 the change to allow United to determine if such change will alter the Services United provides under this Agreement. Customer’s requested changes must be mutually agreed to in writing prior to implementation of such change. United shall notify Customer if United will not implement or administer the change. Upon such notification (a) United shall have no obligation to implement or administer the change, and (b) Customer may terminate this Agreement upon 90 days written notice. Section 5.4 Information Customer Provides to United. Customer shall provide United in a timely manner all information that United requires to provide Services under this Agreement. United may rely upon any written or oral communication from Customer, its designated employees, agents, or authorized representatives. Customer shall, in an accurate and timely manner, provide United with eligibility information as to which Employees and their dependents are Participants. Customer shall notify United of any change to this information as soon as reasonably possible. United may rely on the most current information in United’s possession regarding eligibility of Participants in paying Plan benefits and providing other Services under this Agreement. In the event of an eligibility issue United will not be required to process or reprocess claims, but if United agrees to do so additional fees may apply. Section 5.5 Notices to Participants. Customer shall give Participants the information and documents they need to obtain benefits under the Plan before coverage begins. In the event this Agreement is terminated, Customer shall notify all Participants that the Services United is providing under this Agreement are discontinued. Section 5.6 Affiliated Employers. Customer agrees that together Customer and any of its affiliates covered under the Plan make up a single “controlled group” as defined by ERIS A (if applicable) and/or the United States Internal Revenue Code of 1986. Customer agrees to provide United (a) notice anytime it acquires, divests, or merges with another entity, and (b) with a list of Customer affiliates covered under the Plan upon request. Section 5.7 Escheat. Customer is solely responsible for complying with all applicable abandoned property or escheat laws, making any required payments, and filing any required reports. Section 5.8 State and Federal Surcharges, Fees and Assessments. The Plan is responsible for state or Federal surcharges, assessments, or similar Taxes imposed by governmental entities or agencies on the Plan, or on United in its capacity as the claims administrator of the Plan, whether or not remitted by United, including the funding, remittance, and determination of amounts due under The Patient Protection and Affordable Care Act of 2010. Section 6 Records and Information Section 6.1 Records. United shall keep records relating to the Services it provides under this Agreement for as long as United is required to do so by law. Section 7 Termination Section 7.1 End of Services. United’s provision of Services under this Agreement ends on the date this Agreement terminates, regardless of the date that claims are incurred. Notwithstanding the forgoing, United shall provide the run-out Services set forth in an active Attachment attached Contract # 8577 LLS8 # +OBJ)UO) gaINEd all I uaaM+aq +uauIaai8e 8uIpurq pug pIP A F a}2aJO ol aAr}oaJJa Kll28al aq 111/w Kd03 3ruor+oala pa}noaxa r€1nurs JO aTrurrso€J gong pu€ '(ornpu8rs o}uo4oalo ue JO suearu Aq 8urpnlour) }uatuaar8v SIIP JO £d03 o}uoi)3ala pa}noaxa lulltu is JO al}uITSoeJ pa+noaxa ue JO AraATlap uodn £lai Agu sarH€d oriJJ ')uauuu}sur OUI€S aq) pIle allo a}n}}}suoo ol patuaap aq tIeris raIl)ago) ua>F) SHe(In}unoo qons lle pIle (uoT]u31tmuuu09 OTnorI9ala JO uuoJ £UR 8u}pnlou!) spuciIa}un03 JO iaqumu £ue ur pa+noaxa aq Kew +uauIaar8v StIll 'sarn+eIIB is 3luor)aal’a !s+redra+uno) £'8 ilo! laos ')uauIaai8v sup iapun a3uuuuoJJad SIl ul suor+eInSai pIm SM€1 iallo pug 'q8 is 'lgrapaJ alqe3rlddz IIg q)IM £ldtuoo o) aar8€ sarjled alII •suopeIn8aH pIle SAX81 qt IIU a3uellduroD z'8 uop3as 'luauaarSv SIlj+ Japun suor+B811qo SP )no £u80 OI paiTun ioJ uoT+runoju! BuT4r+uapr iag)o io 'sqreuIaprI} 'SareUI a3r7uas 'o8ol 'aurFU s,rauro}snD asn OI uorss}uuad paIlun SIue:l8 raruo)snD leg I }daoxa haq lo arp JO uorssruuad ua)IUM aq) lnoqljM uoT}euuojuT Str!©}}uap} lay lo io 'slreuIapeJ+ 'salem aol/was 'o8ol 'aureu spall lo gaga asn oi lou aar8e sarlred aHI 'aureN JO asn 1'8 uop33S MmuBIIa3s!]/V 8 uo IJJaS aA I/urls osle IUM +uatuaar8V SIIP JO uor+euruua+ aq) puo£aq anupuoo plnoM amleu SH Aq IjOjtIM ITq IIIxa ue JO uoTsjAoid AIre pug ]uauraaJgv SIIP JO uol}BuiuLn} atp aAI/Lms Ijl/u t'6 puB £'6 '1'6 '£'OI 'Z suoI}oaS bCIll IqBAIAJnS Z•Z 1101)aaS 'saormas +no-urn allI o) £lddR ol anu4uoo III/h uoqrpuoO pIn suLral asaHI let++ aar8e sa}p£d aql '}uaunar8V aq) JO uo}}ru IrIna) alj+ raUe o+any L960899€OW€-OZV8-8£JFVO£9-33903VOV :al adOjOAu3 u61sn30a Docusign Envelope ID: ACAEC6EE-63CA4F3B-BA7C-3AA036880961 Attachment D-1 – Medical Benefit Administration Services UnitedHealthcare The following are the Services United has agreed to provide to Customer. The Services described in this Attachment D-1 will be made available to Customer and where applicable to Customer’s eligible Participants consistent with the Summary Plan Description under which the Participant is covered Section 1 Network Network Access, Management and Administration. United will provide access to Networks and Network Providers, as well as related Services including physician (and other health care professional) relations, clinical profiling, contracting, and credentialing, network analysis, and system development. The make-up of the Network can change at any time. Notice will be given in advance or as soon as reasonably possible. Some Network Providers are affiliated with United, however they are not United’s agents or partners. Otherwise, Network Providers participate in Networks only as independent contractors. Network Providers and the Participants are solely responsible for any health care services rendered to Participants. United is not responsible for the medical outcomes or the quality or competence of any provider or facility rendering services, including Network Pharmacies and services provided through United’s affiliates’ networks, or the payment for services rendered by the provider or facility Out of Network Programs. United offers out of network programs that strive to increase savings to Customer by accessing discounts or negotiating reductions on out of network claims. United offers a mix of out of network programs that offer varying degrees of discounts, consumer advocacy, and cost controls. Customer’s elected out of network programs are identified in Attachment D-5 – Fees. Programs are subject to change or termination at United’s discretion. Value Based Contracting Program. United’s contracts with some Network Providers may include withholds, incentives, and/or additional payments that may be earned by meeting standards relating to utilization, quality of care, efficiency measures, compliance with United’s other policies or initiatives, or other clinical integration or practice transformation standards. Customer shall fund these payments due the Network Providers as soon as United makes the determination the Network Provider is entitled to receive the payment under the Network Provider’s contract, either upfront or after the standard has been met. For upfront funding, if United makes the determination that the Network Provider failed to meet a standard, United will return to Customer the applicable amount. United shall provide Customer reports describing the payment amounts made on behalf of Customer’s Plan. Only the initial claims-based reimbursement to Network Providers will be subject to the Participant’s copayment, coinsurance, or deductible requirements. Customer will pay the Network Provider the full amount earned or attributable to its Participants, without a reduction for copayments or deductibles, and agrees that there will be no impact from these payments on the calculation of the Participant’s satisfaction of their annual deductible amount. Section 2 Prevention and Recovery Services Contract # 8577 ££98 # +3e#uoO atp JO Jleqaq uo puB Jlas}} JO Jleqaq ua 'Jauio]sn) 'paljun q lion os Iou saop JauIo}sn) JI 'pal Tun mo a aol)ou 8urAraoaj JO s£ep og u TIP IM SUppM u! pallun qI)ou IIFtis iaruo}sn) ')uaru£eclraAO atp JO XJaA03aJ aaas o) paITun IneM Iou saop Jaulo]snD Jl 'uo}}ualuT SIT JO JamolsnD ol a9pou uaBUM aprAoid IUM paljurl 'uo IDe sselo r ul anss! )e s! )eqI +uauI£edIaAO u€ Hons JO £raAOoar gaas o) s}oala paIjun JI '}uaunluas ro 'uo}leqlqre 'uoT+eSpn qgnonpJleqaq (sla is TUItupe lo siosuods IT (s)ueld atp JO) scJauio+sn) aq) uo +uaurK€ciraA(') arp JO £raAOoai Fas ol Jay)agM au Tuna lap o) +gBp aq) s8q paImn ']uauI£ecIIa AO Kue UT }saia iu} pIle ol )IISP (sra+s}u}upu JO srosuods }} (s)urld aq) lo) scjauio ISII) )oaJJe ol SUocimd uopoe ss€1o e aJaUW 'saliaA030H IIO!)aV SSBl) – ssa30id £roAOoaH 'z uor)oas sup JO suLla) atp ol tuensrnd loaJJa UT SZM }uauIaar8v aq) ualIM ppd suITelo Aug jOJ sanrAqoe £iaA03ar anu!}u03 uea paljun 'Ned u! lo alot{/u u! 'saIeu luna) }uaunaJ8V SHI JI -uor+BqIqre io uojPST)IT alj+ UT pa)}un gyM a}2JadO03 III/w rauro+snD 'uopu}}qje ro uoT IrS! in satep luI paljun JI 'os op o) UOPR8}lqO ou Sgq paIlun 'AnA03ar e aleplr3€J ol uo}}eqlqr8 jo noT teST in a lz}}luI Kew pal Tun allqA -uol]alaslp s,paljurl ul pauruua lap s€ '1gon3erdru! aq PInoM £JaA03ar Jl lo 'M€1 Aq pauluuad lou s! IF JT £raAOoar £ue ansmd lou IIla\ pa)run 'rauio}sno ielno TIred Kuu ioJ io UPTO relno}pgd £u€ roJ AIaAooai lg}p€d lo llrU ul }lnsaJ lou £eur sarnpaoord puc sprepue is s,pal Tun JO asn ley I sa8pajMouIoe ratuo}sn..) 'uo1}24rqrr IO uor)eSpU arjl JO raIleu ]3aFqns aITI me )RIP suITelo IIe pur £uv ol pue UT s)saJa IUI pue SIrIgu lr8al pu8 ajIP 'dlqsrau/no IIe JO }uauru8}ssr ur pa)!un pa}u€r8 aAzq ol pauraap aq IInn '(s)u8ld- SIT JO Jleqaq uo pUR Jtas II JO Jlwlaq UD 'ratuo}sn) 'uoT}ei}Tqr2 ro uo TBSP it q8norqI £raAOoar sansJnd pa)lun aratjM saoue Isu! IF ul '£raAOoar Tejlua tod all) JO +unoure IIly aq) arq) ssal roJ paIllas io pas}uroidtuoo aq £gtu UI}€j3 F Holy/h iapun saoue+stunor TO all) pIle 'UO!)€J ITqm lo uor}€8rFI £ue aIIps lo asunojdmoo OI JaIl)aljM 'o+ pa)}ulII lou )nq 8ulpnlou} 'uope4}qre io uo}}gBpH Hons o) Buljelm suoTs}oap IIg pIle 'uopeqlqJe lo uo IIeSp Tl Hons UT ansJnd ol saTroarII legal golqa\ 'uorle#rqre jo uone8r Irl IIons JO adoos atl) 'uo}}e4}qre IO noT)gSI in a Iep}ul ol raqlaq/w '£raA03ar ]aas ol sapIoap paIjun JT ale) o) sdats leI{/w 'AJaAooaJ >pas ol lou lo lay)alj4\ 'o) pa IImIT )ou lng 8urpnlour '£)runpoddo AIaA03ar AuF roJ sainpaoord puR sprepug+s asn pIle dOjaAap OI KIlroy)ne pIle uoIjajosrp atp paITun o) sa}e8alap ratuo+snD 'salr3A03a II IIO!)aV sseID-uoN – ssa30id ,£iaA03aU. saad' - S-(..I +uamljOE IIV ul paUl}uaF)1 SB 'sa31/uaS KjIISa luI tuatu£8d leno IIdo pug piepur is JO AgIle lie JamolsnD OI alqelleAU saletu paITun '£JaA09ar ro 'uoi loa lap 'uo}+uaAard JO laAal relnojHed £ue £}ueue/w lo aa}ueren8 lou saop paImrI 'MOIaq qHOJ las sassaooid AIaAooaU. IIe JO uo Tl81)TUT pu8 'uo})e8T+saAu} 's}s£l€ue elep 'qoreasar 'sar)}unpoddo s8u Tms pug £JaAOoar & IItrap! o) VOM Tlr aptIjOu! saojhIas 'srauro+sn3 Iag)o scpa IIun o) pu€ jatuo]snD ot saolmas KIjISa luI +uaurK8d guliaAllap u! spJepue is pIle sampaoord asaHI asn TUM paljun 'suo} IFSjlsaAul pue 'sls£Teue JO sapoul 'sainpa30rd lgjluapyu03 pue Kje+audord scpa+Tun uodn paseq aq 11 TM sassaooJd gaol/was A lpga jtIl +uaur£ed s,pallun slseq paleolpn[pr-+sod lo -aid e uo suljglo BuT/waIAn Aq asnqF pIle 'a IsrM 'pn€# 'sJona leI+tIa lod lsu lege pIerS dlaq sao I/bIas K)pSa luI }uaur£ed scpa IIun '(CGsaoT/tns KIpSa luI }uauI£ed„) stuleI3 reln8an} aAjOsaj pUF '£jr+uapl '}uaAaJd dIali o) saolmas sap}Aord paIjurl 'sa3IAJ3S Xl IISa luI )uaur£ed ']uauIasinquIrai }sanbar OI slap}Aord io/pue s]ued TajjIed o) qoBar}no a+epdordde 8u!£oldtua Aq s+uau£edraAO iaAOoaJ o+ +dma Tlr IIIM paljun 's)uaur£edraAO 'maiar{ paqu3sap se saI]tunHOddo s8u}Aes pIle £raA03aj rnId Ian lo pue s}uaur£€clnAO roJ sao}/bIas £raAOoai pue uo}}uaAard apl/told it IM pa)}url L960g99€OW€-OZV8-g€JFVO€9-33903VOV :al OdOjOAU3 u61sn90a Docusign Envelope ID: ACAEC6EE-63CA4F3B-BA7C-3AA036880961 Plan(s) it sponsors and administers, assigns to United all ownership, title and legal rights and interests in and to any and all Overpayments that are the subject matter of the class action. In such cases, Customer will cooperate with United in any resulting litigation or arbitration that United may file to pursue the Overpayments. If Customer provides United with written notice that it does not want United to seek recovery of an Overpayment related to a class action (whether putative or certified) then, pursuant to its standard procedures, United will provide Customer with related Overpayment claims information, at Customer’s request. Customer is then solely responsible for determining whether it (or the Plan(s) it sponsors or administers) will participate in the class action (whether putative or certified), participate in any class action settlement, pursue recovery of the relevant Overpayment outside of the class action, or take any other action with respect to any cause of action the Customer (or the Plan(s) it sponsors or administers) might have. If this Agreement terminates, in whole or in part, United can continue recovery activities for any claims paid when the Agreement was in effect pursuant to the terms of this Section 2. Offsetting Process. Overpayment recoveries may occur by offsetting the Overpayment against future payments to the provider made by United. In effectuating Overpayment recoveries through offset, United will follow its established Overpayment recovery rules which include, among other things, prioritizing Overpayment credits based on: (1) the age of the Overpayment for electronic payments and (2) the funding type and the age of the Overpayment for check payments. United may recover the Overpayment by offsetting, in whole or in part, against: (1) future benefits that are payable under the Plan in connection with Services provided to any Participants; or (2) future benefits that are payable in connection with Services provided to individuals covered under other self-insured or fully-insured plans for which United processes payments (a “Cross Plan Offset”). In addition to permitting United to recover Overpayments on behalf of the Plan from benefits payable under other plans, United will enable other plans (including plans fully insured by United) to recover their Overpayments from benefits payable under the Plan through Cross Plan Offsets. Customer understands and agrees that in doing so, the Plan is participating in a cooperative overpayment recovery effort with other plans for which United acts as the claims administrator. Reallocations pursuant to this process do not impact the decision as to whether or not a benefit is payable under the Plan. Customer represents and warrants that the Plan SPD contains United’s approved template language authorizing Cross Plan Offsets. In United’s application of Overpayment recovery through offset, timing differences may arise in the processing of claims payments, disbursement of provider checks, and the recovery of Overpayments. As a result, the Plan may in some instances receive the benefit of an Overpayment recovery before United actually receives the funds from the provider. Conversely, United may receive the funds before the Plan receives the credit for the Overpayment. It is hereby understood that the Parties may retain any interest that accrues as a result of these timing differences. Details associated with Overpayment recoveries made on behalf of the Plan through offset will be identified in the monthly reconciliation report provided to the Customer’s Plan. The monthly reconciliation report will contain information relating only to Customer’s Plan and will not contain information relating to other plans for which United acts as the claims administrator. Recovery Fees. Customer will be charged a fee for the Payment Integrity Services described in this Section 2. That fee is set forth in Attachment D-5-Fees. No fees will be charged (a) if the Overpayment is solely the result of United’s acts, or (b) for recoveries obtained through a class Contract # 8577 ££98 # }OBJ)UO) SJaLUo+sno papury-JIas s6pa IIurl JOJ 4u€8 aq) IV paule luIeur }unoooe SuppM- Ioaqo [eraua8 paIlun e trio# panssr io/pu8 ilo ualIUM aq III,w s}uaurKed uerp-uou ro/pw s]3aqD 'spund Sulpp\old puz 8ulnssI JaUIO ISII) o+ aol lou JO algp allI uro# s£ep ssau}snq aAU aApoaJJa aouel€8. }unoooV atl) asjAai Kew paljun 'luaunaJ8v SIIP ur payloads suoTP8}lqo lr}ou€uy pIle guTPUN aq) till/w £ldUI03 OI slleJ Jatuo}snD lo 'pa}gJOua lap SRt{ uorUpu03 leT3wuy s,JauIOjsnD l€r{I sau}uua lap £lq€uos£ar paIjun }uaAa arp UI 'pa}run Aq passass€ sv uop}puoo le}3ueuy sGJauIo}sn) uo pas€q sl aoueTr8' lwro03V aHI 'uorsrAar saimbaJ a3u8Ie8 }rmo03v aHI ualjM pIle JT iauro IsrI) 41 lou IIIM pa)}un '(s}uaurKed aq pIle s+yauaq 8rup uo}}d}r9sard ''S'a) A IIAr Joe Klr8p-uou pa led TO TItle roJ s}uatu}snfpz Ipl/w 'suope8}lqo }uaur£ed ue Td pa}oadxa uo paseq a3uEjB8 +uno03V aq) qsTlqBjsa IITM paljun '(„a3uele8 }unoooV„ aIP) KITAjloe }unoooV Xue8' pa}oadxa JaAOO ol a3ueleq }unoooV }[ue8 e UP IUTBtu IITM laiHO Isn) ')un033V UI a3UBIB8 spuq iauIo]sn3 raqlo Kue tIITm pa18u}uIOO aq lou lITM }un033V Wma aq) UT SPUN s,iauro+snD 'rauIo+snO Aq pazrJot{InF saN (1/) pIle :suor)e8}lqo I8roueuU rauro}sn) iag lo (C) '(s}uatussasse pue sa8ietIOIns ale is se ''B'a) sasuadxa ueld (z) 's+yauaq IIPId (1) :JO ]uaur£ed roJ SPUN s,iauro}snD ol ssaooz paIjun apr,\old o) }un030V 7F188. 8 up luIeur puz uado IITM 'Jluqaq s,rauIo}snD no 'paljun ')un033V Xur8 Jauo+srID ol aoueJnsu} ssol do is aprAOJd sa}€rlUJe sIT lo patTun JT uaAa anl) sl slql 'spuru asaHI ap IAUd o) £llITqTsuodsai lo KFlrq€rl ou seq palrun 's]uauaq ugld lle roJ }uaur£ed roJ spuru gulp}Aord roJ alq}suodsar Klalos sl ratuo}sn) 'papurV-Jlas ST ueld aHI 's)u3ua8 ueld JO )uaur£ed roJ ,hIllqlsuodsoU- spund gulp}Aord } uo! laoS }un033V xue8. aq) luo a leMeJpqIIa\ e q8norq+ PIed aq K£UI saaJ ule IIao 'uoprzjlow+nr +uanbasqns Aq JO }uauIaar8v sup o) }uensJnd JauIo}snD Aq paz TrotIIne JI '}uauIaar8v SInI ul guy las saad raIl lo KIm o) uoI}Ippe ur 'saaJ – s-(I +uaun{o€++v UT payloads saaJ aHI pallun £zd HTM iauro IsrI) 'saaJ saaJ E uop3aS -pnerJ sG,Cued pIll{+ e urog 8u}}lnsai s+uaurKedJaAO paiaA03aJtm JO }uawasJnquI lal roJ alq}suodsai aq palrun III/w saoue}sumu IO ou rapun '}onpuoos IIU ltull lm lo aoua8}18au ssor8 s,pallun o) anp se,u }uaur£edIaA(.-) aq) +eqI sauTuua lap uo Ilo Tps}InF +ua}admoo JO lrnoo io 'TaIled uop24}qie 'joIn+rqre u8 }ualxa aq) o) }daoxa sapaA03ar glyn pa}e}oosse uo})€41qre ro uo IIeSIHI o+ pa+Fjar SIsoo pu€ saaJ csKauIone lou luaur£8(IIaAO paJaAOoarun £ur JO }uaurasrnqmw JOJ alq}suodsar aq lou IInn palrun -rauro}snD JO Jl€qaq uo as€3 }no- Ido ue alg lou soop paIjun alaRM uoT tor L960g99€OW€-OZV8-8€JbVO£9-]3903VOV :al adOjOAu3 u61sn90a Docusign Envelope ID: ACAEC6EE-63CA4F3B-BA7C-3AA036880961 United will issue Bank Account funding process documentation to Customer. Upon agreement by the parties on process and Customer signature of the documents, United will implement the agreed to Bank Account funding process. If United reasonably determines that Customer’s financial condition has deteriorated or Customer fails to comply with the funding and financial obligations specified in this Agreement, United may revise the Bank Account funding process effective five business days from the date of notice to Customer. At Customer’s expense, United will: ( 1) automatically stop payment on all checks that have not been cashed within twelve months of issuance, and (2) provide Customer with reports for the purposes of performing escheat. Customer is solely responsible for making unclaimed payee payments directly. Underfunding. If Customer does not maintain the required Account Balance: (1) Customer must immediately correct the funding deficiency and provide prompt notice to United, (2) United may place stop payments on checks, stop issuing checks and non-draft payments, and suspend any of its other Services under this Agreement for the period of time Customer does not provide the required funding, and (3) if Customer does not correct the funding deficiency within 3 business days, United may terminate this Agreement as otherwise set forth in this Agreement, such termination to be effective the first day such funding deficiency began. Customer will pay interest on the amount of underfunding at the Interest Rate. Termination. When this Agreement terminates, the Bank Account funding method will remain in place for the length of the run-out period. Following the run-out period, the required Account Balance may be adjusted through mutual agreement of the parties to cover Customer’s remaining funding obligations. Customer will close the Bank Account and recover any remaining funds after stop payments have been issued on all uncashed checks. United will provide bank statements and Bank Account reconciliation reports, including reports Customer needs for the purposes of performing escheat. Section 5 Medical Benefit Drug Rebate Allocation and Payment United or a subcontractor may negotiate with drug manufacturers regarding the payment of Medical Benefit Drug Rebates on applicable prescription drug products dispensed to Participants under the Plan's medical benefit. If a subcontractor is involved in negotiating with drug manufacturers regarding the payment of Medical Benefit Drug Rebates, it may retain a portion of the gross amounts received from drug manufacturers in connection with such products. Customer will receive compensation under this program as set forth in Attachment D-5-Fees. United will retain interest earned during the Medical Benefit Drug Rebate processing timeframe. Customer will only receive Customer’s Medical Benefit Drug Rebates to the extent that Medical Benefit Drug Rebates are received by United. For example, if a government action or a major change in pharmaceutical industry practices prevents United from receiving Medical Benefit Drug Contract # 8577 LLSS # Iam)HOD : lou IIens rauIo}snD 'sura IsAS ssaooe OI SJauo)snD JO sar}nbar paITun ras/WOJq laura iuI pIle 'aJeMUOS 'areMpier{ aljI 'pailun o) asuadxa ou Ie 'up}uleuI pue UTe 3qQ }snm rauIo}snD -(slr)lod rauro+sno 'salrsqo/w 8urouJ-JaqunuI 'BuTNodal ''8'a) silla IsAs uIHiT a pau}e+uoo sap}l8uopouru aq) asn pue ssaooz ol }q8Tr alqgrajsurr+uou 'aATsnjOxauou aq) Jatuo}saD s}uer8 £qaJat{ paITun 'ssa33v ssa33V IIra+s£S Z uop3aS 'suo4ezIue8ro MarAar }uapuadapu} arp JO SIlo}s}oap aq) roJ alqlsuodsar lou ST paljun (c) pUB CSJO+OB4UOOqns palrun lou are suo}pzTue8io MaTAar +uapuadapu} aq) WIjl sa8pajMOu]98 mmolsn) (z) 'saaJ – S-(..I }uatuqoe ItV ul qUOJ +as se }uaulljOJua le lo) scmmolsnD uodn pasrq SMa}Aar aaJJ JO raqmnu paI Turn e puoKaq Klddr ITTM aaJ v (1) :Kldd€ 111M 8UIMOljOJ aq) 'as€3 Hons UI -tuer8ord Mar/\al Fun Ixa scpa+run azrlrln £8ur ratuo]snD 's}uetu TRIO o+ UIer8ord MajAn l8tualxa ue aprAoid lleqs ratuo+snD 'suo!)€[nSar /waIAar Ruralxa alqeolldde raHlo lo sleadde UIjelo o) +oadsar IIjIM suo}}e811qo Kio)8ln8ar SIT }aauI ol iatuo}sn) roJ rapJO Irl 'ur8r8ord MOIAaH Ruralxa 'ureigord MarAar Ruralxa arp rapun lradde ue o) HSu s,)ueur}elo e o) se )daoxa 'saI}Ird paIsara IUI lay lo IIe pur }uem}8l3 aHl uo BuTpuTq pug leaH aq 11}/w uo}lruTuua lap sc£prd +FIll 'leaddg leura luT Terry atl) JO aur09}no arp JO }ueui leTO aq) K+!)ou Ileqs KHgd irlII 'Me1 alq80rldd8 Ipl/h aou€}lduroo UI TIe 'ssaooJd l8adde lrtua luT s,UFld aq) Japun s}yauaq ueld JO £}rlrqe[reAe aq) Su}uraouoo guo}}ru luna lap BuTpuTq 'leuy aleur TIeris '(saaJ –9-a +uaurqorllv tI} HUg las se) slradde letna luT laAal puooas JO MaT An leluedmT pIle JTeJ aq) 8uluuoJJad ol }90dsor q+r/w ueld aq) rapun £rF}3npy pau18u arp sr pa}u}oddF K}rRd alII •sl8addv j3Aa1 pu03as 'M€1 raprm paiInbaJ aJe Hou{x\ asot{} pu2 'uol)dTJosa Cl UFld £reurums atp ul quoJ Ias s IriSH leadde aq) amg 11}M +uetu leto allI pIle uo}}€u Tuna lap ]yauaq asJa Ape arp JO ]uetu leTO aq) qT lou IIens paljun ' IIed UT JO aloHa\ UT 'uIjel3 }yauaq u€1d e saruap paIrun JI 'ueld aq) ral)un poljun o) paUjUIqns s98rerio JO AllpIleA aq) au Tuna lap ( I1) pIle UFld arp JO suLla) aq) prcira luT pIle ani}su03 (1) o) KIjroy)ne KJeuo}}mosTP aq) paITun o) sa}=8alap nino)sn) 'IIons sv 'sjFadd€ Teura luI laAal }SJy JO MaIAar le}prdtu! pIle ITeJ aq) gujULro}lad ( I1) pIle }uaur£€d pur suoi+ru Tuna)ap +yauaq ppTu} 8u}unojmd (1) ol }3adsai q1 IM urld arp rapun £rr}onpy paureu 8 pal Tun slulodde Jauro}snD 'sleaddv laAOl IsrIa pIle suopeulurra loa )DallaS Iep luI SI8addV pIle suo!+eulurra+3(1 urleID 9 troTpaS 'pIed lou )nq paur8a sa}8qaH. Sma }uaua8. leorpa lq £UB JO orn}}aJJOJ 8u}pnlou} 'sa}uqaH 8ru Cl }yaua8 leo}paIN. ol )uauIal}}}ua s,ueId pue s,rauio}sn) aleu Tuna) Kla+erparum} 'salpauIar raIl)o o) IriSH s,paljun SuP}ulII )nor{}}M 'KFru paIlun 'saop ueld aq) lo iauro isrI) JI '}yauaq leo}paul s,ueld aHl rapun iam}oejnueur £ue UIO# s+onpord StrIP uo}}dp3saJd JO aserlund aq) io ilo sa+eqau Bru(I +yaua8 leo IpaIN roJ KUM AuF u! +oer+uoo JO aSurn8 JO a+F!+oSau IIl/w u€1d atl) lou rauio IsrI) JaIj1 Tau 'luatuaar8v StIll JO una) all) BuTinT) lujl saar8e iauro)snD pa}eurunla ro paonpar aq £uur saA}aoar ratuo jSII) }unourr aq) 'sa}eqaH L960g99eow€-ozv8-8eJFVoe9-3390=vov :al adOjaAu3 u61sn90a Docusign Envelope ID: ACAEC6EE-63CA4F3B-BA7C-3AA036880961 (1) access Systems or use, copy, reproduce, modify, or excerpt any Systems documentation provided by United for purposes other than as expressly permitted under this Agreement, or (2) share, transfer or lease Customer’s right to access and use Systems, to any other person or entity, provided, however, Customer may designate a third party, with prior approval from United, to access Systems on Customer’s behalf, provided the third party complies with the terms and conditions of such Systems access and Customer assumes joint responsibility for such access. Security Procedures. Customer shall: (1) use commercially reasonable physical and software-based measures to protect the passwords and user IDs provided by United, (2) use commercially reasonable anti-virus software, intrusion detection and prevention system, secure file transfer and connectivity protocols to protect any email and confidential communications provided to United, (3) maintain appropriate logs and monitoring of system activity, and (4) notify United within a reasonable timeframe of any (a) unauthorized access or damage, including damage caused by computer viruses resulting from direct access connection, and (b) misuse or unauthorized disclosure of passwords and user IDs provided by United. Termination. United may terminate Customer’s System access and deactivate Customer’s identification numbers, passwords upon: (1) Customer’s breach of this Section 7, or (2) the latter of the termination of this Agreement or expiration of the run-out period. Contract # 8577 LLS8 # }9u+uoD 'sa+eulpso aAJasaJ IBnuuV ®®®rnFknMne r©R6iaMmmB3-®MnzRRiV ToBir-aMDsDfj5T@M®jidi®ni)3®wnz @ nn$3-©omuiii5 I saDjAlaS IBj3ueu Id pUB 8u}){JMJapUn prepuF is s,pa) lun UT £ljFomo4oala paptAoid („ DHS„) aBrraAO) pIle s+uau38 JO £r8uIurns a aq) q+RW aouepio03e UI sao IxlaS s6pa}}un app\old asT&Iatpo pu8 suITelo la}s}u}upF III/n palrun pa Aoidde pIle pa/waIAU seq nIno}snD +€t{} +uatunoop suoIsnjOxa pUB styauaq ueld' JO AIgununs arp uodn pas8q aq 111/n go!!{/w (Ids l€uo!}uado ue 'uollaiosTP s,paljurl }€ 'a]€ai3 (I1) lo paAordde pIle pa/waIAm seq Jatuo ISII) Holy/w pIle uSlsap ueld s,Jauro+snD JO BuTpue}siapun siT uo pas2q pa}2aJ3 su{ palmn }8t{} ]uaum30p suorsnl3xa pIle slyauaq u€1d- JO £reuuuns aHI aztlr in (1) Ijl& palrun 'gaol/waS s,pajlun JO a leG aAqoaJJa aHI JO a3u8Ape UI KI+uaIOUJns pazrleuU lou st (IdS aHI JI ' Isoo leuorHppe ue )2 alqRj}eAe sl SCI.dS JO Buljumd 'qSIj8Ua UI aq III,w ads alIJd 'pajIUfl Aq paJa}sruuupe u8Isap ueld lrnprArpuI q3ea suearu 'qd€i8eJed SIIP JO sasocimd JOJ '„URId„ '}uauraar8V slt{} Japun u£ld aq) JO uoqeqsTUTupe s6pa IInn qIIM £3ua}sisuoo aJnsua ol iauuetu £lauIr+ e ur Mar/\ai s,pajlun ioJ £d03 F q)IM patrun aptAOJd llnls iauio isrI) 'CId-S uno SIT SURip ratuo+sn) JI '('IdS Ugrp Truy e pu€ s}uatutu09 sciatuo}snD ol asuodsar UT Uerp lguo}}}pp€ auo q)IM 'uodn paar8€ Allen)ntu se 'su€1d aldr+lntu JO urld qoFa ioJ ialIIla 'clds ug JO gulp pazuuo+sn3 e aJedaJd IITM pajlun '}sanbar uodrl 'a3ue+slssv („(ids„) uopdlr3sa(1 u8Id ,Creururns e r lmWIN) &sTI–o–R mnD Aq pas8r{mta:<=No =TaBS ssol do is £+IRd pin{+ r Aq para,\oo aq Arm 3€q+ smIUjo loa)ap ol Kulrqtsuodsar scratuo}snD sl )I stulelo (I.SI) sso'I do is tenp}A}puI JO gully s,iatuo}snD Hoddns ol SHodar j8}9UFUU tuTRIO pr€pue is SIr aprAOJd llr7w paIrun 'ratuo]snD Iq pa+sanbar se 'ropuaA ssol dols ,Cued pITII) q+w a3rjra luI ) q 'alun o) amp luo a ')gSn aq) sa/nasal palrun 'a IIS qaM aq) o) SC11 JO Jaqumu pa}eu8rsap z paprAoid ST rauIO IsrI) '8urpodaJ aurluo puc AIInbur sn+e+s UIrelo 'aoueua+uIern K+Ijrqr8Ija auIjUO 8uIpnl3u! a)is qa,u sa3jAraSa r3uro ISII) s,pallun q8norq} passa33e soIjAlaS uoper)sluTtupe aulluO ) ) aoaM®moTeTIl–IX s Jua pUB b IIla ) 3 M) mIn) @MIIT I jlbadiijMMm©FoliIIi ®mmMFjiToMm)mis–o-a) o aMm®BmRlaaa }un033V)u3tua saajAlaS JO 3Inpaq3S 8 uop3aS L960g99£OW£-OZV8-8€JhVO£9-33993VOV :al OdOjOAU3 u61snooa Docusign Envelope ID: ACAEC6EE-63CA-4F3B-BA7C-3AA036880961 Annual government filings of 1099 reports to the IRS regarding payments made to physicians and other health care professionals. 1 orm 5500. Claims /gt II_rinistration ServiCH t rEed m a flaiR satls@!MiR$1[Jnlted in 'o idgB@ United to determine whether a benefit is payable under the Plan. Customer delegates to United the discretion and authority to use United’s claim procedures and standards for Plan benefit claim determination Standard claims processing, including re-pricing and payment of claims, auto and manual adjudication using proprietary software, and pending and subsequent claim review. Claim determinations and appeals Services. Claim history load from one prior carrier using United’s standard process. Medical claim review and utilization management of specific health care claim: coding accuracy, benefit interpretation, and apply reimbursement polio: Standard coordination of benefits for all applicable claims. I ts. Plan benefits litigation support. If a demand is asserted, or litigation or administrative proceedings are begun by a Participant or health care provider against United regarding Plan benefits related to Services under this Agreement (“Plan Benefits Litigation”), United will select and retain defense counsel to represent its interest. If Plan Benefits Litigation is begun against Customer and/or the Plan, Customer will select and retain counsel to represent its interest. If Plan Benefits Litigation is begun against the Plan and United jointly and provided no conflict of interest arises between the parties, the parties may agree to joint defense counsel. If the parties do not agree to joint defense counsel, then each party will select and retain separate defense counsel to represent their own interests. Litigation Fees and Costs. Customer will pay for all reasonable legal fees and costs United incurs if United gives Customer reasonable advance notice of United’s intent to charge Customer for such fees and costs. and United consults with Customer in a manner consistent with United’s fiduciary obligations on United’s litigation strategy. Both parties will cooperate fully with each other in the defense of Plan Benefits Litigation. In all events, Customer is responsible for the full amount of any Plan benefits paid as a result of Plan Benefits Litigation. e e Attachment D-5 – Fees) and agreed to by United o to the termination date) for a specified period following termination of the Agreement, if purchased by Customer. United will bill Customer for the full amount of run-out fee that Customer owes, if applicable, generally one month prior to the Agreement’s termination date. The full payment of run-out fees is due and payable before run-out claims processing begins. If Customer fails to pay United fees due or fails to provide the funding for the payment of benefits, or if United terminates for any other material breach, run-out will not apply. Run-out fees may apply to partial terminations at United’s discretion. to promote Network Services Network access, I Network access to physical health networks, including chiropractic, physical therapy, Contract # 8577 LLS8 # )on+110) aaa leuo!+Tppe ue roJ alqel Ie/\e are sao}/bIaS pa}elaJ JaHIO ']uauIa8€ueur areo ]ua TIed)no pIle 'sa3r&las raquraur '+uatua8eu€ur ase3 '8ujSsaooJd sul leto 'a3ueua jupIn pug '+uaurdOjaAap 'ssaoor 4JOAtlau 8uTpnlou} unSold }uaura8euRtu qlleaH TwojAer{aq aA}suaqaidUIOO e 'soajAlas II)leaH lejojAeqa8 I oar) IA/olpng aAH pur £8olourloa) au IIno qI}/w q3eorddF laa/h-zg e sasn UI£r8ord aHI 'saseasrp pa}elar £}!saqo raHlo pu8 salaqr TP BuT+uaAaid JO leo8 8 q11/w s}uedTO TIled alg}SITa ol pajaArlap UIrr8oJd alqez}uro}snD 'iauio IsrI) Aq pa}oaIa s€ 'saajAlas uo!+uaAard sa)aq€!(1 pIle ,C)!saqo Ioe m) ®rno@un5i© € 8u}o8uo roJ aa J leuol Ippr on ST alanI }uatuaaige Su LIFtis €+FP BuT Is}xa a8 sml paljurl goTtIM q)IM Ja8ruetn }yauaq £3€uu€t{d g sasn JauIo}snD s£ 8uol sv 'uopzr8a luI leojlojsuI roJ saIldd€ aad v 'lopour OAp3Tpard o Jul e+zp ropuaA A3eurrerld leura}xa BuTo8uo pu8 le3 Ilo is Ill JO IIO!)elSa luI ) IMs JM) MR)Tal17 Su! IUISa)IIT roJ Kldd2 sa8J£q3 leuoplppv 'snIe is q)leaH JIallI aAordu} o) sru€J8oid aAnoeoJd raJJO pUF lsp )e sjFnp TAIPUT 41+uap! o) 'uralsAs £rF+apdoid F trIOa €+€p gulsn '8ullapour aA!)alpaId 'JauIo}snD Aq pa}oala sg 'aaa BuT}8po8au prepue}s e ioJ pap IAUd ST SIlo&lau dVI JO gOD atp JO apIS)no areo JOJ sao}mas uo}}81+oSau }soo }ueldsugrl 'IroMlau (GCdVJ.99) ur£iSord ssaoov }ueldsuerl pUF Ilo/wlau („ac))„) aouallaox l- JO SJa}uaD o+ ssaooe 8ulpnlou} 'saajAlaS a3rnosar )urIdsuer J. I play arp roJ alqTsuodsai aq 11 TM Jauio+sn) 'saA}+ua3u! piR,waJ JaJJO ol s}3ala rauIo+snD Jl 'uoqgj8a+In aorAap pIle 's}lnsar JO preoqqs€p 'sa}}!tmtmuoo 3}lqnd 'ssaoor prooor qIFaq leuosrad 'sa8uall€q3 pUR suo Tss}ul ssaulla/n 'sKa/tms qITear{ 'apnlou} £FUI noTt{/w '33ualradx3 ssauIl3,h pIle II+jBaq le)rBI(I W) We ) ) aWrW®rm®aM5 saa a IFUOPIpp€ :mFoliTO®am€TR63ia ) pIle )uatua8euztu aseo '}uatua8euetu uoTssTmpear 'luamaggueuI aJeo }ua}ledul 'uorleoyr}ou }uaura8€ueuI ase3 s8 ljons 'sa THAT ior aioo }uarua8eueuI argo JO s+uauIala ip 8uqerocLroou} tU2J80Jd ]uama88uem qIFaq leuosrad pa+eJ8a luT 'aAjSuaqaJdur03 e '+roddns rl)leaq Ieuosjad e Alllent) 'AoTlod qljeat{ 8uTpnl9uT 'JO)oaJip poTpaul e Aq pap Ing SR 'suop3unJ KaIlod IBa Ipa]A[ 'uo!}euuojul ssaullaM pug qljraq Ma}Aai pIle 'stool tIljeaH ssaooe 'suo}}d}iosaid a88ueuI 's+uatua luIS qljeaq £lq}UOUI ssa30€ 'spr€3 GII ]sanbaJ io ' luIrd 'prooar qileaH leuosrad MajAar 'snlr is suplo >[oar{3 's)soo pIle strojldo SIuaw)earl algluTlsa 'lap}Aord F pug 's+yauaq }noqR UIeal ol s+ued TajjIed 8mlqFua aHsqazumo ®©)®RTolata ) M®Rj=IEia–];i saIjAlaS )uaulaBeueIAI ale) pIle +uedpB18d neBbrm3 @®)®TFITI o pa)lun Aq o) paaJSe pau (saaJ –9-(1 +uaun{oeDV aas) iamo}sn) Aq pa}oaIa se 'SIU€j80jd Wro,w)au JO )nO L960899eow€-ozv8-8£JFvoe9-33903vov :al odOjaAu3 u61sn30a Docusign Envelope ID: ACAEC6EE-63CA4F3B-BA7C-3AA036880961 Med}car e Part Ds. If elected b)@le1, HTM Customer or, at Customer’s request, directly to Centers for Medicare & Medicaid Services (“CMS”), information for Customer to comply with the requirements of the Retiree Drug Subsidy (“RDS”) program in United’s standard reporting which is compliant with CMS submission procedures and deadlines. Customer will provide United with any information United reasonably requires in order to prepare these reports, including but, not limited to, Plan Variation/Reporting Code used to isolate members for whom Customer is pursuing the RDS, Participants’ social security numbers or health information codes. Customer represents to United, and United acknowledges, that information provided in connection with the Services under this Agreement is used for purposes of obtaining Federal funds. Medicare Secondary Payer reporting. United shall provide the applicable reports as required by the Medicare Secondary Payer Mandatory Reporting Provisions ("Reporting Requirements") in Section 111 of the Medicare, Medicaid, and SCHIP Extension Act of 2007. Customer shall provide United in a timely manner and in an agreed upon format all data United requires to comply with the Reporting Requirements. United shall not be responsible for any noncompliance penalties in connection with the Reporting Requirements that are related to Customer’s failure to provide the required data Catastrophic Events. During such time a state or government agency declares a state of emergency or otherwise emergency procedures are necessary with respect to Participants who may be affected by severe weather or other catastrophic events (a “Catastrophic Event Timeframe”) impacting public health or access to healthcare, Customer directs United to implement certain changes in its claim procedures for affected Participants, including, for example: (a) exemption from the application of prior authorization requirements and/or penalties; (b) waiver of out-of- network restrictions (e.g., out-of-network providers paid at the Network Provider level) , (c) extension of time frames for claims filing and/or appeals, (d) early replacement of lost or damaged durable medical equipment, and (e) other protocols reasonably required to provide Participants with access to health and pharmacy benefits, as applicable. Such protocols are applicable to Participants residing within impacted areas of the Catastrophic Event, and for dates of service that fall within the Catastrophic Event Timeframe ) bring the run-out period and for a mutually agreed upon fee: (a) a one-time standard accumulated extract which shows deductible, out-of-pocket, and lifetime maximum amounts for the current and prior year; and (b) open prior authorizations for Services that were approved but not yet completed. Contract # 8577 ££S8 # +3eJ)uo) Aq paqsrlqe lsa jSIt e ilo payloads su Bru(] uo}}dliosaJd e JO )soo alqe/woIF umtuTxguI anl : DVIA[ 'sral€salor{/w lo sro)ngn)SIP 'saroeuuet{d JO Jaqumu palunIT AaA F io allo ol pa+nqu}sIP alg gaul/w s8mCI £}leIoads :sgnr(I uo IInqjI)skI pO+!UI11 'grucI ou3uar) e s€ £JnuaPr pq) a3rnosaJ ejRP alqelrzAe J9rilo JO ugds-lpa IV aHI ul papnjOUI sro+roIpuI 8mpnIour siol38J uodn pas8q apFtu ST uo!}uuluualap 8rua 3uauaf) all) '}uauIaaiSv SIll) JO saso(Imd lol '(s)}uarpar8uI aAno€ aur€s arp JO +unoruz IzoIjuapr u2 8UIA€t{ SluG uor+du3said puer8 e q+l/n alqea8ueqoJa IUI pUF }uaIFAInba £ljFor}nadgiatli st Ivy) 'am8u £J8+audoid -uou IO Alg}audoJd 'l89nuatIO SIT Aq pay}+uap} raIl)atIIU 'gm(J uo}+d}nsard v :gnr(1 3lrouar) K+notIIne IF}uaunua AOS iossa90ns £u€ io uor In+sIuuWV 8ruc[ pIle pooJ sale is palrun aHI :v(Id 's8mcl uor+duosard JO uor+nqu}sIP pu8 al2s aq} ul pa8e8ua siaT€saToqM apnlour lou TIeris :s8rucl uor+du3sard sa+nqu+sIP lo s)ajJeuI 'sIlas 'sarn+oFJnu€ur IFr{+ KIljua uv :rorn)3ejnuBI/q gnr(I 'uITel) uo}+dlrosaJd F JO guIITy puu 8u}ssa30rd all) ioJ £oeuueqd aronIaN e o+ T)wd uoI+Fsuadtuoo JO a leI paper+uoo ariJJ :aol 8ulsuads!(I 'u€1d sc}uedror IIed at{} IIinn a3ugpr033z UI pap}Aord ST aS8raA03 q9 THat JOJ }u2dr9r IIed e o) KoeuuRr{d 8 Aq pasuadsrp sarlddns io gaol/oas raIllo lo s8ru cl uopdposard :oaIAlaS uo!+dli3said paiaAO) spaau leolpaul IFnprAIpur sc3uedror IIed e paul o+ uo}}vo}patu z az}uro)sn3 o) sgruCI uopdu3said arour ro auo s}snFp€ 10 saxrtu OIl,u +sr3FUuet{d e Aq paredaid sl )gIjl Bru(J uo}ldp3saJd v :gni(I punodUIO) '+onpord puFr8 e 88 £JBuap T +ZIP s30rnosor € 1ep alqrlre A€ raIl)o lo u£ds-Ipa]/\[ aq) Aq pa+eu8rsap s8 SruCI uo}}dlr3saJd a3Jnos-plntu ro aoJnos-a18urs v :gnr(I puer8 'u8ds-lpa IN JO asn luo a 8ursue ratuo}snD ol £pTrqerl ou aAeq Ijl/VI palrun pUF 'drwv qsrlqe+sa lou IIIM pa3run 'luauIaaJ8v SIIP Japun ratuo}snD OI pap}AOJd 8urond arp Bull{srlqF lsa JO sasocimd loI dA\' aunrua lap o) s£€p UOA3S Kla AO uet{+ Kl}uanba# ssal ou pa)run Aq pa}€pdn se ueds-Ipa]/\[ uo £lar III/h paIInn 'pasuads TP a)ep aq) uo Bru(1 uo}+d}JOsaJd aHl JO JaN ITSIP II aq) UD paseq Bmc1 uor}duosaid € JO '(„u€ds-lpa IN„) s}uauralddns tIl1/h 'aprnf) 8uroud uouduosard aeds-Ipa]/\[ aq) UD pa+3aIJaJ sg 'aond aIgsalor{/w a88nAe arIJJ :(dAtV) 3apd ajBsaloqzu a8eraAV 'a3rnoS 8uroud z lo rarn+oejnueuI atp Aq Sura ouauar) JO 8rua puei8. € sv paypuapT lou io ial{+aljM 'asuaoIl F raptm Kjled pnV) € io a}£rlyJe io rapIor{ }tIa led aq) Aq pain+9€jnuFur sl goTHa\ pu€ tug led ropun sl jull) 8rucl puFra F JO +ual€AInbaoIq aq) sl )erp )(.IN anblun g H+T/w gmp v :gnr(1 aA!)eura IIV puBr8 pozlioq+nv 'IeJnld io Jeln8urs aq £2ui spro,w aHI 'MOjaq q TroJ las s8urueaur aq) a Aeg sulla) 8uTAolloJ aq) 'sao}hms aA}}rJ}slulurp8 +uauaq £oruu€qd lod suopjIlya(I I uopaaS 'paraAOO sr }uzdror}r€d aq) gonIM rapun uouduosaa ueld AIetuums aIT+ q+r/w ;ua}srsuoo s}uedrorIIed alqI8rla s,Jauio}sn) ol alqel}eAU apuuI aq III,w Z-C[ luaun{aFIIV sun ur paqnosap saorAras atiJJ 'aaJ l8uor+rppe ue o+ +oafqns aq Ken aprAord OI saar8e paIrun saor/nas Teuo}lrppe £uV '}}qTqxa SjIP UT qUOJ las asor{+ o) uoplpp2 UT sao}hms ap}AOJd pa)}un )eq I }sanbai £rtu JauIo+snD 'a)erlUJe Ja8eu€ur +yauaq £08uu8tld s)i q8norq+ JO £l+oarrp latIIla Jauo+snD o) aprAoid ol paar88 sag pairun sa3r/nas aAr+eJ+srunnpR +uauaq Koeuueqd atl) are Sur/uolloJ aHI sa3jAraS uoper+slulurpV +Uaua8 £3eurreqd – Z-(1 )uaurq38 IIV L960g99eow€-ozv8-8eJP-vo£9-33903vov :al adOjaAu3 u61sn90a Docusign Envelope ID: ACAEC6EE-63CAz+F3B-BA7C-3AA036880961 United. United may have multiple MAC lists, each of which is subject to United’s periodic review and modification in its sole discretion. Home Delivery Pharmacy: A facility that is duly licensed to operate as a pharmacy at its location and to dispense Prescription Drugs via postal or commercial courier delivery. Home Delivery Pharmacy includes pharmacies that are affiliates of United. Network Pharmacy: A retail pharmacy, Home Delivery Pharmacy, Specialty Pharmacy or other facility that is duly licensed to operate as a pharmacy at its location and to dispense Prescription Drugs to Participants and has entered into a Network Pharmacy agreement. An affiliate of United, in its capacity as a Home Delivery Pharmacy or Specialty Pharmacy is a Network Pharmacy. Manufacturer Administrative Fees: The administrative fees paid by drug manufacturers to United for United’s provision of Rebate administration services. NDC: The 11 digit National Drug Code that is the identifying Prescription Drug number maintained by the FDA. Non-MAC Generic Drugs: Generic Drugs where market conditions do not allow for MAC prices to be used. P&T Committee: The Pharmacy and Therapeutics Committee formed by United that reviews a Prescription Drug for inclusion on the PDL and creates criteria, policies and procedures for such inclusion including, but not limited to, clinically appropriate quantity restrictions, step therapies and prior authorizations. Prescription Claim: A single request for payment for a Covered Prescription Service. Prescription Drug: An FDA approved drug required to be dispensed or administered only by prescription from a licensed health care professional in accordance with laws. Prescription Drug List (PDL): The list of Prescription Drugs as developed by United and approved and adopted by Customer for use with the Plan. Price Protection: Amounts received from Drug Manufacturers from contracted restrictions on drug price inflation. Rebate: Any discount, Manufacturer Administration Fees, price concession or other remuneration United receives from a Drug Manufacturer under a Rebate agreement that is contingent upon and related directly to Participant use of a Prescription Drug under the Plan's pharmacy benefit or the medical benefit during the Term. Rebate does not include any discount, price concession , Manufacturer Administration Fees, or other direct or indirect remuneration United or a group purchasing organization receives from a Drug Manufacturer for direct purchase of a Prescription Drug or for the provision of any product or service or tool, including analytical services used in the review of data. Pricing Source: The Medi-Span Prescription Pricing Guide, with supplements, or another nationally recognized pricing source determined by United. Single-Source Generic Drugs: Generic Drugs that have either recently come off patent and do not generate discounts traditionally delivered by Generic Drugs or have an exclusive Drug Manufacturer. Specialty Drugs:Prescription Drugs that have at least 3 of the following criteria: (a) a Contract # 8577 ££S8 # }ou3uo) K luo 's+uauraaige uor}rdror IIed £oeuueqd Ilo/WaN allI JO suLla) ray io pur 8uroud aq) pUB 'Mel alqe3}ldde 'ueld aq) qIIM a3uepioooe UT saoT/was uo!+dp3sard para /\oD roJ stuPID uo}+dposard &d pIle ssaoord 'a}80rpnfpe IIT/w pallun 'uo}}eolpnfpv surFrID 'ssa30rd sul tel) £'z IIO!)aas 'sar3euueqd IJO,wlaN o) sap}Aord paIjun saor/oas roJ UonFSUadtUOO se saojXIas aA}}€r}s}u}urp€ puz Bupa IreuI roJ sa8rrrIO pIle saaJ ssaooF aAraoar £euI puv sunrl3 £3euueqd gtrlssaooid roJ sun IsAs su Ie luIeur paljun -saaJ rossa30id suITeID 's}uFdrorUVd ro raruo+snD Aq +uaurKed ioJ s8urllrq a}eudOJdd2 SUju}uIqns ale saloeuueqd 4ro,wlaN Jay)atIM au luna lap o) saIoeuueqd lro,wlaN JO s;}pne a)!s-uo pa}3alas pIle s}}pnu ]sap aApoadSorlai pug aurp-teal }onpu03 ',u€1 Aq pairnbaJ se pu€ urri8oJd }}pn€ pJepue is SIT gyM aoueproooF UI 'IIIM paljun 'sao I/was ITpnV 'sa}o€uun{d ar04uaN 8u}l€}}uapai3 roJ ssaooJd alqruosFor e uir}ureur pug qsrlqr Isa IIIM paImfl 'lro alau aq) ol sa8urqo luna}8uI Aug JO aoBou aouF APU q jIM JauIo}sn3 aprAOJd ol UOJJa alq8uosear e aljeur 11}/w paljun ']io&lau £oerru€rid all I tuo4 saIoruwqd Ilo,wlaN aAOuraJ io ppe £etu paIjurl -Jamolsn) o) saol/bIas apl/\old ol sa}oruuerici JO qJO,wlau e ure]ureuI puu qsrlqe lsa III/n paljun 'uolleDslulwpV IIlo,u)aN £3euIreqd Z•Z uopaaS suodar aurluo pJ8pue is s,palrun rauIo+snD ol alq8lrR Ae aleuI uIM patrun '8uruodau- '}uauraar8V snl} ul qUOJ las saormas }Uauaq Smp uorldUOsaJd aq) JO iapTAoid aATsnl3xa sIT se a}e}lyJe SII io paljun sa8e8ua Jamo)snD '+uaura8e8ua 'luauIaai8V sup ur gHg )as se pIn (s)(IdS }ua3ar +soul s,rauro}sn) qUa aoueproooe ul u8ld aq) o+ saor/bias aAr}Fr}sIu}urpF apl/\old IIIM pa) lun ')roddns aA!)ei+slulupv I'Z uopoas @\mmwETd®rmaToT}bIg '£oeuuer{d qr04tIaN IIons Aq palrun o+ pauodar se sSm(.I uo}}d}nsard roJ X08uurqd qiOMlaN r s£rd rauro}sno guTArd qs93 e leVI s]unoosrp iauIo+sno alq80rldde lle 8uIpnjOu! 'auld aHI :a8ieq) £izuro)snD pIle lensn 'pa+run JO sa}€rlyJe are }€rjl salo€uuFqd sapnIou I £oRurreqd KIIe loads 's8ru(I &18 loads asuadSIP ol £oruueqd e se a}erado o) pasua3 ll £lnp sl )eq) £}1IToeJ v :£3euIreqd A+lgl3ads aInt) ol amr) UOJJ pailun Aq pa}epdn pIle paulnuTeu SI is II Bru(1 £+l€ ToadS alII :+sII gnr(1 ,C)I8l3adS '8ur IIas }uar}edur aq) ul £luo paia}sruIurpe ale (z) lo ! (dla 'ezuanuu} ''8'a) suo}+TZjunurur} aApuaAard ale (K) :gu}unos Koeuugt{d iealonu armbaJ (x) :]8q} sSm(.I uo!}dp3sard Kue apnlou} lou TIeRS s8ru(.1 Kljul3ads tuFr8ord or}naderat{} K}leroads 8ur+srxa ue JO IIed se pa8eu€ur (g) lo fUOI+}pUOO s,}uedro}H8d arp ul 8mzIjzr3ads Jap}Aord ar99qljear{ r Aq uopeulpro03 argo io/pue }uauIa8eueuI 8upTnbar £dgraq+ (8) JO f(uor}rr}srurmpF JO Isoo aq) lo sa}lddns 8ulpnl3xa }nq) gulllas aJ80q}leaH R ur io leuorssajord aJ€oq]lgaq e Aq paralsruuupe £lleuo}ssajoid sStllp alqe}oafu} para}smnupe algolIilean lo uorstuu} (J) :s)uatuar}nbaJ 8ullpueq/BuTddTqs ou loads raIlio lo lo4uoo a8ero is paz IF loads arlnbar +€rjl sgml) (a) !uoI}eonpa uo!}€J}sju}uIpe/uo!+ziedaid uopoaFu} io/pu€ +uauIa8eueuI }oaJJa apIS JO/pue 8uuo+ruouI aouaraqpe ro/pue uor}eonpa ]uedroIpud qldap-ul 'pasnooJ 8uurnbar s8rup (p) ip[oqsarq} }soo A+j€13ads SiNO aq1 Aq pauyap se )soo-qB TH ST Pq+ 8rup JO uoT}elnuuoJ Kw (o) :snlr+s ueqdIO -er)in lo u€r{dIO pa+€ug}sap v(Jd (q) :£8olourloa) £deiar{} auaS }}q}qxa ro ]onpord £8oloutIONO Iq L960989€OW€-OZV8-8€JFVO£9-33993V9V :al OdOjOAU3 u61sn90a Docusign Envelope ID: ACAEC6EE-63CAdIF3B-BA7C-3AA036880961 Prescription Claims (a) that are prepared in accordance with the NCPDP promulgated standard format that contain all information necessary for processing of a Prescription Claim and are submitted by the Network Pharmacies in a timely manner through United’s system; and (b) properly submitted by Participants as requests for reimbursement for Covered Prescription Services. For home delivery, retail and specialty pharmacy services, United may retain the difference between the amount which United reimburses the Network Pharmacy and the amount which Customer pays for a Prescription Drug or service. Payments to Pharmacies. In connection with Prescription Claims, a timing difference may occur between the time in which United withdraws funds from Customer’s claims account and the time in which United issues payments to pharmacies and other payees. United may retain any interest earned on these amounts during this time. Interest is expected to be paid at overnight deposit rates by United’s banking institution. Claims Determinations and Appeals. These services will be provided for pharmacy claims per Section 6 of Attachment D-1 - Medical Benefit Administration Services. Section 2.4 Benefits Administration and Support - Clinical Services. United will provide the following clinical services to Customer: (1) 1.5.1.1. Utilization Management Development and Support. Customer will implement United’s standard utilization management programs for the Plan. United’s utilization management criteria will not be available for use by Customer or a third-party vendor of Customer. Instead, Customer may choose to implement custom utilization management programs; however, all customizations are subject to approval by United. Additional administrative fees may apply for non-standard utilization management programs requested by Customer and agreed to by United. Such customizations may impact the financial terms in this Agreement. (2) Prior Authorization Services. At Customer’s request, United shall administer a prior authorization program applying rules and conditions applicable to the Plan. (3) Changes Due to Shortages, Recall or Public Health and Safety Concern. In the event of a Prescription Drug shortage or recall or public health and/or other material safety concerns impacting or related to the distribution or dispensing of Prescription Drugs, Customer authorizes United to make temporary clinically appropriate changes to the PDL status and/or tiering of Prescription Drugs, days ’ supply limitations, Pharmacy Network access, utilization management programs or similar programs or initiatives to address such concerns. Prescriptions Drugs impacted by such changes shall be excluded from all financial and performance guarantees. (4) Participant Communication. United may, on behalf of Customer: (a) communicate with Participants to describe health-related products or services (or payment for the products or services) included in the Plan(s), including communications about Network Pharmacies, replacement or enhancement to the Plan(s), and health-related products or services available only to Participants that add value to and are not part of the Plan; (b) conduct population-based activities relating to improving the health of Participants and reducing their healthcare costs; and (c) contact Participants with health education information and information about Prescription Drugs, treatment alternatives, and related functions. (5) E-Prescribing. United will provide prescribers with electronic access to Participant Plan Contract # 8577 ££98 # )OBJIuo) III,w patrun '}uauIaai8V sup JO sulla) aq) q tIM a3uerldtn03 irl sr Jauio ISII) paprAord ')uauIasrnqs TCI '}uatuaaJ8v sup iapun iatuo+sno ol anp sums JaIllo luo# +uauIK8d aq) dnooai £eur palrun lo palrun ol }uaur£ed ljons puryaJ IalIIja llyn rarno IsrI) 'pal Tun Aq rauIo+snD ol +uauI£ed snoauoua JO }uaur£eciraAO Kue JO Ina+xa aqI ol 'pauTe)qo sa}eqau- aq) JO Kue +suTe8e uol Ioe ljons £ue luo a 8ursue 'sasuadxa pw saaJ csKauIOIle alqruosrar 8u}pnl9u} 'sIsoo alq€uosgar AIre lasJJO KgUI pa)lun 'UOI Ioe uor+3alloo e Hons sale}}TUI paljun JI ram+oejnue IN Bma e UIOiJ sa+zqaU. }9alloo oi Iaas ol trot Ioe apr)IUI 'o) paiInbar }ou sr )nq '£8ur paIrun 'sa}gqau roJ luauraarBe ue rapun Sul/no s+unoue JO s}uaur£Fd leI IIed io s}uauIKed-uou £u€ roJ alqTsuodsai aq )ou III/w paljurl 'sa+eqau loalloo pue aoroAur 'ssaoord ol SUOJJa alqeuos8aJ £lle}oiawtn03 asn TITM paIjurl 'uo!+oallo) 'rauro+sn) roJ sa}Rqaa JO }unourg Jeln3 IInd £ue UF+qo ol UOPRS}lqO on suI palrun ']uauIaai8v SPP UT paqposap saa}uerrnB a}Fqau. £ue roJ +daoxa 'saa+uerenr) a}eqaH 'sa}2qaU aAraoar OI alglgIja ar8 aAa}laq lou saop }} IRq) stuPID uo})dposard roJ sa}8qaU ]!urqns ol pa)r8rlqo lou SI pal Tun pIle 'sa}eqau ioJ alqT8 TIa ai2 s8ru c1 nojld}i3said ip lou pue sgm(.-I pUZJa- IIe lou +rH) spur}srapun rauro}snD 'sls€q oy loads rauio}sno F uo lou pIle ssau}snq JO qooq s,paljurl uo pas€q SJam}ozjnue]N 8ruc[ qjlm sa)eqau- saI81 logan paljun PqI sa8pajMOuxog Jatuo}sno sa}Fqau roJ siam+oejnuepN Bru(J qIIM AllouTpuT lo AT+oar}p +o€quoo OI paljufI saz}roll)ne Jauro}snD eLla luo }9rr}u03 a+Fqau s6Jam}38Jnuz}\[ Bma atp BuT£js!}£s uorpz IIT in turzID uo}}dTi9said puz lad '(s)ueld s,Jauro ISII) (I1) pUC saa+u8r8nf) - 9-a }uaturIoe IIV ur qUOJ Ias suLla) aq) (1) :OI ]3afqns sa+eqau aAIaoai oi alqr8rla aq IT IM iauIo}snD -£+}l}qT8Tla a+Fqau •)uaura88ue IA[ a+eqaH 9'z uop3as '8ruCI uor}duosard aq) JO ssauaAr}oaJJa }soo all) uo s]uauissasse pile 'sa)eqau alqrjIeAe 'ol pa IImIt lou lnq '8upnlour }soo uoI}rsmboe s,gm(J uoqduosard aq+ 'o) palunIT lou are 3nq 'apnlou T £eui sro+o€J 9}UIOUOOa '£ldde PInotis s}uauIar}nbar uor+eoyr+ou JO slrmrl Klddns iag)all,w se IIaM se 'Bru(.I uojldTJosaid aq) JO £020yJa aA!}rlaJ JO £+ajes aAr+elar 'Kderaq} ul a08ld aHI JO suo}}enlrAa 'ol pal IUIII lou aJe lnq 'apnl9u} KeUI sro}3eJ le9TU Tl) SJO}32J 3rtuouooa pue lr31mlo 'OI palunIT lou )nq '8urpnl3ul sio}oeJ JO JaquInu e 8uuapTsuoo Aq acid atp JO raIl uwuao e o) gm(I uo}+d}ros3id e JO uo!}€oy}sselo leuy aq) salem poljun 'ssaursnq painsu! KItty s,paljurl JO }uama8euetu aHI ur s£oldtua pIle sdoIaAap paIrun leg) salSa lexIS }uauIa8€ueuI pug lad auies aq) ql Im iauro+snD apjAord pIle raJJO ol sr )ua}ul scpa+run 'suorsroap gujlap 8rup OI pal Turn lou +nq Sulpnlou} suo!+ouru }uaura8rueuI puz }uauIdOIaAap lad UP IIao qI IM rauro)snD }s}ss€ pu€ £lddns paIlun )erp pa}sanbar seq iatuo}snD '(s)'-ICld s,ratuo+snO JO u8Isap aq) But)3alas uo ra]€ur-uolsl3ap a)etur Itn allI ST lauD}snD aTIW 'sraquosard pug 's]uedror IIed pa}oedurr 'iauro}snD oi sa8uerio lad aA}}eSau JO suo}}eoypou a}e}rdOJdd€ aIqe[!eAg aq8ur ro apIAOJd III/h '}sanbar scrauIo]snD Ie 'palrun 'lad allI o) sa8ueq3 8urMOljOd 'ueld aq1 ui payloads se saIl(idrIS lo saoi/was ray+o lo s8ru(.I uo}}dp3said Mau 1(Id aq) ul apnl3u! IPM pallun 'sa8ueqD lad 'a+rsqa,w argo qIFaq }u2dror IIed scraruo}snD iio lad alj+ +sod £gUI mmolsn) 'saar8r paIrun pq) paprAord 'leAorddB ua++u/h loud s,pa)run )not{}rM AIred Jay}ou8 oi 'l(Jd all1 8urpnjOUI 'sl(Jd s6pa}run ap}Aord as},'wraq IO lo llas 'alnq}BSTP '£d03 lou III,n rauIo}snD '}uauraar8v sil{} ul paprAord se +daoxa 'sa}Hed a}£}rdordde Jarilo lo rauIo}snD ol alqelreAe I(.Id aq) a]eur IjIM paIrun lad aq) JO asn lle do is IITM iauIo}snD ')uaunar8v STIjl JO uo Ipod sao}mas +uauaq £oeuu8r{d aHI sa}euluua} iauro isrI) J! JO '+uatuaaJ8v SjIP JO uo}}eu luna) uodn 'l(.Id aq) sr sl(Jd scpa}rufl JO mom lo allo +dope III/n iamolsno '(1(Id) Is11 gnr(I uopdlr3sard s'z uop3as uoWuuoju} L960899€ow€-o£v8-8eJFv9€9-]3903vov :al odOjaAu3 u61snooa DOCUSign Envelope ID: ACAEC6EE-63CAJ+F3B-BA7C-3AA036880961 reconcile, allocate and credit or disburse all Rebates received in accordance with this Agreement. Customer acknowledges that it has no right to receive a payment of Rebates for Rebates United has not received or until such reconciliation and allocation has been completed. Customer’s first Rebate payment will be remitted no later than 210 days after the end of the incurred quarter following the date United began pricing pharmacy benefit administration services, based on actual amounts received. Thereafter, Rebate payments will be made within 90 days after the end of each quarter, which will include true ups on all prior quarters. An annual reconciliation will be performed after the end of each contract year. Rebate reporting will be provided at the time of payment. Other Pharmaceutical Relationships. Nothing in this Agreement shall preclude United from pursuing, directly or indirectly, other sources of revenue from Drug Manufacturers or engaging in other revenue-producing relationships with Drug Manufacturers. Additionally, United or its affiliates, acting as a Home Delivery Pharmacy or a Specialty Pharmacy, purchase Prescription Drugs from Drug Manufacturers and receive certain discounts and purchase rebates from Drug Manufacturers in connection with these purchases. United retains these discounts and purchase rebates and does not pass them on to Customer. Customer Rebate Contracting Prohibited. If Customer, or its affiliates, vendors or third parties contract with or receive payment from another party, including a Drug Manufacturer, for a discount, utilization limit, Rebate or other incentive associated with the utilization of a Prescription Drug, Customer will be in material breach of this Agreement. Upon such breach, United, in its sole discretion, may adjust or eliminate any guarantees described in Attachment D-6 - Guarantees. Upon request, Customer will cooperate fully with United or a Drug Manufacturer to verify Customer’s participation in any Rebate program and to confirm that all Rebate-related payments were made for Covered Prescription Services to eligible Participants. Changes. If a govenrment action or a major change in pharmaceutical industry practices eliminates or materially reduces manufacturer Rebate programs, Customer’s payment amount may be reduced or eliminated. In such event, United shall promptly notify Customer and revise or eliminate such payment to be effective on the date of the reduction or elimination in Rebate payments. In addition, reduction or elimination of Rebates in this event shall constitute a change in the Agreement as described in the Attachment D-5 - Fees such that United has the right to propose a change to the fees as provided for in the Fees Section or change the Rebate arrangement under this Agreement. Termination of pharmacy benefit services shall constitute a change in the Agreement as described in the Fees Section such that United has the right to increase the fees for medical management services under this Agreement. In addition, Customer agrees to reasonable cooperate with United in order to obtain Rebates. Section 2.7 Home Delivery Pharmacy Services. United will provide, through its affiliated Home Delivery Pharmacies, Covered Prescription Services to Participants in accordance with the SPD. Home Delivery Pharmacies will provide customer service support for Participants who use Home Delivery Pharmacy Services. Upon request, United will make available to Customer Home Delivery brochures for distribution to Participants. Home Delivery Rates. Specialty Drug pricing guarantees and terms apply to Specialty Drugs, even if dispensed by a Home Delivery Pharmacy. If Customer or Participants request or require expedited or alternative shipping methods other than United’s standard method, Customer will be solely responsible for those costs Contract # 8577 ££98 # tonIIlo) suITeID uo!}dposaid arp JO aldUIes PIleA £lleo}}spe is e MajAar ual{1 lljM paIFun 'uoqelndod rolla pa+oadsns aITIua arp InjM paljun sap I/\old rollpng SIT lo iatuo}sn) JI 'sJona pqoadsns Aug qIIM pa}e}oosse +unoure Jellop aHl se IIaM se 'uo}}elndod rolla pa}9adsns aITIua aq) io snoauona aq o+ pa}oadsns SUITeID uo!+dposaid JO aldUIrs aAT+e)uasaidai 8 u}e+uoo juM HodaJ }!pnr ljons 'ypn€ aq) JO uo}snlou09 aq1 Jau€ sK€p st ulqlyn pailurl o) guT In& UT podar ]!pn€ UF aprAoid tIeris ioFpne sIT lo Jauio lsu) -uodai ]Tpne SH q)IM paITun gUjp}AOid oi loRd qmFasai IFUo!+Tppe uuojrad OI palrun ioJ stuPID no!}dposaid snoauoua pa+oadsns OOE o) dn pallun puas £euI Joupne SIr JO rauo}snD 'uoT}oas STqI in IM aourTlduI03 ainsua OI paljurl Aq /waIAm o) +oa[qns aJe sa lou Hons puu 'sroua paujItrap} AIre }uamn30p ol KIrssaoau }ualxa aq) ol sa lou up taJ pIle ale) £eui ro+!pn€ s,iatuo+snD '+}pn€ Vans Submp pa}}un Aq papjAmd s+uoum30p pa}€1ai ro s+o€r}uoo ure laI lo (as I&raIllo io salon ua+}}uwpuFr{ q8noJql) £d09 lou XFm ro+}pn8 s6JauIo+snD pIle ro}rpnR KInd pITq+ uodn paar8e Allen)nur e Aq a+}s-uo pa}onpuoo aq }sntu s}uatuaar8r a}eqau JO Fpn€ £uv 'ssal ST iaAatlo}tIM 'r€a£ iad pa]zraua8 anita Aar a}eqau plo) s,iatuo+snD arp JO %gl )seal )e JOJ }unoooR let{} s}uauraar8e a}eqau io s}uauraaiBe a}eqau g do I s,paljun ol ssa30€ '+}pn€ a}eqau € JO aseo alj} ul 'pur 'stuPID uopd}nsard alq£ollddF Tlr 8ulpnlou} 'Hpnz atp +onpuoo ol £mssa3au Klq8uosFar uo!}€uuoju} oyloads-ramo}sn) }ueAalar lle o) ssaoo€ 1pjM io}}pn€ s,ratuo}saD ap}AOJd IITM palrun a3UPAPP UI latElo+sn) arp Aq paAordde puc paMa}Aar aq o) saaJ ljons '}}pne aq) o+ pa}rlar }sanbar jauIo}snD e o) anp srn3u} pallurl sasuadxa £r8u}proeilxa Aug ARd osle lum iatuo}snD 'ppne atl) HIIM uor}oauu03 ul srnou} }} }eq) sasuadxa Kue Ard 11}/h JauIo+snD 'po}rad )}png IRq) lol pa/woIF aq IIT/h s}}pn8 raH+IIU ou pUF 'pasolo aq 11 TM po brad +}pn€ )€q} '(ad03s IIly JO paljmTI lay+aljm) pouad upng jFjn31uFd g roJ pauLrojiad uaaq SFr{ }}pru aouO 'pa}!pn8 aq ol po brad aq) JO pua alp JO sq}uou 9 uu{}rM pa}}TUIqns aq )smu ]}pn€ u€ ioJ s}sanbau 'aalueJen8 le}ou2uy aq) JO una) atp ol pa IImIT aq ljIM adoos ITpng aq) aseo q3}qM u! 'sq}uour ZI 8u}paa3xa poTnd e roJ aa}uvrgn8 l€roueuy 8 o) sa+rlar upnr aq) ssaltm 'sq}uotu ZI paaoxa OI lou pojJad F iaA03 lITM ad03s +}pne aHI 'pouad uor+z+uaunldtuT pu8 l8/uauar lenuur OIl) JO SPUFUIOP aq) JO asn€oaq KrFnuRf ro raqtua33C[ SunnI) pa}3npuoo lo pajRPItIT aq III/h s+Tpn€ ON 'pa IIun Aq ol paarBe pUF alqFUOseai aq +sntu s+!pnD ITe JO uor Iemp pUF 'adoos 'adA) 'aInT) 'aozld ariJJ '+}pne o+ +ua luI s)} JO SUnpM ul pailun £JPou +sntu jauro}snD '(]o€q looT q+now 81 ue o) dn) leaK iepualeo 8uTpaoard £Ta}elpawu! all) pIle 'pa+onpu03 ST ]}pne aq) HOTqM UT JeaX repual20 aq+ o+ Su}+€1ar uo}}euuoju T o+ pallurn aq llrM s+rpne IIV 'parTnbaJ sl paljun ip IM 3uauIaar8z K+}le}luapyu03 alqFaai8e Allen)nur 'parIS is € 'ilpru STIP JO +uoui33uauiur09 aq) o) loRd 'suo}s}Aord ueld qIIM aou€pr033R UT sao}mas Teuo}+oesurr+ sur!£TO sIT Bupa is lu Tupe ST paljun J! Sulu luna lap JO sasoctmd roJ WpnF suITelo £oeuueqd 8 ]onpuoo £8UI 'Jamo)snDJOJleqaq IIO 'KIjlua alqeaar88 Allen)nln e 'pouad +nowu alqFOlldde AIre JO +uauIaar8v alt+ JO tina) all) Submp JeaK JepuajF3 q08a aono 's IIpnV 6'z uop3as 'saaJ leuo}+Tppe ol }3afqns aq £euI pUR uodn paaJgF £ll8n+nuI aq +sntu }sII Snl(I KIte ToadS arp o+ sa8ueqo pa+sanbar rauIo+snD 'IsrI 8rucl KITe loads at{} ul papnl9u} aq o) s8rup aHI aleIIB}sap TIeris paljun -noT In+s}u}uIpv 8rucl ,qletoads -sao}/bIas uo lidlrosaid paJaAOD gma A}lrroads arp JO IIed se s)tIed To}Wed o+ gm(J K+IF loads mau aq) alqeljRAe aleuI IPM pajlun 'Bru(I ,qleroads e sg pal Tun Aq paz}roSa leo pue pau}+uap! ST 8rua uo!+dli3sard Mau r uawA 's8rua K}ler3ads MaN 'saojXIaS uo4du3said paiaAOD Bru(.1 K}l€ 1oads gyM rauro}snD apjAOI(i IITM paljurl 'sa3},mas £3erureqd AIIel3adS 8•z uop3as L960g99€OW€-9ZV8-8£JhVO€9-33903VOV :al OdOjOAU3 u61sn90a Docusign Envelope ID: ACAEC6EE-63CA-4F3B-BA7C-3AA036880961 and provide Customer or its auditor with its response within 30 days of United’s receipt of the audit report. Customer or its auditor shall then have 30 days to respond to United’s response. If Customer or its auditor fails to provide an initial audit report to United within 45 days of the conclusion of the audit or if Customer fails to respond to United’s response to the audit report within 30 days, then the audit will be considered closed. Any payment made, whether by United or Customer, based upon audit findings will be made within 30 days following Customer’s and United’s mutual agreement on the audit results, as reflected in an executed audit settlement agreement. Section 2.9 Miscellaneous. 2.9.1 Transition Assistance Following Termination. Upon notice of termination pharmacy services under this Agreement, United will, to the extent applicable, provide Customer or its designee with up to 12 transmissions, in the aggregate, of the following files in United’s standard format: (a) existing Home Delivery Pharmacy or Specialty Pharmacy open refill transfer files for Participants, based upon Customer’s most current eligibility files; (b) Customer’s prior authorization files; and (c) Customer’s accumulator files. 2.9.2 Government Program Reporting. To the extent applicable, the parties acknowledge and agree that any discount, Rebate, Manufacturer Administrative Fee, credit or allowance provided to Customer under this Agreement and any Rebate retained by United under this Agreement shall constitute and shall be treated as a discount, within the meaning of 42 U.S.C. §1320a-7b(b)(3)(A), provided to Customer against the price of Prescription Drugs provided under this Agreement. To the extent required by Law or contractual commitment, Customer agrees to disclose and report any such discount, Rebate, Manufacturer Administrative Fee, credit or allowance to Medicare, Medicaid or other government health care programs as a discount against the price of the Prescription Drugs provided under this Agreement. Upon Customer’s request, United will provide additional information necessary to support Customer’s government reporting requirements. Contract # 8577 ££98 # }OBJ+UOD ssauIsn8- gaul,w JO }uapr3uI £}LmoaS £u8 (H) ro/pIle !o)(}})(Z)(a)tOg't,791 'U'J'D gt qIjM aouepJOOoe UI meMe saurooaq }} HOTqa\ JO '+uauraaJ8v aHl JO/pug wa STIjl Aq roJ pap IAUd lou IHd JO arnsolosrp io asn Kue (1) KIllua paraAOD OI Nodal '£€1ap alq£uos€arun }notIlIJU '}uauIaar8V aHI ro/pu8 wa snp Aq roJ paprAOJd sg uer{+ raIllo IHd JO amso losTP lo asn +uaAard ol 'uo}}euuojul qtleaH pa}oa}oJd 9ruoJ loaTH ol +oadsar qlrM s}uaruaiTnbai aInD- £}!inoas alq80rldde HI IM £lduroo pIn spren8ajes leo TuljoaI pIle poTsKI{d 'aA IIrris}ultupe a}eFrdoJddz agn pue +uauraldm} £'Z Z'Z 'SUO1}88ljqO asot{} JO aouruuoJJad aq) ur All lug paiaAOD ol Al(ide pqI aInT X08Apd aq) JO s+uauiar TIIbal alj1 ql IM Kldur03 IIT,w al€}30ssv ssaulsna- 'alnu £oeA bId arp rapun suor+F8}lqo s,KIjlua paraAO) +no £neo OI SI a}€}oossv ssauTsn8. )ualxa all) o I )eq I }daoxa 'M€1 Aq pannbau- asT,may lo su JO '(a)I/os-t,791 'U'J'D gP JO }uaurailnbar alqeorldde qoea ql}/w aoue}lduroo UI pIle 'luaunar8v aq) ro/pue vv8 SIg) Aq parTnbar JO panuruad se 'sa3rmas atI I apl/\old o) £iessaoau se }daoxa IHd asolos ip ro/pue agn lou I'Z :o) saar8e a}er30ssV ssaursn8. 'IHd JO arnsol3srp ro/pue asn SIl o) pre8ar qJIA a sa M( sm®arQjJ5B 'auII I o I am}} moa saIjled atp JO }uauIaar8e ualin/w Aq papuaurr sr 't uor+oaS ul VV8 SIg) u! q}roJ las asor{} 8u}pnlou! '}uaruaar8V aq) ul q}JOJ ias s8 KlpuS paraAOD o) a}eroossV ssaursng Aq papjAord saojAlas aq) 'IHd JO arnsolos TP lo asn 'uo}sslwsuen 'aou2ua}urzur 'uoueaJO '}dra3ar OHI 3AjOAur Kari} }ua)xa aq) o) Kluo pIle Iualxa aq) ol :saajAlas '(O # V SUBdq"S) t91 p=" 091 SH-d 'U'd'O gt +' paUlpoa pl:' VVdIH o1 }u8nsind panssr 'auir I o I am!) luo# papuaure se 'suo1}8[n8ar K+}moas IerapaJ ariJJ :alnH X)!rn30S 'sa3r,was aq) JO aouruuojrad aHI o) +wnsJnd a}er30ssv ssaursn8 Aq KIljuH paJaAO) 'JO Jleqaq uo paIFaro lo paA}a3ar IO 'trio a paAja3ar uor}euuojuI qll£aH pa}9a}oJd aljI ol pal Tulj1 ST puB 6£01•091 •X'J•D gt UT pauyap SV :(66IHd99) UO!+BUIJOJUI IIljEaH palaojodd '(a # V SH.dqnS) t91 p11e 091 slled 'u'a'9 gt 1' P.yIPO. ptle WdIH o) luensJnd panssr 'auii I o) aInT+ luoa papuame se 'suoTleIn8ai £oe Apd leJapaJ aHI :alnH £3€AjJd '(,.WdIH„ 'XI'AP.allo') alun o) aurI+ trIOa papuaure sr suo}+gln8ai 8u}+uauraldUIT sIT paF 9661 JO Iov £}111qg+unooov pue £Flrq8 Trod aou€JnsuI qljeaH aq) JO sasoclrnd roJ parIs}lq€ 1sa s8u}ueatu aq) a Aeg pauuap asr/WIaqio lou VV8 SjIP u! pasn suua+ paz}l8+!dro lle 'VV8 STqI u! payloads aslmay lo ssalun u .naaPaas :SMOljOJ se aar8e £qaiat{ saIUed aVI 'CGsar IIed„ aq) se KlaApoaljOO io „Kped„ e se £llenp IAIPUT UTmay o) pauajar aq q}oq £etu a}eroossv ssaursn8 pIle K)pug para/\oo '£zoz 'I £nnuef no aAp3aJJa sl pIle („K}Tlua paraAO)„) ua)ua(..I JO AIID pUB (6,a}B}oossV ssaulsnH„) sa}€}lyJB s)! pUB Jlas}} JO JPIPq uo („paljun„) on1 'saor/naS areDq}lvaH paIrun uaa/wlaq („}uauraar8V„) +uatuaarSV sao},waS aA}}81}s}u}uIPV allI JO Ind apetu pIle o+ul pa+grocir03u} ST („vv8„) ]uatuaaiBv a)e}oossv ssaulsn8 STqI +u3uraargV o}el30ssV ssaulsn8 – E-(I +uaurq38 IIV L960899£OW£-OZV8-8€Jt-VO£9-33933VOV :al odOjaAu3 u61snooa Docusign Envelope ID: ACAEC6EE-63CA-4F3B-BA7C-3AA036880961 Associate becomes aware in accordance with 45 C.F.R. 164.314(a)(2)(i)(C). 2.4 with respect to any use or disclosure of Unsecured PHI not permitted by the Privacy Rule that is caused solely by Business Associate’s failure to comply with one or more of its obligations under this BAA, Covered Entity hereby delegates to Business Associate the responsibility for determining when any such incident is a Breach. In the event of a Breach, Business Associate shall (i) provide Covered Entity with written notification, and (ii) provide all legally required notifications to Individuals, HHS and/or the media, on behalf of Covered Entity, in accordance with 45 C.F.R. 164 (Subpart D) Business Associate shall pay for the reasonable and actual costs associated with those notifications . in accordance with 45 C.F.R. 164.502(e)(1)(ii) and 45 C.F.R. 164.308(b)(2), ensure that any subcontractors of Business Associate that create, receive, maintain, or transmit PHI on behalf of Business Associate agree, in writing, to the same restrictions and conditions on the use and/or disclosure, of PHI that apply to Business Associate with respect to that PHI. make available its internal practices, books and records relating to the use and disclosure of PHI to the Secretary for purposes of determining Covered Entity’s compliance with the Privacy Rule. after receiving a written request from Covered Entity or an Individual, make available an accounting of disclosures of PHI about the Individual, in accordance with 45 C.F.R. 164.528 2.5 2.6 2.7 2.8 2.9 2.10 after receiving a written request from Covered Entity or an Individual, provide access to PHI in a Designated Record Set about an Individual, in accordance with the requirements of 45 C.F.R. 164.524. after receiving a written request from Covered Entity or an Individual, make PHI in a Designated Record Set about an Individual available for amendment and incorporate any amendments to the PHI, all in accordance with 45 C.F.R. 164.526. comply with the applicable requirements of 42 CFR Part 2 to the extent Covered Entity, a Part 2 program or another lawful holder provides Part 2 Records to Business Associate in accordance with 42 CFR § 2.32 or Subpart D. Section 3 Responsibilities of the Covered Entity In addition to any other obligations set forth in the Agreement, including in this BAA, Covered Entity: 3.1 shall provide to Business Associate only the minimum PHI necessary to accomplish the Services. 3.2 shall notify Business Associate of any limitations in the notice of privacy practices of Covered Entity under 45 C.F.R. 164.520, to the extent that such limitation may affect Business Associate’s use or disclosure of PHI. 3.3 3 .4 shall notify Business Associate of any changes in, or revocation of, the permission by an Individual to use or disclose his or her PHI, to the extent that such changes may affect Business Associate’s use or disclosure of PHI. shall notify Business Associate of any restriction on the use or disclosure of PHI that Contract # 8577 ££98 # )OBJIuo) lo pa}£aro IO moO paA}aoaJ IHd' IIe £oilsap IO umlal ll€qs a}groossV ssaursn8- 'Wg STIjl JO/pu8 tuauraaJ8V aq) JO uoseaJ £uv iOJ uopeuTuna+ aHI iayV 'uopeuluual JO }oaJJa VV8 SIg) ro/pug luauIaar8V aq) a+€urunal Ann K+pug paJaAOO aq) uaV) 'ain3 JO alqed83u! £lqeuoseai ST q3€arq atp +uaAa aHt ul lo 'auFgaurp payloads at{} u}li IIM X+PUB para/\oD aq) o) Alo louIS IIzs £Iqeuos8aJ arno e JO aouasqe aHI ul 'ao TIon uaWPM arp JO }dTa3ai iaUr s£ep OE aJOJaq ro uo uo}}elorA arp pIn jo qOBOJq altI ainD }snLU a}eloossV ssau}snH aHI 'uolleIO IA JO qoeaJq aq) JO am)eu OII) sayIoads letII a+e}30ssV ssauTsn8 aq I o+ IIO IIFjojA lo qoFarq aq) JO aol lou uaIIPM apl/\old ITeqs AIrIng paJa AO) alp ualII VV8 SIIP JO UOPBIO TA JO qoBaJq IEIla+Blu B saITIp}suoo }EtP a+eIOOSSV ssaulsnH atp JO aopoeid io KHAT+32 JO un+}zd r JO SMOu>1 Kw)ua paiaAoo JI 'uoI+euruual Z'9 I'g UOPBUIUIJ3JJ S UOn33S alnU K3eA bId atp ip in aou8pr030e UI )aS ejR CI palltuTI e asolos}p pIle asn 'a+FaJO ol IHd asn 9-b 'alnU- £oeAud aq) IjIIM aowprooou UI ZIg-1/91 A'J'D gt/ tr} pall}uuad sg 2)gp pUR IHd asolosrp pug asn 'alnU £9€A bId aq) HjIM aourpr030F UI XII)ua paraAo3 atl) JO suoperad(,) aieD q}lzaH aHl o) 8u}}2laJ saolmas uo}+88aiS8v eIea aprAojd Jl8r{aq UMO s,a}F}oossV ssau}snH uo pasolos}p pur pasn aq Kern pUF VV8 STH+ o+ +oa[qns lou ST 'IHd a+n}}+su03 lou saop UOPRUUOJUT payT}uap}-ap HOTqM 'alnU, £oeApd atp qIIM 30u€pr0338 UT VV8 SjIP ropun a}e}oossV ssaulsnH Aq pajFaro lo poAjaoar IHd KJnuaPr-aP paqo€aiq uaaq svq uo!+euuojuT aq) JO K}}TF}juapUu09 alp gottIM UT areM2 saruooaq }} Holy/h JO saoue Isu} £uv JO a}r}oossV ssau}sn8 4pou llrM Kl}dUIord £}r8d pITy) aqI ( I1) pu8 'MRl Aq puTnbaU se io Kprd pITy) aq) o) pasolos TP sex\ IT Holy/w JOJ osodrnd aq) roJ Kluo pasotos TP ray IIly lo pasn pu£ £lle!+uapyuoo plat{ aq III,w uor+€uuoju} aq) (1) let{I a9u2APF UT saoueinssR ual iBM sap}Amd sasociInd asoqI roJ IHd sasolosrp a+£!30ssv ssau}sn8 HolqM o+ Kp€d prTIP £ue ro /we'I Aq par}nbaE arr sarnsol3srp aq) leg) no}]}pu09 aVI no 'a+el30ssv ssaulsnH JO saT}}l}q}suodsaJ !e8al aHl )no £JiR3 OI lo a)€130SSV ssau}sn8 JO uo}}er+slulurpe pue }uatua8euetu radord roJ 'AIessa3au JT 'IHd asolos TP pIle asn g't +'t £'P Z't KIT+uH p3roAo9 OI sao}mas aq) ap}Aord ol £ressooau IHd JO saJnsojOS ip pu€ sosn TjR pUF AuF a){eu I '} :£eur a}e}30ssv ssau}snH. '+uaunaigv arp lo vva sly) Aq paJInbar jo pa}]}uuad 'sarnsolos TP ro/pIle sasn ialIlo £ue ol uo}HPP8 UT 'VV8- SIg) UT paljInII asr,wnqlo ssalun soJnsoI3s1(1 pUB sasn pa)+!uIJal Isoo UT aseaJOu} ljons JOJ a}eloossV ssau}snH asrnqur Ial netis A)pun pma AOD 'wa. STIjl Su}pnIou} '}uaunar8V aq) japan saolmas 8u}p}Aord JO )soo s,a}FjOOSsv ssaulsnH as€arou} £llr FmIeur silo IsjAm io suoBe InuIT asolli JT 'uoPIPPB ul 'Ja}s}u}uIpe TITM IT guo IIe ITull JO suo1}3T4sal HaItIA aploap TjBqs a+€!oossV ssauTsn8. 'uop3aS SjIP u! paqliosap se uop3£ sale) ATpun paraAOD +ua/\a aq) ul IHd JO arnsol3s ip io asn s,a}eToossV ssau}snH )oaJJe K€tu UD}}apIsar Hons leg+ +ua)xa alj+ o) 'zz9't9 1 'v'd') gt rapun Aq apTqe o) par}nbar sl lo o+ paaiSF seq A)qua paiaAOD 9'£ L960989£owe-o£v8-8€JP-voe9-33903vov :al adOjaAu3 u61sn90a Docusign Envelope ID: ACAEC6EE-63CA'+F3B-BA7C-3AA036880961 received by Business Associate on behalf of the Covered Entity, if feasible to do so, including such PHI in possession of Business Associate’s subcontractors. In the event that Business Associate determines that return or destruction of the PHI is not feasible, Business Associate may retain the PHI and shall extend any and all protections, limitations, and restrictions contained in this BAA to Business Associate’s use and/or disclosure of any PHI retained after the expiration or termination of the Agreement and/or this BAA, and shall limit any further uses or disclosures solely to the purposes that make return or destruction of the PHI infeasible. 5.3 Cooperation. Each Party shall cooperate in good faith in all respects with the other Party in connection with any request by a federal or state governmental authority for additional information and documents or any governmental investigation, complaint, action, or other lrlqulry. Section 6 Miscellaneous 6.1 6.2 Construction of Terms. The terms of this BAA to the extent they are unclear shall be construed to allow for compliance by Covered Entity and Business Associate with HIPAA. No Third Party Beneficiaries. Nothing in this BAA shall confer upon any person other than the Parties and their respective successors or assigns, any rights, remedies, obligations, or liabilities whatsoever. Contract # 8577 LLS8 # )OBJ+HOO Jea£ iad aouo }seal }€ fsu€1d BujlsaI pug 's]uaumorTAua uo}lonpord pIle luauIdOjaAap JO uo!)rJedas 'uo1}3adsu} apoo '+uama8ruruI a8ueqo ioJ sassaoord :uoI}euuoJUT pug sura IsAS uopeuLIOJUl paIlurl pr2nSaj£s leI{} slor}uoo JO IroMaureg a}enbape ue :s+uatussassg Isri 9rpouad :tU€i80Jd }uama8€uruI ISII IFUUOJ r :JO pasudur03 sl unSold Aljmaas s6p3}run 'sprepue IS £}pnoaS £4snpuI are3q}leaH aTqguoseor qII& aouepr030u ul Z-Z '(..XOS„) X'I*O-sal”qJ-S p'" '(„ssa IOd„) SP--P11' IS XII"-;S -lea XJISnpl=I prFD }uauI£rd aq) '(„HDaliH„) IOV q}lraH lro lun) pIle O}UIOU03a roJ £8olour{oaI uo!}ruuoju[ q+leaH aq) '(„VVdIH„) +oV KIll}qe+unoooV pue £}11}q€}JOd UO!}FUUOJU[ q)leaH aq) 'alq23llddr se '8urpnlour 'MrI alqF3}[ddT JO suo}s}Aord aq! q+1/w aou€rldtu03 arnsua ol parIS}sap aq TIeris pug +uatuq3e++v SjIP JO s+uauraJjnbai aq) InT/w )ua+s}suoo aq ll€qs UIFr8oid £+}Jnoas s,paljurl 'uoPzuuojul rauolsnD pIle sma IsAs uo}}euLIOJUI paIrun JO £}Lmoas pIle '£ulrqzlw Ae 'KIuSa)ur 'AHIFr+uapyuoo alp +3a+oJd (q) pu€ fM€1 qlrM £ldUIOO (€) :o) AIessaoau spren8ajes lro}ul{oai pIle 'aA TIer)STultupe 'leo}sKIId atl) suI2)amIn pIle 's+uauraldu! 's+uaum30p paIlun gonIM Japun UIeJ80Jd K}un9as aATSuaqaJdUI03 8 urF luteIn TIeris palrun r mr©arqT55R I'Z '(„iSD„) I'QMa„„'d X+bm.aS uomtuo) lsnu.JJIH JO lro/hamza pIle spiepue]s aHI :sprepue JS ,C+!rn3aS Xr+snpuI arBaq)l8aH '}uatuaai8v aq) rapun sao},was lo s}onpoid 8urprAord UI pa)lun Aq pasn are qa II{/w KwAI+oauuoo laura luI pUF 'suo!+€oIldde £i=+a}rdord 'sla lund 'gIpatu a8£ro is 'saseqe}rp 'ar€Muos 'aieMprFq 'sdo+dgl 'suo IIV Is]roM 'suratsAs ia+ndruoo 'aInIOInlse BUT Ilo,wlau 8urpnlou} 'palrun Aq pa}eJado io parlddns sa3rnosar sura IsAs not+euuojul :suia IsAS uopeurrojuI paIlun '(SJaqulnu £]}rn9as le130s 8urpnl3ur 'MRI ale is io leiapaJ alqvoIldde Aq paion+sai sr IIonIM JO asn JO/pUB aJnsojOS IP aLl) 'slenp IAIPUT XJ}+uap! o) pasn aq uea )BIjl uo}}euuoju} JO 'sjEnpjAlpu} +noqr uoT}€uuoju} alqey!}uap} £Ileuosrad raIllo ''a'}) uo}}euuojm IRuosrad raIl to (t) pug :(suoq€1nSar aieis lo lerapaJ pa}elar £ue pu€ 'saInIels ajR is pa)8lar Ku2 'IaV £al}18-qoFal-muIerr) lgJapaJ aq) Japun „uor}uuuojm leuosrad 9}lqnd-uou„ pauua] aq plnoM leIi) uo}}euuoju} £ue ''a'}) uopFuuojur [euosrad orlqnd-uoN (z) JaUIO}SnD cJO Jleqaq UO paIBaID JO paAjaoal JO 'tUOJJ paAjaoaJ UOT}BUUOJUI tIljEaH paloa}old alj+ o+ pa;HUll SI pUB '£OI'091 'U'd'D gt/ ul pauyap SB 'uonelluojuI qljEaH papa+old (1) :BIljMolly aq) JO £u€ JO pasndUI03 sl JO sapnlou} letjI }uatuaar8v anl Iapun sao}mas lo s}onpord gulp}Amd JO asmoo aITI UT palrun Aq pa+eaJ3 JO 'pa)oall09 'paprAOJd +2uuoJ 31Uor+oala ur uo!+euuojuT Jauio ISII) £uV :uoperurojuI rouro]sn) :MOTaq qPOJ Ias se s8ujUFaru atl) al\Fg TIerIS suua+ 8UI,WOljOJ alII suopIUDa(1 1 uop3aS :SMOljOJ se aaJge £qaraq saI}rzd aHI '(MOjaq pauUap 58) uo}+euuojuI iauIo}snD £ur JauIo+snD JO Jleqaq uo ro UIorJ saAjaoaJ io 'Ol ssaooe suq 'sa)raio pailurl )erp )ualxa all) o) pu2 Jl alqFo}[dde aIF K}}inoas – t-(.I }uatuqoe liv SjIP JO s+uatuarmbar asaril /bjJn3aS – F(I +uaulq3B++V L960g99eow€-ozv8-g€Jhvo€9-33903v9v :al odOjaAu3 u61snooa Docusign Envelope ID: ACAEC6EE-63CA-4F3B-BA7C-3AA036880961 perform enterprise-level penetration, perimeter vulnerability testing, internal infrastructure vulnerability testing, and application testing; facility and environmental controls to prevent unauthorized physical access to United Information Systems and areas where Customer Information is stored or processed; encrypt transmissions of information via public networks (i.e., the Internet), laptops / desktops, devices, removable storage media (e.g., thumb drive, external hard drives, writable CD drives, backup tapes), applications, and network data storage containers. United will establish and maintain written business continuity plans for the services and supporting facilities, written disaster recovery plans for critical technology and systems infrastructure, and proper risk controls to enable continued performance under the Agreement in the event of a disaster or other unexpected break in services. Business Continuity Management. United will, at its sole expense, establish and maintain (i) written business continuity plans for the Services and supporting facilities, (ii) written disaster recovery plans for critical technology and systems infrastructure, and (iii) proper risk controls (collectively, the “Contingency Plans”) to enable continued performance under the Agreement in the event of a disaster or other unexpected break in Services. United will update and test the operability of any applicable Contingency Plan at least annually and will maintain each such plan upon the occurrence of a declared disaster event. As used herein, a disaster is defined as an unanticipated incident or event, including, without limitation, force majeure events, technological accidents, or human-caused events that may cause a material service or critical application to be unavailable without any reasonable prediction for resumption, or that causes data loss, property damage, or other business interruption without any reasonable prediction for recovery within a commercially reasonable time period. Customer Audit. At Customer’s own cost and expense, no more than once each year, United will permit Customer and/or its duly authorized representatives, upon 30 days advance notice and subject to a mutually agreeable confidentiality agreement, reasonably necessary access to United’s data processing facilities, administrative and security procedures, and documentation in order to ascertain compliance with applicable law and the terms of this Attachment as it relates to the processing of Customer’s data. The scope, timing, nature, and approach of such reviews shall be mutually agreed to in writing by the Parties. Audits will be performed during regular business hours in a manner designed to minimize the interference with United’s operations, and will not require on-line access to United Information Systems. United shall provide reasonable access to relevant personnel, physical premises, and reasonable documentation. The duration of any on-site assessments may not exceed more than 1 business day. Service Auditor Reports. United may make its Type II service auditor report (“Report”) available to United’s self-funded customers each year for Customer’s review in connection with Plan administrative purposes only. The Report will be issued under the guidance of Statement on Standards for Attestation Engagements #18 (“SSAE18“). Should new guidelines covering service auditor reports be issued, United may make the equivalent of, or any successor to, the SSAE18 Type II Report available to United’s self-funded customers. The Report is United’s Confidential Information and shall not be shared with any third parties without United’s prior written approval, except that Customer can share the Report with: (i) Customer’s independent public accounting firm; and/or (ii) Customer’s 2.3 3. 4. 5. Contract # 8577 ££98 # +oeJ}uoD 'sar]rlua ro suosIad raIllo £u€ oi uodau IIons asolos ip lou AaH) leVI pug le!}uapuuoo sr podau. all) up laI Karl) pIP annbaj TIeris raruo+snD 'uopoaS STg 1 UT pan}uuad se }ue+lnsuoo e JO lulU 8u}}un030€ orlqnd +uapuadapu! s)! o+ HodaU. aHI apIAmd saop ratuo}snD }81II )ualxa aq) OJ_ 'asn rIallI JOJ pandajd lou srM yoda aljI l81{+ slue}lnsuoo siT suuojuT rauro jSII) Ierp pIle s,paljurl JO JO)padIHOO E ABM £ue UT Iou ale s}uB+Insuoo ljons )eq) uo!)}Puoo alp uo 's+uBljnsuoo L960899€ow€-ozv8-a€JFVo€9-33903vov :al OdOjOAU3 u61snooa Docusign Envelope ID: ACAEC6EE-63CA4F3B-BA7C-3AA036880961 Attachment D-5 – Fees These are the Fees Customer agrees to pay to United in exchange for the Services Medical Fees The following financial terms are effective for the period January 1, 2025 through December 31, 20299 unless otherwise specified. Average Contract Size: 2.43 Final Claims Fiduciary: United Prescription Drug List: Traditional United will provide a Wellness Credit, Administrative Credit (General Purpose) to help Customer mitigate costs associated with additional wellness services from United, administration of the plan These credits are available as follows: • The parties must have an executed Agreement. • The first month of service fees under the Agreement has been received by United. • Customer’s enrollment with United must always exceed 1537 Employees. • Credits must be used between 01/01/2025 and 01/01/2027. Any Credits not used during this time period are forfeit Upon request from Customer, a credit will be issued in United’s fee billing system. Upon presentation of receipts for costs, a credit will be issued in United’s fee billing system in the amount of the receipted expenses, total amount not to exceed the full credit. If Customer terminates the Agreement prior to 12/3 1/2027, Customer will repay United a prorated portion of the credit paid in the year of termination based on the termination date. Credits in prior years are not subject to repayment. All unpaid credits are forfeit. If enrollment with United falls below the enrollment threshold, Customer will repay United an amount proportional to the enrollment reduction based on the amount of the credit paid at the time enrollment falls below the threshold. The amount of the credit not yet paid is reduced proportional to the enrollment reduction If during the course of the first year unforeseen or additional expense items arise related to the Customer implementation, United reserves the right to use a portion of this credit to offset such expenses. • • • • • • Contract # 8577 99 dna') q}leoHpo+!un JO uolleLLUOJUl Kre}olrdoid '30plla/W pIle 'CI)V puZ 'Isane) 'uaAeW 'O8UOAll 'paqoariDlar)sla1 hIe)I 'qljeaH agu TH :§uTMolloJ aq) are SJopuaA qnH 3Hn 'luauIaaJ8v sup JO alep aHl JO sv 'lun030v ]uea atp trIo# TeMeJpq IjM e q8non{} PIed aq llrM saojMas pIle s)3npord qnH DHn roJ saaJ 'a3jMas JO +3npoid }erp ioJ pagreqo aq 11}/n saa a raIjHIV ou pIle ropuaA leVI trIo# paprAoid aq ra8uo[ ou Ijl,n aolmas io }3npoJd aq I 'a3ue Isu! )erp ul '}uatuaar8v SjIP JO uual lunauau io uuaJ_ in)tuI arp JO alpp rtu aq 1 UT a)eu}uma; Avm qnH DHn ul uo!}€d TajjIed s,iopuaA Awed-pITy+ v 'saa;wrenS um)u lurouvuu io aoueuuoJJad Hons roJ Ke,u Aug tr! alqeII JO alq}suodsor lou s! paljun Pq) saaJge rauro}snD 'sropuaA AIred -pInII asor{1 Aq apetu saa)ueren8 umlu lzl3ueuu ro a3ueuuojiad £ue sul!€j3s ip pailun pIle 'pa) Tun In} a palellUJe lou an legI SJopuaA AIred-p Pq) Aq pap I/\old pIle pm%;o an sao!/was pue s}3npoJd qnH DHn ley) sa8pajhou>Toe ratuo}sn3 L960g99€OW€-OZV8-8€]hVO€9-33903VOV :al OdOjOAU3 u61snooa Docusign Envelope ID: ACAEC6EE-63CA-4F3B-BA7C-3AA036880961 Payment Integrity Services Service Description Fee Advanced Analytics and Recovery ' United’s large-scale analytics to identify additional recovery opportunrtres. Claims re-examined every month for up to 12 months. • Post-adjudicated claims. • Verify primary/secondary payer accuracy. • Identify claims to be investigated using a layered approach to identify other primary payers: 1. Eligibility match to other commercial payers. 2. Eligibility match to Medicare. 3 . Eligibility match to newly enrolled Medicaid members. 4. Eligibility match to membership validation vendors using proprietary algorithms. 5. Additional oversight and identification of primary payers using United professional resources 6. Advanced analytics using COB-specific triggers to identify 30% of the gross recovery amount 30% of the gross recovery amount prImary payers • Correct pre-adjudicated claims prior to claim payment. • Update claims systems with other primary/secondary payers’ information COB indicators set to edit subsequent claims with lrimary/secondary payers’ information Cred • Review, validate, and recover credit balances (dollars) on existing patient accounts through a combination of analysis and technology. • On-site at hospitals and facilities. • Post-adjudicated claims. Focused Claim Review • Review of claims for inappropriate billing of services not documented in clinical notes Board certified, same-specialty medical directors. Pre-adjudicated claims or post-adjudicated claims. lud, Waste, and Abuse Management Detection and recovery of wasteful, abusive, and/or fraudulent claims Search claims for patterns which indicate possible waste or error by identifying specific claims for additional review • Pre-adjudicated claims or nost-adjudicated claims i • In-depth review of hospital medical records or other related documentation compared to claimed amounts to ensure billing accuracy. • Post-adjudicated claims a • Litigation, arbitration, or other judicial process to recover any Overpayments and other Plan recovery opportunr tres. Outside attorneys’ fees and costs or administrative process fees directly incurred with litigation, arbitration, or other judicial process. • Pre-adjudicated claims or post-adiudication claims a Coordination and Injury Coverage Coodination • 30% of the gross recovery amount 30% of the gross recovery amount. 30% of the gross recovery or prevented amount + 30% of the gross recovery amount Outside attorneys’ fees and costs or administrative process fees will be deducted from the gross recovery prior to the assessment of any applicable United fees (as indicated in this Exhibit) 33.33% of the applicable savings amount 56 Proprietary Information of UnitedHealth Group IS dna') q}leoHpo}!un JO uo!}etLUOJUl AJe}ojJdoJd saor/was aq) iOJ uor)esuaduroo se paljun Aq paulelal st a3ueIeq aq) 'ratuo}snO OI %08 uopzsuaduro3 a}eqaH gnI(I ]Uaua8 paIpaWmt mJUOTeTS31Fe asnel9 SeB-pw s6rauro}sn) uoddns ol a8en8wI apl/told £msearJ. JO }uawwdaa -s'n arp lo sao!,bIaS uetunH pue qtpaH JO }uauI}wdaa 's'n 'Ioqel JO luauI}ndaa s'n arp Aq paielput st}pne suo jle)Full ju3uI}earl paynuene)-uoN KIjled qtlzaH [etua Pq ot pa)eIa UoddnS SIjlq IB31F)am asudrns roJ uoddns sjBadde IeuIa}xa pue area JO A) InurltroD • • sluatuaouequa £ropanp raprAord (K13uaIm3 SF)leo CII qI IM sluvdror Ind ueld saprAord PaFun JI) SIno aI ueId leolpaul pasTAaH luno03V Iwa aql q8norq} saaJ rolw}!qre HaI IIZ pIle aaJ uo}}eI}s}uFUlpe ual 0 gS alp purU Iletis JaUOISIL) }unoooV IIna all) q8nonl) uorsloap ssa30rd ual Ku? JO }lnsaI z se paInbar sluatuKed pUB SWIOtIR }Haulajl)as IIB purU IIBEIS laIHo}srl3 VSN aLP iaF>un para/\oo sa3r/was It? o) KlddB OI anu!+u03 llyn aSreqo pallrq sciapl/\old eJJO paAarq92 s8u IAgS alj1 ul metis saIjred aq) goltIm ul stuer8ord ioJ saaJ aRI VSN arp Aq paiaAOO saa/nas roJ s:jlo,w lou rapt,\old AIred pIn{} 8ursn aq lou IIIm paljun pajl tIll Aq paia)sruItupe surld qljearI dnor8 parnsu}-JIas IIE SSOJOB p>WELI aotrBJns trl UB 110 paseq papln3jBO aq IInn VSN aKI iapun slunour8 luaurKzd But&!tent) IIV rama+sn) roJ UCII aq) Uoddns ot suolssFuqns pIle suorsroap 3]2m pu2 'Ioar IP 'a8euetu ll!in paljun 'suoQoamd 8urllrq VSN arp o) }3afqns UIel3 e roJ pouad uo!}e!}o8au paqp3said arp ulqI!in ]uaLuagrBe 0 0 0 0 C ue ol aur03 oi alqrun ale lapjAmd e pw paljun Jl o suor loa Iold SwIng VSN aq) o) ]oafqns sl uljglo e JI auluua lap 111m pallurl o :(„ual„) 'laprlIQsaJ a+ndsrp luapuadapu! arp pIle gu111 lq leolpaul VSN • • • -pauruua lap ale s}uaurarrnbai aouerldUIOO leuy pIle paAja3ar sr a3ueprn8 £iolelnBar a3uo aiep amIIV e le pap IAUd aq juM tzoz Jaue sreaA ueld roJ saolmas pod(ins vv3 roJ saa I aaa :SMOljOJ se alep luaura3iojua aA1]3adsar arp Aq '(„VSN„) pv sasudrns ON aljI 8urpnjOUI 'VVD arp JO sluaurarFbar aHI lp},u a3ue}ldtu03 s,rauIo}sn) uoddns IDM paljun -saa!/bIas HoddnS („w3„) lzoz 'pv suollelrdorddv pa]epllosuo3MmFa3jAr5i SODa laiHO s3nl2r3ads pIle 'gaol/was 'sr3prAord JetTIUIS JOJ pa/no IIe puz paIllq s)unoiue leojloIslq ;o) palnull lou )nq '8ulpnlnn SIndH lueAalu raH lo pue 'sa3ua}mdxa }uaur£8d sulleIa Iged pIle IIe lap laAaI UIjelo ioJ s}un033e Ierp 3r8ol 8msn PaeTnoTe3 ale s8ujAes }unoue patuaAaid IO pa}e3}pnfp8-old ol pa)elm saaJ aojhms Alpga luI luauI£ed Fialanl)31111 oWl @t WMXFM o) pauun }da3xa AIIluI Ktm a8e8ua lou 111/h i9tuo)sn3 'sunel3 'paleorpnfpe-)sod io sturelo pale31pnfpe-aJd sluatuKgciraA t.) Jan 10 JO 'aJe31pa Pq (s)gauaq JO UOI}BUIPJO03 gUm uoIDauuoo UI ppd s}yauaq apnl9u! lou sooa pIn{I ? Aq pled aq plnor{s gonIM 's}yauaq ueld raA03ar lo 's)yauaq ueld JO lu9tuAed alp )uaAaid OI sao!/bIas L960g99€OW€-OZV8-8€JbVO£9-]3903VOV :al OdOjOAU3 u61sn90a Docusign Envelope ID: ACAEC6EE-63CA-4F3B-BA7C-3AA036880961 This arrangement replaces and supersedes the Medical Benefit Drug Rebate Compensation arrangement in the Agreement )Naviguard Program Offers reimbursement methodologies for emergent and non-emergent out of network claims which calculates allowed amounts based on what a healthcare provider generally accepts for the same or • similar service Includes an advocacy component where• Participants can access resources, and on-line tools and materials to help Participants stay in network and where assistance is provided in explaining reimbursement methodologies, For claims above a threshold established by United, the advocacy component includes United negotiating • with a provider on behalf of a Participant with respect to Participant’s balance billed amount (e.g., non- emergent, choice claim). If the provider objects to what it was paid Rom the application of the allowed amount, or member contacts United for support with resolving a balance • bill, United will increase compensation for a particular claim if: (a) United reasonably concludes that the particular facts and circumstances related to a claim provide justification for reimbursement greater than that which would result from the application of the allowed amount, and (b) United believes that it would serve the best interests of the Plan and its Participants (including interests in avoiding costs and expenses of disputes over payment of claims) Extra-Contractual Cost Negotiations External Reviews $8,333 per negotiation If and when applicable, for each subsequent external review beyond the limited number of free reviews based upon Customer’s total enrollment, a fee of $500 will apply per revIew. Prime + 4% 12 months ofrunout No charge after the Initial Term. Interest Rate on Fees and Underfunding Bank Account Run-out Claims Administration OnePass Access and Implementation Pharmacy Benefit Rebates - Termination Enrollment fees Dass through to member Pursuant to the termination section of this Agreement, if Customer terminates the Pharmacy Benefit Services portion of this Agreement only during the Term of the Agreement and termination is for any reason other than for cause, United may retain all Rebates that have not been remitted to Customer as of the effective date of such termination Additional Disease Management, Specialty and Wellness Programs (Fees are on a PEPNI basis unless specifIcaljy noted) 1/1/202 1/1/202 1/1/202 1/1/202 1/1/202 1/1/202 965874 through through through through through through 12/31/2 12/31/212/31/2 12/31/212/31/2 12/31/2 026025024 029028027aMm:a:EW3m Bariatric, Resource Services (BRS)Included Included Included IncludedIncludedIncluded Medical Management Programs 58 Proprietary Information of UnitedHealth Group 69 dna') q}leoHpo+!un JO uo!}etLuoJul AJe}olidoJd ')uamaaJSv SIRI rapun Jawo IsrI) Aq PIed saa J aq) uo loedtu} ou seq STqI 'a}zlIBJe paIrun e Aq (01 S o; dn JO aaJ uo}+3esue4 Jad e lapjAmd arp JO uop3ala arp Ie io '+unotue uoT}oesu€r) lelo) aq) JO %c o+ %1 ''8'a) uo!)esuaduroo iag lo lo saaJ uopoesuer} JO Id}a3aJ aHl UT }lnsaJ Kew pIle aaJ e JOJ srapjAord le3rpaur o) aTqeTnAr aJe suo}}do atuos 'sqoaqo pue SPJFO lunN}/\ 's}uaruKed o}uo4oala 8ulpnl3ur 'suorldo pu8 spoqpur }uatu£ed snoueA tIILIn slap IAUd leolpaul slago pIle £4snpu} aieoq)leaH all) o) sao}mas ]uatu£ed sap IAUd a}ellyJe paIrun v :3rnsol3s!(I aol lou s£ep OE q+1/n anul}un03s ip o) +liSp atp svq Jauro)snD+ aHI aHI aHI aHI aHI aHI Gal aol cal aHI uoISsaS 'ad gS$ uoISsaS lad ZZ S ase-sn 00S' IS aSBD Jad 9£r'z$ aSBO lad gZ6$ lea][ Jad ILI edrorUed lad 919$ aSBO lad ttl S aSBO lad OtZ$ uoISsaS Jad gg$ uoISsaS Jad CIS aSBO lad QOS'IS aSBO lad 9£r'cs ase3 lad gZ6S JeaA lad lu edrorUed lad sr9s aSBO Jad ++IS aSBO lad OkZ$ lle3 £[4aQW 8ulqoeoO leiojAeqa8 IBrW} A aHI aHI cal aHI aHI Gel aHI agE 8u}q080D IUorABrIag TenIJIA suoT+nloS 3uaura8eu2 IN )srler3adS gaol/aaS uorurdO pu03aS aHI aHI tueISoid tPuoW ZI K)!wa18 Pq aHI aol aHI aHI aHI cal cal aHI IjIjEaH IBPmSOjr13Srlw Gal a81 cal aHI +Z IjIUOP( Sulq380) lrrojAeqa8 £l}tu€ J pue Pl}tD 8ulq3eo3 lerorAzqaa KlnueJ pug PIlliD qBnortI) pa+33lloo saaJ) sa3nras/surBr8oid ray+O+ paprljoul p3prljouI papnl9uI papnlolll paprljouI papnlouI Bela unTmard Kep-St uoBdaoxa 8ussa90id uvapaprljoulpaprljouIpaprljoulpoprljoulpapnlouIpaprlj3ul paprlj3uI papr\TouI papnIoul paprlj9ul paprljouI papnlouI papnl9uI paprlj3uI papnIoul papnl3uI papnloul paprlj3uI paprljoul papnIouI papnI3uI papnl3uI papnIoul papnl9uI papnlouI paprlj9uI paprljouI papnl9uI papn[oul paprljouI s}oeJjxa BIB(I £lelonpld tuleID suoprIIOS LIljeaH IBJOjABLja8 O'£ SHd uoIsnD Xl :s03lxiaS/suIer8ord Iag+C) jITatlIDRT? rTPI\1 1.IOnIaN (mv)) auTolpaW aAIBtua IIV AreluauIaldtuoO VMain€&Tall qoaads/£duaql leuo!}edn030/£deiaqJ_ leo is/(qd qioxtlaN 3nOeldOIIB- papnlouI I papnlouI I papnlouI I papnl3uI I papnl3uI I papnl3uI p3pnl3ul I papnIouI I papnl3uI I papnIoul I popnl3uI I papnlouI paWn ) ml paIr nDpnlout :suopn IOS qijEaH IeITS.(IId R-lsGepapnI3uI I papnlouI I p9pnloul I popnIouI I papnlouI I papnlouI L960g99€OW€-OZV8-8€JhVO€9-3390=VOV :al OdOjOAU3 u61snooa Docusign Envelope ID: ACAEC6EE-63CAdIF3B-BA7C-3AA036880961 Attachment D-6 – Guarantees UnitedHealthcare The Fees at risk do not include Customer-elected optional and non-standard programs Fees, all credits, Payment Integrity Proorams Fees, Out-of-Network Proorams Fees, Commission Funds, Consultant Funds, and ancillary product Fees. The Fees payable by Customer under this Agreement will be adjusted through a credit to Customer’s Fees in accordance with the guarantees set forth below unless otherwise defined in the guarantee. Unless otherwise specified, these guarantees are effective for the period beginning January 1, 2025 through December 31, 2025 (“Guarantee Period”). With respect to the aspects of United’s performance addressed in this exhibit, these Fee adjustments are Customer’s exclusive financial remedies. These guarantees will become effective upon the later of (1) the effective date of the Guarantee Period, or (2) the date this Agreement is signed by both parties. In the event these guarantees become effective later than the effective date of the Guarantee Period: (1) quarterly guarantees will become effective beginning with the next calendar quarter following signature of this Agreement by both parties; and (2) annual guarantees will become effective commencing with the Term of the Agreement during which this Agreement is signed by both parties. United shall not be required to meet any of the guarantees provided for in this Agreement or amendments thereto to the extent United’s failure is due to Customer’s actions or inactions or if United fails to meet these standards due to fire, embargo, strike, war, accident, act of God, acts of terrorism or United’s required compliance with any law, regulation, or governmental agency mandate or anything beyond United’s reasonable control. Prior to the end of the Guarantee Period, and on the condition that this Agreement remains in force, United may specify to Customer in writing new guarantees for the subsequent Guarantee Period. If United specifies new guarantees, United will also provide Customer with a new Exhibit that will replace this Exhibit for that subsequent Guarantee Period Claim is defined as an initial and complete written request for payment of a Plan benefit made by an enrollee, physician, or other healthcare provider on an accepted format. Unless stated otherwise, the claims are limited to medical claims processed through the claims systems. Claims processed and products administered through any other system, including claims for other products such as vision, dental, flexible spending accounts, health reimbursement accounts, health savings accounts, or pharmacy coverage, are not included in the calculation of the measurements. Also, services provided under capitated arrangements are not processed as a typical claim, therefore capitated payments are not included in the measurements. Claim Operations Definition Time to Process in 10 Days The percentage of all claims United receives will be processed within the designated number of busines@ of receipt ) Measurement business days Criteria Level Period Payment Period e Payment Amount r Standard claim operations reports Site Level Annuallm Total Dollars at Risk for this metric Of the Fees at Risk for this metric, percentage at risk for each 11 business days 12 business days 13 business days 14 business days 15 business days or more 10 :radient $11 ,000 20% Measurement Definition Procedural Accurac' Procedur,11 accuracy rate of not less than the desjgnated percent Percentage of claims processed without procedural (i.e. non-financial) errors 97% 60 Proprietary Information of UnitedHealth Group 19 dna') q}leoHpa}!un JO uo!}etLUOJUl AJe+ojJdoJd %0Z ooa' ItS qoea loI IsjI le a8quauad 'i+t OFnaII1 s ltP JOJ ISU IB SJeIIO C1 IB lol llenutrV llenutrV }url033B s,Jattlo}snD sao 1/Has leg) mealom/m@ajR–{Faq)aIIgn@9n)=BRIT 8 M a8eDmM£F3aFBj€=manny aiFm®> eme mma–aIR a JeW. }ualp1 notuV )uaaitil )[STU IB saaJ no lad tuaiGC8T poLIad [aAa1 eLla}LI) %08• I )uauIUopuBqV IIopIHUa(] spu03as 8£ ueql JaIcajf) ssal JO spu03as 8£ 8501 JO $Puo03s 9£ ssal JO spu03as tE ssal lo spu03as ZEw@®©ns6aOImms }mqaFla ajBatH SIIP JOJ asm IB gIUIIO(.] IB lol llenutrV .ljBnlrLrV }unoooe s,Jatuo]sn3 saojAlas )BIll UIealam®)mRFRE W sulpamMFaTaii) qPOJ las SJa)OUiBJB aol/was JauIOjsno Aq paraMSue aq pIle ua isAs auoqd s,pa3Fun q8non{} a3uanbas IITM SIIeO m@JTF)alagMm3iF %az OOO' t iS s}ualpBJr) t >ISIE IB saaJ nOJadIR£aCii pouad la/\al ella ILI) Ot %001 spuooas iuamajrlseap\ atp UIIIInK HOI IInDa(-I t gqd s4ratuo IsrI) sl pajlun uaq,u }da3xa) £oeuIret{d 'a$nqe aoue}sqns/q}leat{ Ieluatu se ljons 'leolpaIn u8q) inDO s]onpoid/sao}mas roJ sIIgo apnI3ur Aarp op JOU 's}uedror IIed areo lpa IN iOJ ra]ua3 io}uas atp o) slleo ro/pUB lauuosJad luatuo8zuetu areo ol apeur sllu3 opnlou! lou op AaU 'laAal JO/pug ja+ua3 lpa allo uup aiour Ipl/n papua[q aq Kern s)lnsar aq) lapour a31/was auoqd pazIIe loads z s}9ala rarno+sno JI 's}tmdr3rued s6ratuo+snJ sao!/was £lpeur IId tern ra+uao aieo ratuotsno arp o) apeur slleo iuedl3lpzd ol £Idde spnpue is pIn saa)ueren8 aor/was auoqd aljAlaS auoqd laqulol/\[ @ 00'£6 - %6t'£6 O/o09'£6 - %66'£6 O/o00'86 - %6t'86 %0S'86 - %66'86I OII)gUI SIIP JOJ }IS FX Ie SJBIIO(1 IB IOI llenulrV .ljBntrLrV laAal aoyJO o s! possaooid sluTelo JO aldtues tuopuer +ueoy lug is Klle9Bsqe is WepassamTej6i>-R©3MaRa-aT ®nuaal)T®FaVTaiiR©MJTTP=mMTqrdaTfiiFM®nTITFd %0Z Wo }ualpe,L ( lnsBa IAL SILla Ipmr) t XsrX Ie saa, > pOI.la laAa uljelo JO a8e}uaoJad arp auruna}ap ot pa/war, %66 UuerF;Cue Ella III) uoR[uga(J o O/o00'S6 - %6P'96 O/o0$'S6 - %66'S6 %00'96 - %69-96 o/o0$'96 - %66-96 I ojIjaul SIIP JOJ }tsN )e SJBIIO CJ leIo1 llenuLrV .[lenLILrV la/\al a3yJO r atiI au luna lap o) pa/ua IAm ST passaooid stu leIa JO aldtuzs mopuer ]ueoy lug is Klleo} is IIe is %0Z 000' IT$ ]ualpB. s}ualpeJr) t XSIU IB saa, > poTJa. FAa tanIa JO a8e}uaoiad Ella II.13 L960989eowe-ozv8-8£JFvo€9-33903vov :al OdOjOAU3 u61sn30a Docusign Envelope ID: ACAEC6EE-63CA-4F3B-BA7C-3AA036880961 Gradients 1.81% - 2.30% 2.3 1(Ho - 2.809/o 2.81(yo - 3.30cyo 3.31% - 3.80% Greater than 3.80% Definition Measurement Call Quality Score Mdintain a call quality score of not less than tIe I Random sampling of calls is each assigned a customer service quality score, using United’s call quality assurance program. Office that services Customer’s account Annualjy Annualjy o Criteria standard internal 93% Level Period Payment Period Fees at Risk Payment Amount r Of the Fees at Risk for this metric, 92.99% - 91.00% 90.99% - 89.00% 88.99(yo - 87.o09“a 86.99% - 85.00% Below 85.00% lercentage at risk for each Fadient SII ,000 20% Satisfaction Definition miMi The overall satisfaction will be determined by the question that reads “Overall. how satisfied are you \ME way we administer your medical health insurance plan?” e 0'F, Operations standard survey, conducted over the course of the year; may be customer specific for an additional charge Office that services Customer’s account Annualjy Annually Total Dollars at Risk for this metric Of the Fees at Risk for this metric, oercentage at risk for each gradient Not applicable MMHTmt Measurement Criteria Level Period Payment Pellod e Payment Amount r $5,500 N/A Definition Customer The overall satisfaction will be determined by the question that reads “How satisfied are you overall with UnitedHealthcare?” I Standard Customer Scorecard Survey Customer specific Annuall Annuall o Of the Fees at Risk for this metric. oercentage at risk for each gradient Not applicable 5Measurement Criteria Level Period Payment Period e Payment Amount r $5,500 N/A Pharmacy Findncials In the event any of the terms herein are inconsistent with the requirements of any federal, state or other applicable law or regulation, then the inconsistent terms will be null and void and United will have the right to revise, reprice or revoke this arrangement Definition Measurement and Criteria Pharmacy rate guarantees, 01/01/2027 Proprietary Information of UnitedHealth Group C9 dna') qtleaHpo+!un JO uo!}euuojul Are}ojJdoid stu}=13 ia}un03-aqFiaAO 'stulelo A)11}oeJ sr}=JJe ,sueia laA sapn lou! }uatua8uenV atLL , gIll leIa K)11}oeJ arz3 una) SuoI 'sau looe/\ 'stu}elo Areuolsno 2g lznsn sapnl3xa }uatu98uenv aIn , SUITBl) aol/waS tOpaH ue IPUT pm (}uatua8uern aaJ 8ulsuads ip JQ) s&up rapro IIguI 'SUIT2l9 VOM lau JO lno Iplal 's8rup punodtu03 sapnI3xa ]uaua8uzu8 anl , dJWVJO go s8u I/\es }unoos ip o8nuauad aq) }uasaidar s}un03s ip raIllo IIV -s3Fnua8 DV IN-uou iq dA\vJJO s8urAes }un09s}p a8z+uamad pIle s3FnuaS DV IN roJ gtIj9}Id ( OWN) +soD aIqeMollV ummlxe}NJJO SSmABS uo pas€q dywv o8eiaAe aq) luasardai suo!)d}nsaid o}nua8 rapro IIeu pIle llepr roJ s+unoos la 'dJUV aq) Aq papIAlp s]un03s ip arp me sa8r}uaorad }unoos IP :+soo }ua}par8u} aq) ssol dluv IIO paseq pa}elnojBO s}unoosra , sisIxo ainseatu dA\V ou golqm JOJ uzld aq) iapun paiaA03 small ol Kldde lou saoa , }uauodUI09 Aq dnAVJJO atm lunoos ip pa+ouluoo aRI Aq dluv arp 8u!£ld}}lnuI Aq pauluna lap aq 11 IM )unoun )unoos ip paa}ueren8 aRI sStup rapro Ipm pue Iplai JO agesn 3}nua8 pIle puzrq Koeuu8qd arontIaN lenloe uo paseq ow slrm03sr CI , suoplpuo) ay padS aaa 3suadsl(I ? +unoos la SUO[tIPUO) sa+BqaU WIOLaV }uatuARd saa I' 8ursuadsr(I }utloulV }uatuKRd s}unoosICI WnomV tuatu£gd poIJad }uatu£ed lunour8 a)zqaX paa lumenS pau}qu03 aq) un{I ssaT sl lunouIe a]eqaX lentoe pau}qu03 aq) }unoun anl 'aaJ 8ursuadSIP pa}oB4u03 paulqmoo arp spaa3xa aaJ 8u}suads}p pnIoe paulqtuoo atl) )unoure aVI 'luauodUIOO pnpjATpuT qoza roJ }unouIe }un03s ip paatu2ren8 alp ueril ssol ale s}unoos ip pnioe atp }unourz atIJJ All?nuuV 9yloadS iauIO)sn3 £llenuuV pouad laAal IIe laB ul paprljouI IIe taX LII paprljoul IIe laU III paprlj9uI A}l2r9adS trott'is 86-990' IS £6'68 l'IS g8't 068 6t'OOO' IS SZ'O££$ABa 06 pUB OC - IIB IaU )du3s Iad 'SIS?8 JapJO jle IV puu8 %0-001 %0'00 1 pueJ8 %o'00 1 pUBJ8 a883uauad 8uuetiS azqaX (lad IBuoHIpeJJ) aa+ueJBnr) a+B(laW UInlUju IIAr roJ a+zJ paI381)aoa atp Aq acK) wma ioJ s}dFns lenl08 aq) 8u}£Id!+lntu Aq paluIn3jBO aJe SIrIO) aaJ 8ursuadSIa go'o$ $(ros g(ros qddns Ke(1 06 – opauar) llelaa g£'O$ gO'O$ St-OS gO'O$ g£-OS gO'OS KIddnS Aea 06 – puma [rqau Ae(I OE - ouauar) lrelaa g£'O$g£'O$gt-OS &CI OE - puer8 Ire)aH }{lo.\VaN SA)/}ralaS prepu8 IS - gaol 8ulsuads!(I ']uauodUI03 gma Aq dAVEO )un03s TP paau8Jeng arp Aq d/uv aq) BuT£TdpTnur Aq pattIuu9pp aq TTjM }unowe lrm03s ICI paqwrenf) aLL o/,O$'98 %OS'98 %Og'98 ssal dN\V 'opaua9 JapJO IBW %0S'SZ %0S'SZ o/o0S-gZ (>60S't8 ssal dJUV (pueJg JOPJO jle IV (}/'809't 8 %0S-t8 ssal dAIV '£lddns ARa 06 pIle OE - opauar) IIe laB ssal dluv 'Klddns Aea 06 – purr8 jle lax ssal ( auv) aolrd alesalorlaA a8eia,\V 'pUZIa tre taX (3/o09'ZZ O/o09-ZZ %09-ZZ %09-61 O/o09'61 (3’'60S'61 L960g99eowe-ozv8-8eJFvo£9-33903vov :al OdOjOAU3 u61snooa Docusign Envelope ID: ACAEC6EE-63CA-4F3B-BA7C-3AA036880961 ' The 90 day supply Retail guarantee includes drugs dispensed for 84 days or greater • The Mail Order guarantee includes drugs dispensed for 46 days or greater; claims with less than 46 days supply are reconciled at retail • When a drug is identified as a brand name drug, it will be considered a brand name drug for the calculation of discount guarantees. When a drug is identified as a generic drug, it will be considered a generic drug for the calculation of discount guarantees. • Specialty drugs dispensed outside United's specialty Pharmacy Network are included in the retail guarantees. Specialty drugs dispensed through United's specialty Pharmacy Network are excluded from the Retail and Mail guarantees Rebate Specific Conditions • Assumes implementation of United's Traditional PDL • Client directed deviations from the PDL and PDL exclusions or uptiers, or clinical programs may result in changes to pricing and guarantees, which will be factored in at the time of rebate payment and/or reconciliation. • Calculation of the guaranteed rebate amount will exclude ineligible claims including - claims where the plan is not the primary payer (e.g., coordination of benefits and subrogation claims) - claims approved by formulary exception - claims not covered by Customer's benefit design or PDL - claims receiving 340B pricing - long term care pharmacy claims - federal government pharmacy claims - claims for non-FDA approved products - compound drug claims - direct member reimbursement claims • Over-the-counter and repackaged drugs are excluded from the claim counts; Insulins are not excluded. • Devices are excluded from the claim counts; Test Strips are not excluded. • Vaccines are excluded from the claim counts • Rebate guarantee payments or reconciliations may be adjusted in the event of a change impacting the level of Rebates due to the introduction oftherapeutically equivalent, lower Rebate drugs (e.g. biosimilar, authorized brand alternative, lower cost non-Generic Drug alternative) or the reduction of Wholesale Acquisition Cost on a Brand Drug subject to Rebates. In the event a payment or reconciliation adjustment is required, such adjustment will be based on the difference between a) pharmaceutical manufacturer revenue prior to the introduction of the lower Rebate drugs and b) the actual pharmaceutical manufacturer revenue received after the introduction of the lower Rebate drugs. Such adjustment does not apply to Generic Drugs that launch after the Brand Drug no longer has patent protection • The Rebate guarantees set forth herein account for projected Rebate reductions in the following classes of Prescription Drugs in connection with the elimination of the Average Manufacturer’s Price (AMP) Cap pursuant to the American Rescue Plan Act of 2021 : Insulin products and Respiratory Medications. United reserves the right to modify or eliminate any Rebate guarantees if there are any additional changes to Rebates received from pharmaceutical manufacturers United reserves the right to modify or eliminate this arrangement as follows based upon changes inRebates • if changes made to United's PDL, for the purpose of achieving a lower net drug cost for Customer and United's other ASO customers, result in significant reductions to the Rebate level • in the event that there are material deviations to the anticipated timing of drugs that will come off patent and no longer generate Rebates Proprietary Information of UnitedHealth Group 64 99 dna') q}leoHpo}!un JO uo!}etLUOJUl Aie}ojJdoJd -pojlad aa+uerBnf) e ST poTlad q+uotu aAja/ul qoea '(„uual 8ur9nd £3euueqd„) £zoz/IE/cl q8norq} gzoz/ 10/ lo JO pojlad }oequoo all Iua OID IOJ loaDa ul ujBlum IInis saauenn8 8UIOUd IIV , suoPIPuo) IBJ3uar) 'a Iep aAnoaga aqI o) loud s£ep 09 }szal le }uatuaar8v atp o) tuampuawe ue pa)noaxa gujAeg sa}pvd aq) o) +oafqns bBa/C t3e4u09 8urmolloJ arp JO £ep }sly alj1 aApoaJJa are suo!}e!}ogau ,saIlred aVI tuo4 8u!}lnsai struat lz}oueug ol suoIsrAai £uv 'rualuo aAoqe aq) HI I/n a3ueproooe lr! po]9npuoo se,u s}sKlvue aq) Ierp alepIleA ol poljun roJ uopeuuojm }uaIoq;ns 8uunu03 Nodal Roarto laaJeu a}aldur03 arp JO Idla3ar JO s,Cep oc ulq) IA iauo)snD oi spuodsai paIjurl 'suua} lerou8uy atp aslmi Ol qIPJ poog UT ale}}o8au lila\ saIlred arp 'paRa laxJetu atp JO paFqns atp st )erp pouad gull roJ suua+ 18loueuU s6iauIo}snD pu? SJauIOjsno rel Fur is £Ile!}wlsqns IIons roJ gunn lelowuV alp JO uelpaul arp uaa4yaq ]uaoiad (£) aarq1 uetII raIearS JO sSCI}Aes paz}Ienuue ue satgplleA Nodal loatH )ajl?ul aq) Jl sppaJD }ualID saaJ aAPBJ}sIumpV saaJ aAT leas}ultupe EmA Flap raIn}oejnuuu 8urpnlour ' saleqaa sa13euuerld £ller3ads pue 'sa}oeuuetld AnAllap atuoq 'saloeuuerld IIe in luo# saaJ 8ulsuadsrp pIle s}unoosrp }soo luarpai8uI :JO onle/\ lau paulquoo aq) gulpnlou} suuat gUjO}Id JO anI% a)v8or88r aq) arzdtuoo III/h ]oar{9 p]nuI alII uoI8ai olqd8r8oa8 alqBredtuoo e ur pa}eool dn{sraqmau JO ,quo[eur v . po}lad q}UOUI-XjS )sed u Iq tIm palonE) Bura IId - }3er}uoo aurzs roJ §uroud JO uosuedtuo) (-ola 'AIIZ loads 'AraAllap auIoq 'Ilelm) gaol/nas JO sad/C) atueS i€aK ('3 Ia 'plealpaW 'aJE31pap{ 'jB13Jawuoo) ssauIsnq JO auII HUBS (-ola 'uoP}IBoo 'ul-a/HBO) acK) Jatu03sno aLUBS ]unoo dlqsraquaur leIO) JO %OI unI IrA\ :Uodar ]3aq3 Ia IIeu atl) ul papnl3ur aq Ismu qortl,w 8na luo 8UrMOUOJ aq) Aq pauluuatap se stoeDuoo aA IDe rapun SJatuo)sn3 Iet IIU is £Ilepunsqns rnoJ uer{} raMaJ ou apnlouI . platTq lyn £lqeuosBarun aq ol lou IeAoidde Kjled pIjlit uodn paai8e £Ilun}ntu e Aq palonpu03 aq . }uatuaarBV aq) JO a ira aApoaJJa arp JO £resiaAjUue tSJy arp raUe Jatnnb pru{} arp ur paleIIluI aq . :lletls srsKleu8 ljons 'sratuo}sn3 reITU is KIlequWsqns roJ talreuI aq) ur olqeI Ie/\e £I}uorm3 asorii qjLM aAnI}odtuoo are suual leloueuy sil uuguoo ol uual SuloFId £ouunqd atl) Su Irnp Vago Paietu auo ]onpu03 AzuI rauIOjsno }t3aq3 JaIl IBW 'Kldde llm saatueien8 a)equ umm}uFU JO uopBIIl3u03ar ou pUB saojhms ]yauaq £9etunqd JO uo IIeuluna) atp JO a Iep OAItoaDa aljI}o se ]uatuaai8v aq) iapun aIqe£zd sa}2qau UNIV lo 8ulpuad lle pIle £ue ure lai III/n palrun 'uual SUjOjId K3euueqd aq) JO pua aq) ol iopd paIjurl to}/n sao I/was }yauaq £oeuuetld sateuruua} ratuo)sn3 Jl , 'luaura8uene a)eqai paa}ueren8 arp ul papnl3u! lou are saaJ aA IIZ asluTtuE>V rarrU3€jnue IN 'stuer8ord a}eqau SULla+srurtupe pue 8ulS2ueuI roJ £mssa3au sassa30rd pue gina IsAs gulutz)meru ioJ uouvrapISU03 se a)BIIyJe wad s,patlun ol slam)3ejnu8tu Smp Aq PIed saaJ OAPFi}sluFupe aHI aIr saad aAr)e4srurtupv raIn}oejnug Iq , 9AOqg salequ }dEns-rad IF laI paa Iu?lenS all) ur papnlour aru sa}gqu £}jzloads , adAI )dEns Ierp roJ lunourz a}equ alqe3rldde aq) Aq pally sld bIOS JO raqumu pnIoe aq I guIKId! IInux Aq lunoure a)eqor umur lunn aq) sa}eIn3le9 uonerIr3u03ai aHI a]aldtuoo £lle!}ue)sqns are s}uauI£8d a}eqaa ual{/h pue poIlad loerluoo lenuu8 qoea JO pua aq) rage rn030 III/w s}unourz a}zqaa altI JO uojlelllou09ar v -}uatuaar8v aVI q jlm lua}srsu03 sa}eqaH Xed IInn palrun , sa}eqaX JO uclsI/\old atp ot palelm sao!}oerd ro slapom 9pols lq (s)rarn}9ejnueur 8rup e JO uopeou}pouI ppa)gUI lo uoUeuuurIa arp ol pa}8lar sa8wq3 Bmpnl3ul '(s)Jam+oejnugru gmp Aq pale;o sqeqaa JO lunotue IO A}111qel}eAU arp 8u1+3edw! a8ueqo e s! map Jr , L960899eowe-ozv8-8€JPVoe9-33903vov :al adOjaAu3 u61sn30a Docusign Envelope ID: ACAEC6EE-63CA4F3B-BA7C-3AA036880961 • Specialty drugs typically covered under the medical benefit (administered / handled by a provider, administered in a physician's office, ambulatory or home infusion), and/or transitioned to the pharmacy benefit, are excluded from all guarantees. • Drugs, products, supplies approved, covered and/or prescribed for the diagnosis, treatment or prevention of COVID-19 are excluded from all guarantees. • On mail order drugs, specialty drugs, and retail pharmacy drugs and services including dispensing fees, United will retain the difference between what United reimburses the Network Pharmacy and Customer's payment for a prescription drug product or service. • Pricing and guarantees assume enrollment of 1,708 Employees and 4,142 Participants; pricing and guarantees may be revised or withdrawn if actual enrollment varies by 10% or more from assumptions • The lesser of three logic (non-ZBL) will apply to Participant payments. Participants pay the lesser of the discounted price, the usual and customary charge or the cost share amount. • All pricing guarantees require the selection of United’s PBMI as exclusive provider of pharmacy benefit services, including but not limited to retail, mail order, and specialty networks. United will have no financial guarantee obligation under the Agreement for any partial Guarantee Period if Customer terminates with an effective date prior to the end of the Pharmacy Pricing Term • United shall on Customer’s behalf, administer a fee (“Consultant Fee”) to be paid to Lockton (“Consultant”). The Consultant Fees are included in Customer’s pharmacy financial terms. United shall provide Consultant with a monthly payment for all Consultant Fees collected in the amount(s) of $2.00 pmI)m. The Customer acknowledges there is a contract between Customer and Consultant. Therefore, in the event that there is a dispute between Customer and Consultant over continuing to make the Consultant Fee payment(s) or in the delivery of consulting services, Customer shall hold United harmless in such disputes. In the event of any change whatsoever in the Consultant Fee, Customer shall immediately notify United of such change and United may propose changes to the pharmacy financial terms • in the event any of the terms herein is inconsistent with the requirements of any federal, state or other applicable law or regulation, then the inconsistent term(s) will be null and void and United will have the right to revise, reprice or revoke this arrangement, • United reserves the right to revise or revoke this arrangement if: a) changes in federal, state or other applicable law or regulation require modifications; b) there are material changes to the AWP as published by the pricing agency that establishes the AWP as used in these arrangements; c) Customer makes benefit changes that impact the arrangements; d) there is a material industry change in pricing methodologies resulting in a new source or benchmark; e) it is not accepted within ninety (90) days of the issuance of our quote; f) if Customer changes their mail service benefit; g) Customer utilizes a vendor, that facilitates steering members to different drugs or pharmacies to the extent these services impact the financial guarantees under this Agreement. Brand / Generic Reconciliation Definition • Brand Drug: An FDA approved drug, or a drug that is designated by FDA a DESI (Drug Efficacy Study Implementation) drug, or product, which is manufactured and distributed by an innovator drug company, or its licensee , set forth in Medi-Span’s National Drug Data File as a brand drug identified by all of the products meeting at least one of the following criteria: - Mech-Span Multi-Source Code ("MSC") is equal to M, O, or N • Generic Drug: An FDA approved drug, or a drug that is designated by FDA a DESI (Drug Efficacy Study Implementation) drug, or product, that is therapeutically equivalent to other pharmaceutically equivalent products, as set forth in IV[edi-Span’s National Drug Data File as a generic drug identified by all products meeting at least one of the following criteria: MecIi-Span Multi-Source Code ("MSC") is equal to Y. TRRX 05/2024 66 Proprietary Information of UnitedHealth Group 29 dna') q}leoHpo}!un JO uo!}etLUOJUl AJe}ojJdoJd :XJBUIq3Ua cl lo aoinos Mau e ur But)lnsai sar8olopoqlatu Bu TO bId u! a8ueqo £r}snpu! Ielia}etu e s! uaw (p :aalueJzn8 aRt pzdul Pgl sa8ueqo iyauaq sa){eur ratuo)snD (a iaa tumenS SIIP in pasn sg dAhV atp saqsrlqe Isa )eq) £3ua8e guloFId arp Aq paWsIIqnd se druv aq) o) sa8ueq3 legaleu me magI (q :suoljeoylpolu annbar uoueln8aI lo ,weI alqB3}ldde Iag)o lo alels 'lunpaJ ul sa8wqo Izpa)euI (e Jr aaluuenB SIni a4oAar IO as IAU ol IrISH all) sa/uasar paIlurl , saalueieng lle tUOg papnl3xa are 'lyauaq K3euueqd aql ol pauoplsuer} io/pug '(uo}srvu! atuoq ro Aro}elnqtue 'aoyJO s,uel3ls£qd e ul paralsrultupe 'rapIAord e Aq paIpuzq / paIasjUIupe) lgauaq leolpaul aID iaptm para/too £lle3 ldA) s8rup £lje loads e uorsroap raIn}3ejnueu ua paseq a8u2q9 ol pafqns sl snlels ( CIal) uo!)nq Ins ICI pal IUIII , '(iapro julu lo IInn) pasuads ip are Kato Holq/u u! [auueq3 arp ul aa}uerenS Koeurmqd £lje loads arp JO apIs;no palr3u03ar aq 111/h pouad aa}uennr) aljI 8ubmp s8rup KIP loads se pauyap aq oi aseao q3lq/n s8rup pals}1 p paprljoxa ale s}slxa arns8atu dNV ou gonIM ioJ s§rup pue VOMIaN K3euueqd KIIe loads s,paljun apIsino pasuads ip s8rup KIte loads B djWVJOJJO s8u lms }un03srp a8quaorad aHI ]uasardar slunooslp iaqlo IIV 'souaua8 3V}q-uou iOJ drWV DO s8urAes lunoosrp a8e)ua3rad pug souaua8 ov IN roJ Sur9ud (DV)N) Iso) alqeMOITV umunxe}q uo paseq dAVJJO s8urAes a8eraAe arp luasaidar suor}du3sard ouaua8 roJ s}rmoosIa 'dr\\V atp Aq papl/\IP s}unoosrp arp an sa82lua3rad lun03srp iisoo }uarpar8u! atp ssaI dAIV aID UD p9seq paNltlc)lea SIunc)OSI(I • }un09srp a]rsodUI03 aw InTI ssal are s]unoos}p &up A IIe roads lauDe paulquroo arp lunoure gIll IenutrV SU OIIIPUOD ]unoLUV }uatuK2d pol_lad )uauIAgd pOH3dIBnuuV mr ®iamoBTi5 'pouad aajUBJerlr) aq) 8uunp s8mp asap IOJ paAaIqoe s}un03s IP 1?rtl38 o) paredtu03 aq 111M lelol slql 'sallddz )un03s ip palsllun a}endas arp Hall{x Ol sgrup palsllun JO uopezIInn uo pas=q pa}snfpe aq Keur srellop p§Je} ltm03s ip lleraAO aHI 'sreIIop la8re) }unoosrp lluraAO aKI auruua lap o) }a8Je} 3un03s ip aq) tsuIe& palldjljntu aq llyn Ilo/yUaN £3zuLmqd £ilz loads mo q8noiql s8rup ,qIeroads paIsrI JO 'elep rno gulsn 'sr?llop UI (d]uv) aojId al2saloqjw a82raAV gulsn 'uo!)ez III in len}3v 0/0 0/60000-tItI laAal eLla)LID 0/b OO'tl aaa aprlj3ul tW i £ZOZ ZOZ SZOZ /10/10 /10 /10/10 /10 pa+sINn % OO' IZ aaa aprlj3uI [lV j £ZOZ ZOZ /10/10 /10 / tO pals11 IHatH aJnsBaW 'suorHpuoo }alretu uo paseq £lleroads-uou ot A)leroads uro4 Smp e JO uorpugrsap alp a8ueq3 oi Iggy aq) sa/uasu paIjurl -arox\PN £oeuueqd Klje loads s,paljurl q8noJqI pasuads ip s8rup ,ale loads aq) roJ uo}}ezIIpn gulp AIIe loads Ienl3e uo pas€q lanl lun03s ip gmp AIF loads U ot}luya(I I larru.lurId A+lrl3adS L960899eow€-ozv8-8eJFVo£9-33903vov :al odOjaAu3 u61snooa Docusign Envelope ID: ACAEC6EE-630A-4F3B-BA7C-3AA036880961 • On specialty drugs, United will retain the difference between what United reimburses the Network Pharmacy and Customer's payment for a prescription drug product or service. Specialty Drug Ca£egor y LD D In dic ato r Includ ed/Exe iuded From Guara ntee Speciak y Drug Categor y LD D Ind ical or Incl IId ed/Exe luded From Guara Ittee Drug Name rNF£M MMAT ORY CONDI TIONS ANEMI A 1 ARANESP No Includ ed HULI I I Includ O I No ! ed INFLA MMAT ORY CONDI TIONS INFLA MMAT ORY CONDI TIONS INFLA MMAT ORY CONDI TIONS [NFLA MMAT ORY CONDI TIONS INFLA MMAT ORY CONDI TIONS ANEMIA 1 EPOGEN No Includ ed HUMI I I IncludRA I No 1 ed ANEMIA 1 PROCRIT No Includ ed HYRI I I Includ MOZ I No 1 ed ANEMI A 1 RETACRIT No Includ ed IDACI I I Includ O I No 1 ed ANTICO TqVULSANT I DIACOMIT Ye S Includ ed ILUM I I IncludYA I No 1 ed ANTICO }fVULSANT I EPIDIOLEX Ye S Includ ed KEVZ I I IncludARA I No 1 ed INFLA MMAT ORY CONDI TIONS ANTICO NVULS ANT I FINTEPLA Ye S Includ ed KINE I I IncludRET I Yes I ed INFLA MMAT ORY CONDI TIONS INFLA MMAT ORY CONDI TIONS [NFLA MMAT ORY CONDI TIONS ANTICO NVULSANT 1 ZTALMY Ye S Includ ed OLUM I I Includ IANT I Yes I ed ANTIHY PERLIPI DEMIC IJUXTAPID Ye S Includ ed OPZE 1 1 in,hId LURA I No 1 ed ANTI- INFECTI VE ANTI- INFECTI VE ARIKAYCE Ye S Ye S Includ ed Includ ed OREN CIA OTEZ LA Includ ed Includ ed rNFLA MMAT ORY No DARAPRIM No Proprietary Information of UnitedHealth Group 68 69 dna') y)leoHpa+!un JO uo!}etLUOJUl AJe}ojJdoJd pa prljouI pa prljoul ON EX ZI+Vflax ZNVflax AUO IWWV VldNI SNOII iaNOD AHO IWVW VldNI SNOII IaNOD AEO IWVPV VljNI SNOII laN03 Aao IWW VIJNI SNOII IaNOD XUO IWVPV Vl INI SNOll laNOD AEO IVFVW Vl INI SNOII ICLNOOxao IVPVPN VIJNI SNOII IaNOD AUO IVPqP\ VIJNI SNOII iaN03 AEO IVyVPV VIJNI SNOII IaNOD AUO IVWIN VIJNI SNOll IaN03 Aao IVPVyV VIJNI SNOII laNO) XUO IVIV IN Vl INI SNOII iaNO) pa prljouI pa prljouI S ah ON arIaAva S INa9v SND S INa9v SN) ON oaalsnv RITa–R–LT pnl9ul I I islaA pa prljouI S al r fIDSVA OICIUV3 FR=v pnIouI 1 1 WHI pa prlj3uI S b}\ al rIDSVA OICIW) FT(= pnIouI I I llVI pa prljoul S aA HI n)SVA OICIW) Erb=vpnIouI I I lals pa prljouI ON =Y fIDSVAoiaw) FrIar pnl3uI I I XIOS pa prljouI S ah nY fIDSVA oicrwD rrNHI pnpuI 1 1 Hms pa pnIouI S a/L Tv yVHLSV rrNnI pn[oul I I dWIS pa prljoul S aA Tv wnLsv OP A prljouI pa prlj3uI S Bk q PVHLSV rHN pnIouI pa prljouI S aA IT IAIINV FI–Tm–Tm prl1.'l1 1 1 vard pa prljouI ON Ta iIDadNI -IINV L960889eow€-ozv8-8£JP-vo£9-33903v9v :al odOjaAu3 u61sn30a Docusign Envelope ID: ACAEC6EE-63CA-+F3B-BA7C-3AA036880961 CONDI TIONS INFLA MMAT ORY CONDI TIONS INFLA MMAT ORY CONDI TIONS IRON OVERL OAD IRON OVERL OAD IRON OVERL OAD IRON OVERL OAD IRON OVERL OAD KIDNE Y DISEAS E CNS AGENT E ENSPRYNG S Ye S Includ ed :::: 3::t N1 o Includ ed CNS AGENT S CNS AGENT S CNS AGENT S CNS AGENT S CNS AGENT S CNS AGENT S EXSERVAN Ye S Ye S Ye S Ye S Ye S Ye S Includ ed Includ ed Includ ed YUSI MRY DEFE RASIR OX DEFE RIPRO NE No Includ ed Includ ed Includ ed FIRDAPSE Yes HETLIOZ No INGREZZA Includ ed Includ ed Includ ed EXJA DE 1 Yes Includ ed Includ ed Includ ed RADICAVA FERRI PROX I Yes RELYVRIO JADE NU I No CNS AGENT S CNS AGENT S RILUTEK No Includ ed Includ ed TARP EYO I Yes Includ ed Includ ed LIVER DISEAS E MONO CLONA L ANTIB ODY MISCE LLANE OUS MOOD DISOR DER DRUGS MULTI PLE SCLER OSIS MULTI PLE SCLER OSIS MULTI PLE SCLER OSIS RILUZOLE No OCAL IVA 1 Yes CNS AGENT S SABRIL Ye S Includ ed BENL YSTA I Yes Includ ed CNS AGENT S SKYCLARYS Ye S Includ ed SPRA VATO I No Includ ed CNS AGENT S SODIUM OXYB ATE Ye S Includ ed AMPYRA 1 No Includ ed CNS AGENT S TASIMELTEON Ye S Includ ed AUBAGIO I No Includ ed CNS AGENT S CNS AGENT S TETRABENAZINE No Includ ed AVONEX 1 No Includ ed TIGLUTIK Ye I Inciud I MULTI I BAFIE I I Includs ! ed I PLE F RTAM I Yes I ed Proprietary Information of UnitedHealth Group 70 LZ dna') q}leoHpo}!un JO uo!}euuojul AJe}ojJdoJd P' 1 QN 1 draga prljouI ald I pa 1 ON 111nw I pnIouI aalVHaod 1801 S ISOU81J DIISAD S ISOX81d )IISA) FI–MIA–lIB pnIouI I I ANOd SISO HalOS aldIllflP\ SISO aalos 31d IllflyV SISO uaIDSald lllfLP\ SISO aalosald Illfl IN SISO vaIJS aId IllflPV SISO uaIDSald IllflyV SISO aaIDSald 111fl PV SISO val 3S aId IllflW SISO aa13sald 111flW SISO aa19sald 111flPV SISO MalOSald 111flW SISO aaIDS ald ImfIPV SISO va13sald IllrlP\ SISO val OSald IllrlPV SISO XglOS pa prljouI ON iaol FFAmA pnl9uI 1 1 9ald pa prlj3uI S ah 0 ISOU81J OIISAO rrN=1 pn tsuI I I ZAVW pa prljouI ON a ISOU81d 311SX) NIaTA––T pnIouI I I Vl DN aAvyv pa prlj3uI S BX Ts ISOU81J DIISA) FTbnvpnI3uI L 1 isla pa prIIouI ON X ISOUgIJ )IISAD FI–Ta–fM pnIouI I I IV19 pa prlj3ul S aA Ts ISOH81 1 311SA) F–Fm prljouI Ha WWI IV19 VAN ali9 pa prljouI S aA N ISoa81J DIISX) F–T–& prII3uI Pg prljouI S BX Ts ISOU81d 311SX) F–T–® pnl3uI ao yVIIO 9NIJ VIA vlxa pa prlj3uI ON S ISOU81d 311SA) F–fm prljouI pa prljouI S bX AV/KAX S INa9v SN 3 pa prljouI ON alva VPVfIJ IXHI aw Ia NIai UdPW dIva pa prlj3ul S ok WJUAX S INar)v SNO pa prljouI ON pa prljouI S aA aNIzvNHX S INa9v SN) ap o pnIouI I I Vd03 pa prlj3uI S Bk aNOuav9iA S INaDV SND F–[–® prlj3uI N ouasvlga pa prlj3ul ON NrHlv8v9iA S INaDV SN3 L960g99€ow€-ozv8-8€]Fvoe9-33903vov :al OdOjOAU= u61snooa Docusign Envelope ID: ACAEC6EE-63CAd}F3B-BA7C-3AA036880961 SCLER OSIS MULTI PLE SCLER OSIS MULTI PLE SCLER OSIS MULTI PLE SCLER OSIS MULTI PLE SCLER OSIS MULTI PLE SCLER OSIS MULTI PLE SCLER OSIS MUSCU LOSKE LETAL AGENT S MUSCU LOSKE LETAL AGENT S NARCO LEPSY NARCO LEPSY NEUTR OPENI A CYSTIC FIBROSIs 1 TOBRAMYCIN No Includ ed REBIF REBI DOSE No Includ ed CYSTIC FIBROSIS I TRIKAFTA Ye S Includ ed TASC ENSO Yes Includ ed DERMA TOLOGIc 1 LITFULO Ye S Includ ed TECFI DERA TERIF LUNO MIDE No Includ ed ENDOCRINE I BETArNE Ye S Includ ed No Includ ed ENDOCRINE i BUPHENYL No Includ ed VUME RITY Yes Includ ed ENDOC RINE 1 CHENODAL Ye S Includ ed ZEPO SIA Yes Includ ed ENDOC RINE I CORTROPHIN Ye S Includ ed EVRY SDI Yes Includ ed ENDOC RINE ENDOC RINE ENDOC RINE CUPR[MINE No Ye S Ye S Ye S Ye S Includ ed Includ ed Includ ed VOXZ OGO LUMR YZ Yes Yes Yes Includ ed Includ ed Includ ed CLIVRIOR CYSTADANE WAKI X ENDOC RINE CYSTADROPS Includ ed FULP HILA NEUTR OPENI A NEUTR OPENI A NEUTR OPENI A NEUTR OPENI A NEUTR OPENI A NEUTR OPENI A No Includ ed ENDOC RINE CYSTARAN Includ ed FYLN ETRA GRAN IX No Includ ed ENDOC RrNE DEPEN TITRATABS No Ye S Ye S Includ ed No Includ ed ENDOC RINE DICHLORP}IENAMIDE Includ ed LEUK INE No Includ ed ENDOC RINE EGRIFTA Includ ed Includ ed Includ ed NEUL ASTA No Includ ed Includ ed Includ ed ENDOC RINE ENDOC RNE FIRMAGON No Ye S NEUP OGEN NIVES TYM No GATTEX No 72 Proprietary Information of UnitedHealth Group ez dna') q+leoHpo+!un JO uo!+eLLUOJUl Kre}audoid pa prlj3uI saA 111I I rlsoa I -A90 1 prll3uI IWHO - ADO I03NO TVUO - ADO IODNO TWO - ADO IOONO IVUO - A90 IOONO IVHO - ADO I03NO IVHO - X90 IODNO TWO - A90 IODNO IVUO - A90 I03NO pa prlj3uI pa prII3uI pa prII3uI S QX S a/L S ah S bX ON AaT80DTX aNiH ooaNa pa pnIouI ON aNalox vxa8 vsva Alva Il)IAVH aRra ooaNa aNIH DoaNa pa pnl3uI saA IasxDOXd pa prljouI saA IIE VARY pa prljouI aNVHnaaHd aNN 30aNa pa prljouI pa prlj3uI saA Drag Nf11V pa pnl3uI pa prIT3uI pa prlj3uI aMyvvlliDLNad aNrd )oaNa ON Nva axlv ON aLVla3v aailOTH130 aNIH 30aNa aNN )oaNa pa prlj9uI pa prIIoul saA vsNa Dalv S al S BX VWVdIVN ON 78 adsla aol INlaY MOI INIJV pa prljouI VSSdVDAW aNN ooaNa pa prlj9uI pa prljouI pa prljouI ON TWO - ADO IOONO TWO - ADO IODNOalav IDafNI - ADO IODNOalav IDafNI - ADO IODNO alav I)afNI - ADO IODNO alav IDafNI - ADO I03NO pa prIIouI pa prljouI pa prlj3uI S all ON IdgTVXW aNIH DoaNg ON UNOualv HIav oai VFtAS aaIIOTHNVI aNIH DoaNa aNIH DoaNa saA S BR NVAnH pa prlj9uI ON aa llOX dfla1 V NO XLNI pa prlj3uI S ah I 90GLNa pa prljouI saA pa pnIouI S ah S )oaNa pa prl[ouI ON (IEV 911a pa prljouI S BX a )oaNa pa prIIouI ON ozNa lxalz V iNadoulflaN pa prlj3uI S al S ah S aX S al aoIDAAVf gNIU DoaNa pa prljouI pa pnloul pa prljouI ON 01 XWZ V INado UlfIHN V INado alrlaN V INado alrlaN pa prlj3uI pa prljouI pa prIIOUI vsrHrLLsi aNIH DoaNa ON VOX Naarl VIHd aAAN amAI OWI aNN )oaNg aNrH )oaLNa ON YVH13V 'd'H L960899eow€-ozv8-8£Jt-voe9-33933vov :al 8dOjOAU3 u61snooa Docusign Envelope ID: ACAEC6EE-63CA-4F3B-BA7C-3AA036880961 ENDOC RINE SAMSCA Ye S Includ ed ONCOL OGY - ORAL ONCOL OGY - ORAL ONCOL OGY - ORAL ONCOL OGY - ORAL ONCOL OGY - ORAL ONCOL I Includ I OGY - I ORAL ONCOL OGY - ORAL ONCOL OGY - ORAL ONCOL OGY - ORAL ONCOL OGY - ORAL C OGY - ORAL ONCOL OGY - ORAL ONCOL OGY - ORAL ONCOL OGY - ORAL BRAF TOVI I Yes Includ ed ENDOC RINE ENDOC RINE SANDOSTATrN Includ ed Includ ed BRUK INSA CABO METY X CALQ UENC E CAPE CITA BINE Includ ed Includ ed Includ ed No Ye S Ye S Yes SAPROPTERIN Yes ENDOC RINE SIGNIFOR Includ ed Includ ed Includ ed Yes ENDOC RINE ENDOC RINE SODIUM PHEIqYLBUTYRATE No No Includ ed SOMATUL[NE DEPOT No Ye S CAPR ELSA I Yes Includ ed Includ ed ENDOC RINE ENDOC RINE SOMAVERT Includ ed Includ ed COME TRIQ I Yes SYPRINE No Ye S COPI KTRA I Yes Includ ed ENDOCRINE I THIOLA Includ ed COTE LLIC I Yes Includ ed Includ ed ENDOC RINE ENDOC RINE TIOPRONIN No Includ ed DAUR ISMO I Yes TOLVAPTAN No Includ ed Includ ed Includ ed ERIVE DGE I Yes Includ ed ENDOCRINE I TRIENT[NE No Ye S Ye S ERLE ADA i No Includ ed Includ ed Includ ed ENDOCRINE I XERMELO ERLO TINIB I Yes ENDOC RINE ENZYM E DEFICIE NCY XURIDEN Includ ed ETOP OSIDE I No ONCOL I EVER Ye I Includ I OGY - I OLIM s 1 ed I ORAI. I US ENZYM E DEFICIE NCY ENZYM E DEFICIE NCY ENZYM E DEFICIE NCY CARBAGLU Includ No 1 ed ONCOL Ye I Includ I OGY - I EXKI s 1 ed I ORAI. I VITYCARGLUN41C Includ Yes I ed ONCOL Ye I Includ I OGY - I FARY s 1 ed I ORAL I DAKCHOLBAM Includ Yes I ed CYSTAGON Ye S Ye S Includ ed Includ ed ONCOL OGY - ORAL ONCOL OGY - ORAL FOTIVDA I Yes Includ ed Includ ed ENZYM E 1 GALAFOLD GAVR ETO 1 Yes Proprietary Information of UnitedHealth Group 74 gZ dna') y+leoHpa+!un JO uo!}eLLUOJUl Aie}ajJdoJd pa 1 ON prljouI VI TVHO I pa 1 s SSTHI I - mo I pnIouI I aX IODNO XANIHOZ as GIHOsia D IlaNa9 Ma aHOSla D ilaNa9 ua CIHOSIa J IlaNaD ) prIpuI RT Tp mb TaM I - ADO 1 pnl3uI I03NO a)iOfLA F–FiR prljouI HI–Tmc[–Irl-I Ot)Nr 1 - mo 1 prl1.ul 1 aX IODNO IAloroa RIta pn[ouI TFTR XINI I - ADO I pnl3uI I aA I09NO V91aGIHaD a svasia STa H3rlv9 S INa9v TVNII SaINIOalsv9 A)N ai3iJaa a WAZNa A ON =l)IJaa a wxzNa AON aIJI laa a PVAZNa AON aIDIJaa a PVAZNa X ON aIDI laa a PVAZNa A ON aiDI lga a WAZNa AON alOIdaa a PVAZNa AON al)IJga a wxzNa X ON ai31Jaa a WAZNa AON aIOIJaa F–FiR prljouI FT TR 31/\n I - ADO 1 pnl3uI I aA HaWI I IODNO S pa prlj3ul ON alv1 AsaPV aIN IIVPVI V dIHaI mRp - ADO 1 pnl3uI IODNO S BR v3saAVZ pa prljouI ON mRp - ADO 1 pnl3uI IODNO S B}\l Iaas991 FMT9 v Tp R pnIouI I I snIDI I - ADO 1 pnIouI I aA I03NO arPa ons EVA prlj3uI mT TR VHaI I - ADO 1 pnIouI I aA I03NO llSNTHIS rRToTR pnIouI I I VDXH I - AgO I pnloul I aX I03NO ) rTN Tso TR pnloul 1 1 0319 1 - ADO 1 pnl3ul I aA I03NO NICIVJUO FFN prlj9uI RT p R 8319 1 - ADO 1 pnIouI I aA IOJNO MAIIN ) pnIouI m1 Tp nbolr9 1 - AgO I prl1.„I IODNO aNONisiiiN pa prljouI Tna I Tnb liJa9 1 - X90 1 pnI3uI IODNO IVlsn191w L960B99£ow£-ozv8-8eJFVo£9-33903vov :al adOjOAu3 u61sn30a Docusign Envelope ID: ACAEC6EE-63CA“+F3B-BA7C-3AA036880961 GROWT H HORNtO NE DEFICIE NCY GROWT H HORMO NE DEFICIE NCY GROWT H HORMO NE DEFICIE NCY GROWT H HORMO NE DEFICIE NCY ONCOL Includ I OGY - I JAKA No 1 ed 1 ORAL 1 FlGENOTROPrN Includ Yes I ed ONCOL Includ I OGY - I JAYPI I I Includ No 1 ed 1 ORAL E RCA 1 Yes I edHUMATROPE ONCOL Ye I Includ I OGY - I KISQ s 1 ed 1 ORAL I ALIINCRELEX Includ No 1 ed KISQONCOL I ALI Includ I OGY - 1 FEMA No 1 ed ! ORAL I RA I No Includ ed GROWT H HORMO NE DEFICIE NCY GROWT H HORMO NE DEFICIE NCY GROWT H HORMO NE DEFICIE NCY NGENLA ONCOL Includ I OGY - I KOSE I I Includ No 1 ed I ORAL I LUGO I Yes I edNORDITROPIN ONCOL Includ I OGY - I KRAZ I I Includ No 1 ed 1 ORAL I ATI 1 Yes I edNUTROPIN AQ ONCOL Includ I OC,Y - I LAPA No 1 ed 1 ORAL I TINIB Includ No 1 ed GRO WT H HORMO NE DEFICIE NCY GROWT H HORNtO NE DEFICIE NCY GROWT H HORMO NE DEFICIE NCY OMNITROPE ONCOL I LENA Includ I OGY - 1 LIDO I I Includ No 1 ed 1 ORAL I MIDE I Yes I edSAIZEN ONCOL Ye I Includ I OGY - I LENV I I Includ s 1 ed 1 ORAL I IMA I Yes I edSEROSTIM ONCOL Includ I OGY - I LONS No 1 ed I ORAL I URFSKYTROFA Includ Yes I ed Proprietary Information of UnitedHealth Group 76 LL dna') q+leoHpo}!un JO uo!+etbuoJul Are+olidoid pa prII9uI saA XAA 0980 IVHO - ADO IOONO WHO - ADO I03NO IVdO - ADO I03NO TWO - ADO IODNO TVHO - ADO I03NO ]VUO - ADO ]OONO IVUO - ADO IODNO TWO - A90 I03NO IVUO - ADO IOONO TVHO - ADO IOONO IVUO - ADO IOONO TWO - ADO 10)NO pa prljouI S aA S al\ ON H30anzTU 1 319010 IVPVaH pa prlj3uI pa prljouI ON 93 XfLNO OZW oao pa prlj3uI pa pnl9uI pa prIIOUI mD IVwaH ON mD IVW3H pa pnIouI saX S BIt ON mo IVPVaH pa prlj9uI ON OYV ININ pa prlj3uI r IVPVaH P oprlj9ul pa prljouI ON 3almv in IIN P oprljoul pa pILI3UI pa prIIOUI ON no OIVHy3H ON N ouaN VaINlrvA vxaN S all mD IVPVaH pa prljouI saX S OX no iv)NaH pa prl[ouI pa prlj3ul saA XNLX THaN pa prljouI S ah no ivivaH ON xa NsaPV pa prlj3uI pa prII3uI pa prlj3uI S BX S BX S aA S ah S bX S aA mD IVPqaH pa prIIOUI ON N VWH dlgPV IAO INurl mD IVFvaH pa prIIoul saA mmFoTo–o–n IVyvaH pa prljoul pa prlj3uI pa prljoul saA ISIN IUBIN IVHO - ADO I03NO IVUO - ADO IOONO TWO - ADO IODNO pa prljouI pa prlj3uI pa prlj3ul mD IV)NaH saA aNv1 fllVW vrav d}tAI mD IVPVaH saA aAIlgHOZ A ON alOIJaa IN OPVHOH H I/KOUD A ON aiDiJaa aN OyVUOH H I/KOU9 A3N aIOIJaa IN OyVHOH H I/woaD FrAnI Tnb pnpul k I vwn1 1 - ADO 1 pnl3uI IODNO N019VWOZ FrAno Tp m prl1.'II I I wor I - mo 1 prll3111 IOONO VAOUr)OS L960889€ow€-ozv8-8€JP-voe9-]3903vov :al adOjaAu3 u61snooa Docusign Envelope ID: ACAEC6EE-63CA4F3B-BA7C-3AA036880961 HEMAT OLOGIC I RUCONEST Ye S Ye S Ye S Ye S Includ ed ONCOL OGY - ORAL ONCOL OGY - ORAL ONCOL OGY - ORAL ONCOL OGY - ORAL ORSE RDU PAZO PANI B Yes Includ ed HEMAT OLOGIC I SAJAZIR Includ ed Includ ed Includ ed Yes Includ ed Includ ed Includ ed HEMAT OLOGIC I TAKHZYRO PEMA ZYRE PIQR AY Yes HEMAT OLOGIC HEMOP HILIA - INFUSE D HEMOP HILIA - INFUSE D HEMOP HILIA - INFUSE D HEMOP HILIA - INFUSE D TAVALISSE No ONCOL Includ I OGY - I POMA I I Includ No 1 ed 1 ORAL I LYST I Yes I edADVATE ONCOL Includ I OGY - I PURI I I Includ No 1 ed I ORAL I XAN I No ! edADYNOVATE ONCOL Includ I OGY - I PYRU I I Includ No 1 ed I ORAL I KYND I Yes I edAFSTYLA ONCOL Includ I OGY - I QINL I I Includ No 1 ed 1 ORAL I OCK I Yes ! ed HEMOP HILIA - INFUSE D ALPHANATE/VON WILLEBRAND ONCOL Includ I OGY - I RETE I I Includ No 1 ed I ORAL I VMO I Yes I ed HEMOP HILIA - INFUSE D ALPHANINE SD ONCOL Includ ! OGY - I REVLI I I Includ No 1 ed 1 ORAL I MID 1 Yes I ed HEMOP HILIA - INFUSE D ALPROLIX ONCOL I ROZL Includ I OGY - I YTRE I I Includ No 1 ed 1 ORAL 1 K 1 No 1 ed HEMOP HILIA - INFUSE D ALTUVIIIO ONCOL Includ I OGY - I RUBR I I Includ No 1 ed 1 ORAL I ACA I Yes I ed HEMOP HILIA - INFUSE D HEMOP HILIA - INFUSE D HEMOP HILIA - INFUSE D HEMOP HILIA - INFUSE D BENEFIX ONCOL Ye I Includ I OGY - I RYDAs 1 ed 1 ORAL 1 PT I NoCOAGADEX Includ ed ONCOL Includ I OGY - I SCEM No 1 ed 1 ORAL I BLIX I NoCORIFACT Includ ed ONCOL Includ I OGY - I SORA No 1 ed 1 ORAL I FENIB I NoELOCTATE Includ ed ONCOL Includ I OGY - I SPRYNo 1 ed 1 ORAL I CEL I N,ESPEROCT Includ ed Proprietary Information of UnitedHealth Group 78 62 dna') q+leoHpa}!un JO uo!+eLLuoJul Aie+oIJdoid pa 1 saX I oats I WHO I pa 1 ON pnl9uI I I wdm I - A90 1 pnloul I03NO aNINIIJOad a asfldNI - V111H dOPVIH a asiLiNI - V111H dOPvaH rTNTTT Tp nb pnIouI I I OIOZ I - A90 1 pnIouIown I IODNO m) pa prljouI ©TT1 Tp TN own I - ADO 1 pnIouI IODNO IU NaAasoAON a asfIJNI - VIlIH dOPvaHfrAnTTFN pnIouI I I AZVI I - mo I pnl3uI I03NO IH91aOAON a asrlIHI - VIlIH doyvaHrFA Tv TTnb pnI9ul 1 1 91SVI I - ADO F pnl9uI I03NO aNiNONOW a asfliKI - V111H dOPvaHrTTN Tl TFN pnl3uI I I OWI 1 - ADO 1 pniouI IODNO XUITVAOH a asfIJNI - VIIIH dO INaHrT\nnTA) pn[ouI E 1 )XVI I - ADO 1 pnl3uI I03NO SI alVNa90x a asrIJNI - V111H dOP\aH a asrIJNI - VIIIH doyvaH rMTaTTp m pnloul I I ZIVI I - ADO I pnI3uI IODNO IAa-alvox ErATTTp nb pnIouI I I a9vl I - AgO I pnl3uI IODNO alvox a asfIJNI - V111H doy\aHap nA Tv TH a pnl3uI t 1 NIdVI I - A90 1 pnl3uI I03NO IAIf a asnJNI - VIIIH doyvaH@–T–® prlj9uI mT Tnbaavl I - mo I pnl3uI IOONO XIINIXI a asfLINI - V111H dOPvaHF–F–W prlj3ul Ml TFNlavl I - ADO 1 pni3uI IODNO NoiAlaal a asrIJNI - VIIIH doyvaH a asflIHI - V111H dOwaH a asfIJN] - VIIIH dOPvaH a asrlINI - V111H dOPvaH ) prljouI TI TH nb Hms I - AgO I pnI3uI I03NO d-alVwrIH Dp aA rN HE aF pnIouI I I liNns I - ADO I pnIouI IODNO W IIJOWaH ErATT Tm pnIouI 1 1 VAllS 1 - ADO 1 pnl3uI 10)NO valad L960g99€OW€-OZV8-8€JPVO£9-33903V3V :al OdOjOAU3 u61snooC] Docusign Envelope ID: ACAEC6EE-63CA2}F3B-BA7C-3AA036880961 HEMOP HILIA - INFUSE D HEMOP HILIA - INFUSE D HEMOP HILIA - INFUSE D ONCOL Includ I OGY - I THAL I I Includ No 1 ed I ORAL I OMID I Yes I edREBTPNN ONCOL Includ I OGY - I TIBSO I I Includ No 1 ed I ORAL 1 VO 1 Yes I edRECOMBINATE ONCOL In,1„d I OGY - I TRETI No 1 ed I ORAL I NOIN I No Includ ed HEMOP HILIA - INFUSE D RLXUBIS ONCOL Includ I OGY - I TRUS ed 1 ORAL I ELTIQ Yes Includ ed HEMOP HILIA - INFUSE D HEMOP HILIA - INFUSE D HEMOP HILIA - [NFUSE D HEMOP HILIA - INFUSE D HEMOPH ILIA - INJECTA BLE SEVENFACT No Ye S ONCOL Includ I OGY - I TUKY ed I ORAL 1 SA 1 YesTRETTEN Includ ed ONCOL Ye I Includ I OGY - I TURA I I Includ s 1 ed I ORAL I LIO I Yes I edVONVENDI ONCOL Includ I OGY - I TYKE No 1 ed I ORAL I RBWILATE Includ No 1 ed ONCOL I VENC Includ I OGY - I LEXT I I Includ No 1 ed 1 ORAL 1 A 1 Yes I edXYNTH A ONCOL OGY - ORAL ONCOL OGY - ORAL ONCOL OGY - ORAL ONCOL OGY - ORAL ONCOL OGY - ORAL ONCOL OGY - ORAL ONCOL OGY - ORAL ONCOL OGY - ORAL ONCOL OGY - ORAL HEMLIBRA Ye S Include d VERZ ENIO VITR AKVI Include Yes I d HEPATI TIS c 1 EPCLUSA No Includ ed Includ ed Includ ed Includ Yes I ed HEPATI TIS C HEPATI TIS C HARVONI No VIZIM PRO Includ Yes I ed LEDIPASVIR/soFOSBLrvIR No VONJ 0 Includ Yes I ed HEPATI TIS c 1 MAWRET No Includ ed VOTR IENT Includ Yes I ed HEPATI TIS c 1 PEGASYS No Includ ed WELI REG Includ Yes I ed HEP ATI TIS c 1 SOFOSBUVIRMELPATASVIR Includ ed Includ ed Includ ed No XALK ORI Includ Yes ! ed HEP ATI TIS c 1 SOVAI'DI No I XELO I DA I xosp I E ATA Includ No 1 ed HEPATI TIS c 1 VIEKIRA PAK No Includ Yes I ed 80 Proprietary Information of UnitedHealth Group Lg dna') q}leoHpo)!un JO uo!}etLUOJUl Kie)OjJdOjd pa prl[ouI saA FtA HOdV a svasia SNOSN IXWd S ISOVOdoalso S ISOUOd oalso S ISOUOdoalso )IWTV HIHdO pa prljouI ON IV WIIS1110d IlaaJNI pa prIIouI pa prIIOUI ON SO IPVAL pa prlj3uI ON 1 IIUaJNI ON Hal IWW drual 03 IUO I pa prIIoul pa prljouI pa prlj3uI ON a1 llxaJNI pa prlj9uI pa prl{3uI ON ON =X IIHgINI saA alVA aaxo S aX soalqAVI S INa9v TV 319010 bLrlP\wi S INaDV TV D19010 btflPVPVl S INaDV TV D19010 HflPNWI S INa9v TV 919010 lqflP\WI XOIV Iflaoyv a Nfl}NytI UOIV Iflaoyv a bLriPVPvi A HIVdO XHdaN VOI vwaa 019FW XXVI iaJdaH XDOIO IVdaH FrAnITR pnIouI 1 1 DIVA 1 VOIdOI 1 pn IDUI 1 aA - ADO IOONO VIZXOJTVd pa pn[QUI aN TT T= 9HVI I V)IdOI I pnl3ul 1 aA - ADO IODNO snqAHdnl pa prl[3uI ON rv ru a IIAZ I - ADO 1 pnI3uI I aA I03NO vrNaof FrAnv I TR pn IDUI I I VXAZ I - A90 1 pnl3uI I aA IOONO ISAIV DTV rFA To T TR pnIouI I I aclLZ 1 - ADO 1 pnl3uI I aA I03NO a}{nwwil DV Fm prljouI mT Tp R IIOZ I - X90 1 pnIouI I OX IODNO IYVdSIId rFARI Tp B pnIouI I I alaz I - ADO 1 pnl3uI I aA I03NO OAaavTdo pa prljouI S Iflraz IVUO - X90 IOONO TWO - A90 I03NO IVHO - A90 IODNO TWO - ADO I03NO pa prljouI S al S al ON ITUVWAII pa I prll'111 1 1 SNOA I pa prl1.UI I I Nvrx I pa 1 prll3111 1 1 AOdX I ©Tv SNOX pa prIIOUI pa prljouI pa prlj3uI XVAIA8 X9010 IVdaH mT–IT }(VIX xaIIVdaz O Stl IIVdaH 3 SIX IIVdaH 0 AOdX ON IAaSOA L960989€OW€-OZV8-8£JFVO€9-33903VOV :al OdOjOAU3 u61snooa Docusign Envelope ID: ACAEC6EE-63CA-4F3B-BA7C-3AA036880961 PARKI NSONS DISEAS E PARKI NSONS DISEAS E PARKI NSONS DISEAS E PULMO NARY DISEAS E PULMO NARY DISEAS E PULMO NARY DISEAS E PULMO NARY HYPER TENSIO N PULMO NARY HYPER TENSIO N PULMO NARY HYPER TENSIO N PULMO NARY HYPER TENSIO N PULMO NARY HYPER TENSIO N PULMO NARY HYPER TENSIO N PULMO NARY HYPER TENSIO N PULMO NARY [NFERTI LITY I FYREMADEL No Includ ed APOM ORPH INE Yes Includ ed INFERTI LITY I GANIRELIX ACETATE No Includ ed INBRI JA Yes Includ ed INFERTILITY I GONAL-F No Includ ed KYN MOBI No Includ ed INFERTI LITY I GONAL-F RFF No Includ ed ESBRI ET No Includ ed INFERTILIrr I MENOPUR No Includ ed OFEV PIRFE NIDO NE Yes Includ ed INFERTI LITY I NOVAREL No Includ ed No Includ ed [NFERTILITY I OVIDREL No Includ ed ADCI RCA No Includ ed INFERTI LITY PREGNYL No Includ ed ADEM PAS Yes Includ ed INFLAM MATOR Y CONDIT IONS INFLAM MATOR Y CONDIT IONS INFLAM MATOR Y CONDIT IONS ABRILADA No Includ ed ALYQ No Includ ed ACTEMRA No Includ ed AMBR ISENT AN Yes Includ ed ADALIMUMAB-ADAZ No Includ ed BOSE NTAN No Includ ed INFLAM MATOR Y CONDIT IONS INFLAM MATOR Y CONDIT IONS INFLAM MATOR ADALIMUMAB-ADBM No Includ ed LETAI RIS Yes Includ ed ADALIMUMAB-Flap No Ye S Includ ed Includ ed LIQRE V OPSU MIT Yes Yes Includ ed Includ edADBRY Proprietary Information of UnitedHealth Group 82 eg dna') q}leoHpo+!un JO uo!}etLUOJUl Aie}ajJdoJd tzoz Ol azljrlqaN saprljouI+ SNOI liaNO) A UOIWV WVIJNI SNOI naNO)k UOIVyV PWIJNI SNOI IIaNO) A aolvyv WVIJNI J pa 1 QN prljouI vwiiavH pa prII3ul saA +SIAV INgA N oisNai EaaxH A}rvN oyvlrld N OISNal aadXH A}rvN OWlfld pa prlj3uI ON ITHaNa pa prIIoul saA IAV Hldf} pa prlj3uI S bX vzvIJwa pa prIIouI saA OS VAAL N oisNai uaaAH A}rvN OPVlfld pa prII3uI ON INaxldna SNOI liaN03 A UOIVPV WVIJNI SNOI IIaNOD A UOIVW }WIJNI SNO] naNO) A UOIVP\ WVIJNI pa prlj3uI ON uaal Dval N OISNaI aaaxH AWN oyvlrld N oisNai uadXH AWN OyVlfld N OISNaI UgdAH XWN o}\lrld N OISNaI uaaAH AzrvN oyvlrld N OISNgI aadAH AWN oy\lrld N OISNal uadAH xlrvN oy\lrld N OISNaI uaaAH pa prlj3uI ON ozalIA) pa prlj3uI saA a)I(rvl pa prII3uI ON.xxINasoD pa prljouI ON IIJVIvavl pa pnl3uI ON VIZWID SNOI liaN09 A XOIVW PWIINI SNOI IIaNOD A UOIVPV PWIJNI SNOI naNO) A UOIVW }WIJNI SNOI IIaNOD A VOIVW yWIJNI SNOIIIaNO) A pa prlj3uI ON IIJVN aaIIS pa prljouI ON ) pa prljouI ON 011 VAaH pa prljouI ON xlazwia pa prII3ul saA W VHII NTUO pa prIIouI ON vlIAafyw L960889€owe-ozv8-8£Jhvo£9-33903vov :al odOjeAu3 u61sn30a Docusign Envelope ID: ACAEC6EE-63CA-+F3B-BA7C-3AA036880q61Eihl bit E-CIQ CONFLICT OF INTEREST QUESTIONNAIRE For vendor or other person doing business with local governmental entit' This questionnaire reflects changes made to the law by H.B. 23, 84th Leg., Regular Session. FORM CIQ This questionnaire is being filed in accordance with Chapter 176, Local Government Code, by a vendor who has a business relationship as defined by Section 176.001 (1 -a) with a local governmental entity and the vendor meets requirements under Section 176.006(a) and by City of Denton Ethics Code, Ordinance 18-757. By law this questionnaire must be filed with the records administrator of the local government entity not later than the 7th business day after thI date the vendor becomes aware of facts that require the statement to be filed. See Section 176.006(a-1), Local Government Code. A vendor commits an offense if the vendor knowingly violates Section 176.006, Local Government Code.misdemeanor. a M UnIted Healthcare Services , Inc . An offense under this section is a 2 a Check this box if you are filing an update to a previously filed questionnaire. (The law requires that you file an updated completed questionnaire with the appropriate filing authority not later than the 7th business day after the date on which you became aware that the originally filed questionnaire was incomplete or inaccurate.) d Name of local government officer about whom the information in this section is being disclosed. Name of Officer Describe each employment or other business relationship with the local government officer, or a family member of the officer, as described by Section 176.003(a)(2)(A). Also describe any family relations hip with the local government officer. This section, (item 3 including subparts A, B, C & D), must be completed for each officer with whom the vendor has an employment or other business relationship as defined by Section 176.001(1-a), Local Government Code Attach additional pages to this Form CIQ as necessary. A.Is the local government officer named in this section receiving or likely to receive taxable income, other than investment income, from the vendor? = Yes n No B . Is the vendor receiving or likely to receive taxable income, other than investment income, from or at the direction of the local government officer named in this section AND the taxable income is not received from the local governmental entity? [–] Yes E No C. Is the filer of this questionnaire employed by a corporation or other business entity with respect to which the local government officer serves as an officer or director, or holds an ownership of one percent or more? n ,„,n .,. D Describe each employment or business and family relationship with the local government officer named in this section 4 5 [X] 1 have no Conflict of Interest to disclose. @?lz Signature of vendor doing business with the governmental entity June 12, 2024 Date 9LOZ/DC/bl posIAaU sri 'xyo}e+s's9lq}o'MM/u UOISSItUtUOO SOIq+3 SeXOI Aq pOPIAOJd LUJO leaK ( 1) auo JO poFnd e ioJ 'Kpadord Izar io 'saojhms 'spoo8 JOJ tuatuaSwxe raHlo io )on luca AIID e OjUI ialu3 ol alqI8Ijau} patuaap aq iopuaA aq) letII raBeue Pq A)!) aq) Ol puatuur03ar £etu preo8 aq) 'ala IPV SjIP paNIc! /\ seq iopuaA e )eU spuy SOIqH JO pieoa atp JI £]}Ilq1811aul (9) '(q) uoplsods ICI – -Z8Z-Z ucjlogS 'apoO solwa uclua(I JO All) atp lad Ira/i le3su a18u TS e lad (00-DOCS) sreIIop parpunq o/w) ueq} mom le panl ZA £laAnelnumo FU IS aIdpIntu io y18 nd (oo'og s) snIIop Aug Bulpaa3xa leIamc) Kilo o) Bir) v aA IS lo logo o) ropuaA e roJ atojjIV SjIP JO UO}PjOjA e aq lleqs }1 (c) SIIO IljqIgold – '££Z-Z uopoaS 'apo3 soIHla ualua(..I JO KilO aW Jad 'asn oIIqnd JOJ s3saJa3u! KuadOJd lear Jag lo JO KeM-Jo- Iggy 3llqnd saJ}nboe XII) atp uroqM luoa uauMO £uadoid asoq} apnjOUI lou saop uo!}!uyap slqI -uolpsuadtu03 io; a8wq3xa UI All) arp ol ,Cuodoid lem io/pIle 'saolmas 'spoo8 OPI/\old Ol s>pas lo sap!/\old OHM uosr3d e :M> rwo8. saIIUpn ollqnd io 'uo Isslnwo) lrerupu21 OFloIsIH '3uatuisnfpV JO pJeo8 'siaquIa Pq uorsswtuoD 8uruoz pug BuTuueld 'SOjIpa JO preoa atp JO raqtuaur JO 'speaH }uauruedaa 'sJaqura IN llounoD aq) JO stslsu03 una I atp 'alo TIle SjIP JO asodmd JOJ :MXJRq]3 uorlclope ro poolq lrurnBuesu03 iO (aBetueui Wm®1=T>ITtB anl ulqIT/n IepgJO AII) e o) pateIn iaqtuauI £I}ureJ e :M :SUOtlma J r) ra3tBO }uaunuaAog le30l e q)]m drqsuoqelar £lrureJ e JO (3) lo !(e) no]toasqns £q paqjJ3sap gutS now JO auo nang seq ropuaA alp )eq) (8) t(z) uoQoasqnS Aq paqnosap baoUJO aq) JO iaqmaur £lrureJ e io qaou;o luarutuaAo8 leool e qjlh drqsuor lzlai ssaursnq raqlo ro luatu£olchua ue JO (v) :are/he satuooaq JopuaA aVI app aljI (C) JO :Aljluo le)uatuwaAo8 le30l ati1 ql!in 1381)nco lejlua tod e o) pale[al 8unu/h raqloue ro 'a3uapuodsou03 'splq io s[esodoidroJ tsanbar e o) asuodsu 'uoRe3lldde ueA)! luo lquotuuraAo8 le30laq}o}s}rtuqns (a) lo :/aljua lz)uatutuaAo8 le30l arp qIun l3e4u09 e o)ur r3lua ol suol+er+o8au io suorssn3srp sur8aq (v) :JOPUOA aW )Eq; Hep aq) (1) :JO Ja let allI JaUe &p ssaulsnq qruaAas atp uup rareI lou lol8as luItupe spr03ai alepdOJdde arp IpjM paly aq]snuI arleuuojlsanb lsaralu! JO lojuu03 papldur03 aHI (1-e) 'X}pua IquaurtuaAo8 Ie30l reIn JO raoUJO luawtuaAo8 l8301 e q Inn drqsuorlelu £lnneJ e seq (t) io tCl-e)£oo'9£ [ ucl)oas Aq paqu3sap urS Kw 8mpnl3xa '(8)(e)(8)£OO-9LI uonoas Aq payloads anleA a+e8uB8e all) tp IM suB aroturo allo 'raoula atp JO iaquaur KllureJ e io '£]1lua lnUaUUUaAO8 le30l letp JO ra3UJO }uamtuaAo8 [e30l e uaAr8 seq (z) :(V)(Z)(e)£OO-9£l 'lojI.aS £q paqInsap 'Ja.W. .'nJQ iaqtu3tu Allmy elo 'AllluI [eluatutuoAo8 le30l leIit JO r03yJO }UOtUW3AO8 le30l e qI!/h dlqsuojNjm ssaulsnq raRlo lo +uatuKoldua ue seq (1) :pm /CHIna IquauIUIaAo8 le30l z qHIn dlqsuo TWIn ssaulsnq g seq ropu3A aq)JI arlewo!+sanb }sara In! JO 13rIJu03 pq3ldur03 e alg 1181is iopuaA v (e)M©tMml 'iOPU3A arp qI!/u )oerluoo e olu} Bupa Iua gu Flaplsuoo sl XIIiua InuauIwaAo8 Ieool atp (11) io :pa}n3axa ua3q seq iopuaA pug Ajl)ua lquaurw3Ao8 Ieool aRI uaa/hIaq 13e4uoo e (1) :181l1 are/he satu03aqia3u;a aq) alep aw 8u}pa3ad poInd WUOUI-cl atp u1 00 is ww aroujoanleA o}e8a88e ue aAeqleql SBl8aiotu ro auoia3uJO 9rpJoraqunu £jIurejeroi33H;oluaturuaAOB Fool arp o) ua/\IS seq (8) Uc>pmA atp qI Im +3uluoo e o luI Sujla+ua Bu}nprsu03 sl £lnua [2)uauIruaAog le30l aq) (ir) lo fpa)n3axa uaaqseqropuaA pw /Ct Itua TeluaurtnaAog le30I aW uaa,n+aql3er+uoo e (1) Pq I aJe/we sauI03aqiaouJO aq1 )etp a)gp atp 8ulpa3aJd po}lad qtUOUI-zI aq) 8upnp 009'z$ spaa9xa }2gI 'aui03u! }uaunsaAUT uet{} Jawo 'auioou! aIq€x€} 8ujAjaoai iaquIaur KITmy JO ia3UJO aq) ur sljnsaJ IetF iaoUJO arp JO iaqmam £lruIeJ z ioraoUJO luaurtuaAo8 leool arp HIm drqsuonzlm ssaursnq Ial{}Dio }uaru£oIdua ue seq (v) JopuaAaIP (C) ;J}iopua/\ e or l33dsar qlpn luauralqs ainsol3s ip s)3}IJuoo e aID lleqs ra3UJO }u9urtu3AOB IeooI V (V) RTFr'TVlrZlr'J€6T9 Mm®9T'7oI 'K3uaSe }erp 'o) 8uIuodaJ pue 'Aq uopeulmexa rz[n8u ol l3a[qns sl leq) pIle £oua8e leiapaJ io ale is e £qparauzq3 sr PHI uosrad e moo sao!,was lo spoo8Joas8al ro aserlund e o) lo :3rlqnd arp o) alqejIeAr suLla) o+ +oafqns pug a3ud e +e pa+3npu03 uon3esu2D e (8) : KjljtIa letuaurtu3Ao8 leool IO 'alvts 'IeiapaJ e JO Koua8e u2 io A)}}ua Ie)uaunuaAOB le30I io 'algis 'lwapaJ e Aq uorpln8ai aaJ io aIm ol pafqns sl IetF UOn3eSUVI) e (v) uo paseq uo1}3auuoo e apnlou! lou saop una) aql 'sar tIed atp JO allo JO KITAjloe le}uatutuoo UO paseq sajjIed aiotu JO 04U uaaJw}aq uo})oauu03 e sueatu „dlqsuojlelaJ ssaulsnH„ : uuoJ SIg) uo paIja suol30as alp JO aLUOS ale MOjaq 'aouaJajaJ XseoJOJ 'turq'9£ lr)1/urw)17s30a /sn'xl-alers's18al'salmqs'/wwu//:dug re punoJ aq£rur apo3 ruaUrwaAor) le30laqrJo9£l ialdeq) JO Kd03 alaIduI03 v All)ua lr+uauruJaAo8 Ie30l qlpu ssaulsnq Bu TOP ropuaA rod auIVNNOIrsanO rsTuarNI dO r31raN03 L960g99€OW€-OZV8-8€JFVO£9-]3903VOV :aI edDIe/\u 1 u61sn30a [Xx:uSign Certificate Of Completion Envelope Id: ACAEC6EE63CA4F3BBA7C3AA036880961 Subject: Please DocuSign: City Council 8577 Medical Network & Claims Status: Completed Administrators/Pharmacy Benefit Source Envelope: Document Pages: 86 Certificate Pages: 6 Signatures: 5 Initials: 2 Envelope Originator: Ginny Brummett AutoNav: Enabled Envelopeld Stamping: Enabled Time Zone: (UTC-06:00) Central Time (US & Canada) 901B Texas Street Denton, TX 76209 Ginny.Brummett@cityofdenton.com IP Address: 198.49.140.104 Record Tracking Status: Original 9/5/2024 11 :09:22 AM Holder: Ginny Brummett Ginny.Brummett@cityofdenton.com Location: DocuSign Signer Events Ginny Brummett ginny.brummett@cityofdenton.com Buyer City of Denton Security Level: Email, Account Authentication (None) Electronic Record and Signature Disclosure: Not Offered via DocuSign Signature Timestamp Sent: 9/5/2024 1 1 :37:13 AM Viewed: 9/5/2024 11 :37:22 AM Signed: 9/5/2024 1 1 :37:32 AM Completed Using IP Address: 198.49.140.104 Lori Hewell lori .hewell@cityofdenton.com Purchasing Manager City of Denton Security Level: Email, Account Authentication (None) Sent: 9/5/2024 1 1 :37:40 AM Viewed: 9/5/2024 1:15:28 PM Signed: 9/5/2024 1:16:52 PM Signature Adoption: Pre-selected Style Using IP Address: 198.49.140.10 Electronic Record and Signature Disclosure: Not Offered via DocuSign Misty Hambright misty.hambright@cityofdenton.com Security Level: Email, Account Authentication (None) Sent: 9/5/2024 1:17:00 PM Viewed: 9/5/2024 1:18:31 PM Signed: 9/5/2024 1:18:49 PM Signature Adoption: Pre-selected Style Using IP Address: 198.49.140.104 Electronic Record and Signature Disclosure: Accepted: 9/5/2024 1:18:31 PM ID: 8a87dc87-8c132le61 -91dc-6594d01054dc Marcella Lunn marcella.lunn@cityofdenton.com Senior Deputy City Attorney City of Denton Security Level: Email, Account Authentication (None) -DocuSigned by: IMArdhtgml .4B070831B4AA438 Sent: 9/5/2024 1:18:57 PM Viewed: 9/5/2024 1:30:48 PM Signed: 9/5/2024 1 :35:59 PM Signature Adoption: Pre-selected Style Using IP Address: 198.49.140.10 Electronic Record and Signature Disclosure: Not Offered via DocuSign due+saLUII SII Ie IS S+UOA3 AreAlloCI paUINo') duetsoulII SII IBIS S)UOA3 AreAlloCI ArelpaLuio luI due+sotuII SII letS S+U3A3 Ar3Alloa +uo6V due}saLU ll SII Ie iS s+uaA3 AoAlloCI ro+!p3 due+saLUII oin)eu61S s+uaA3 rau61S UOSiOd ul u61Snooa ejA pOJOgO )ON :3insolosla ein)eu61S pue pJO03U ojUOJ;oe13 OL'Ot L'6t'96 L :sSOJPPV dl 6ulsn aIRIS popalas-aId :uolldopV ain}eu61S (.L”N) uo!)e91)uot{}nV +unoooV 'lleLu3 :jOAO] A}!JnooS Aie}oiooS Aila LUOo-uo+uapJOA+lo©)uopoq}-uornel uoPoqI uoJne I mv LL:20: L L tZOZ/9 L/6 :Pou61S mv 99:90: LL tZOZ/9 L/6 :POMOIA mv Ct:gP:6 tZOZ/g L/6 :}uoS ~,„qC ~„„q :Aq pau61sn30a u61snooa ejA paiagO )ON :arnsol3 sla orn+eu61S pue pioaoU oluor)3813 allqoLU 6ulsn pou61S OZL'Z?'06 L'Zt :SSOJPPV dl 6ulsn aIAis pOPOjOS-OJd :uo!}dopv OJn}eu61s (.L„N) uo!}e91}uaq}nV }un099V 'lleLu3 :laAO I A}!JnoaS uo+uea JO AllO io6euem AllO LUOo-uo}uapJOK}!o@)Aolsuaq'eres AalsuaH eJeS PNV PC:By:6 tZOZ/g L/6 :Pou61S mv gZ:gP:6 tZOZ/gb/6 :paMOIA mv 90:CL:6 tZOZ/g b/6 :}uaS £zPozz96z8a9t:zs \ we.:q:X'I pa11Qsr1,oa –--/ u61Sn30C] eiA paogO )ON :oJnsol9sla 3in)eu61S pue pJOOOU oluoi+3313 (.L„N) uo!}e31+uoq}nV }unoooV 'jleLu3 :jOAO I X+lin90S uo Iuo(-] JO &10 JOSjmodnS uo!}eJ)SjUjLUPV )uotuoJnooJd LU09-uoluapJoAllo@)aajop'auuoAoy9 aajoC] ouuaAaq':) mv 99:ZI:6 tZOZ/g L/6 :Pou61S mv tt:ZI:6 tZOZ/g L/6 :paMa!/\ md ZZ:CC:+ tZOZ/9/6 :}uoS OL'OtL'6t'96 L :ssaJppV dl 6ulsn pa;oldLUOO u61Sn90C] ejA pOJOgO )ON :oinsolosla OJn)eu61S pue pro03U oluoi+3813 tO L'OtL-6t'96 L :SSOJPPV dl 6ulsn oIAiS po}3alas-aid :uo!}dopV ain}eu61S (auoN) uolle3lluoq}nV }un033V 'lleLu3 :jOAOl K}!inooS sooJnosaU ueLunH - ualua(] JO Ajl'.) JO}OOJ!(,J UH tu03-uo+uoPJoA+!9@)q}eoiql!')-ue6akN q}eoJql!') ue6om md ZI:CC:t tZOZ/9/6 :pau61S Nd st:ze:+ tZOZ/9/6 :paMa!/\ md ez:90:+ tZOZ/9/6 :}uaS eZp6J996p L La-9eOg-96Zhq€ LZ-066a LZ9g :al md gZ:90:P tZOZ/9/6 :po+d090V :oJnsojOSja orn+eu61S pue pioooU OjUOJ;9813 t€'£Z'9ZZ'9£ L :ssaJppV dl 6ulsn aIAiS pa}oalas-aid :uo!}dopV OJn}eu61S (aL„N) uo!}eo!}uoy+nV +un033V 'lleLu3 :laAO I A}!in3aS Jo6euem peJ}uoO leuo16aU LUoo'3qn@)seLunp–ioJjUUOl seLuri(."] JOJIUUOr S)UOA3 rou61S md tL:90:+ tZOZ/9/6 :pau61S md 9Z:90:t tZOZ/9/6 :POMOIA Wd gO:9£: L tZOZ/9/6 :}uaS due;satuII 6vtJ89Y633e86=>t \ ""a $T"qaq pauqS J oin+eu6 IS Carbon Copy Events Cheyenne Defee cheyenne.defee@cityofdenton.com Procurement Administration Supervisor City of Denton Security Level: Email, Account Authentication (None) Electronic Record and Signature Disclosure: Not Offered via DocuSign Status Timestamp Sent: 9/5/2024 1 1 :37:40 AMCOPIED Gretna Jones gretna.jones@cityofdenton.com Legal Secretary City of Denton Security Level: Email, Account Authentication (None) Electronic Record and Signature Disclosure: Not Offered via DocuSign Sent: 9/5/2024 4:33:25 PM Viewed: 9/6/2024 8:30:23 AM City Secretary Office citysecretary@cityofdenton.com Security Level: Email, Account Authentication (None) Electronic Record and Signature Disclosure: Not Offered via DocuSign Sent: 9/1 8/2024 11 :07:19 AM Viewed : 9/1 8/2024 2:14:52 PM Misty Harnbright rnisty.hambright@cityofdenton.corn Security Level: Email, Account Authentication (None) Electronic Record and Signature Disclosure: Accepted: 9/5/2024 1:18:31 PM ID: 8a87dc87-8c132le61 -91dc-6594d01054dc Sent: 9/18/2024 1 1 :07:20 AM Martha Skinner martha skinner@uhc.com Associate Contract Manager Security Level: Email, Account Authentication (None) Electronic Record and Signature Disclosure: Accepted: 3/1 3/2023 4:14:00 PM ID: 4d422b67-de89217bd-b182-2b9594a562f0 Sent: 9/18/2024 1 1 :07:22 AM Viewed: 9/18/2024 1 1 :38:54 AM Witness Events Signature Timestamp Notary Events Signature Timestamp Envelope Summary Events Status Timestamps 9/5/2024 1 1 :37:13 AM 9/1 8/2024 11 :06:56 AM 9/18/2024 1 1 :07:11 AM 9/1 8/2024 11 :07:22 AM Envelope Sent Certified Delivered Hashed/Encrypted Security Checked Security Checked Security Checked Signing Complete Completed Payment Events Status Timestamps Electronic Record and Signature Disclosure sn UIOJJ Klle31Uoil3aTa saJnsojOsrp pug saoTlou atp JO AnAllap aATaoar OI lou BuTtoaIa Jno£ JO saouanbasuoo alj1 saqposap leql aAoqe £la]elpatuuIl qdrrSei8d ati1 aas osTZ as8ald ','wolaq paqposap se MOU>1 sn laI aseald 'ssa30rd STH) q3TM aarSz lou op noK Jl IIla ISAs KIa AHap THur JadZd arp q8norq1 leuuoJ rad€d UI io £ll€3TuoD3ala saollou pug sarnsol3s TP ajl IIZ aAjaoar uea noK 'snriI 'sn ua Alg aAeq noK 18111 ssaJppR alIIes arp Ol pIle polj]auI aures atp Aq noK Ol saJnsol3sTP puc saojlou parrnbaJ aq 1 JO IF aprAord ol JajaJd aM 'aJnso losTP lo aol lou £uv guTAja3aJ lou £pua]JOAp€u} noK JO aoueqo aq I aonpar ol 'no/( q IT/n dlqsuoT)elar ino JO asrn03 aq) 8upnp noK ol alqeITeA8 apeuI JO paprAOJd aq ol paJTnbai aw )eq I stuaurn30p iag lo pIle 's]uauIaSpaTMOu:Ioe 'suoTlez}log Ine 's9rnsolosrp 'saorlou parTnba IIU lun033€ rasn u8TSn30('I Jno£ q8nonjl noK ol £lle3Tuoil3ala aprAOJd llrM aM 'upraq paqposap saJnpa30Jd arp HI IM aouepJ033r UI asIanIno sn TIal noK ssalun £lle3luor)3ala noK o) ]uas aq III/u sarnsops ip pIle saa! lou IIV sn UIorJ s)uauIn30p £lleoruoHoala ugrs OI JO sn uroJJ £lleoIUODoaIa s]uasuoo pIle sao}lou parlnbaJ aA}a3aJ Ol ]un033= Jasn ssaidxa u81snoo cl moX asn Ol alqe aq ia8uoT ou III,u noK pIn sn UIorJ KlleoTuorloaF saJnsojOS TP puc saopou pmInba aAraoar ol ]uasu03 rnoK u&vrpq3rM aAzq noK l€t{ 1 sn Ol a}€3 1PUT IIT& SIqI '}unooo€ uglsn30 cl rno£ JO a8Fd gurugTS arp uo uuoJ lluasuoD Mzrpq]Ttw1 u81snoo('I all I SuTsn luasu03 JnOK MerprIIT/w lsnuI noK 'punu Jno£ SuT8ueqo aw noK Irq 1 sn Ol a]eoTpu! ol 'sainsol9sTP JO saopou iaded q3ns JO ]dn3ai ino£ JO ]uauI8pajMOuxoe ino£ noK uroiJ ]nq aATaau a/w ITlun ITeM IraqI pUF 'tFUUOJ Jaded ur noK o) saJnsojOS TP JO sa3Tlou paInt)al aIn puas ol }SJU paau UTM aM asne3aq noK ol saorhias SuuaArlap pue noK qIIM suopo€surrt UT sda IS UP IIao a}aldru09 uzo aM qa TrjM le paads arp MOjS IIra\ 11 'Hung iadud UT £luo sarnsolosTP pIle saoT lou parTnbar aApoaJ ol ]3ala noK JI pu IUI rno£ 8u18ueq3 JO sa3uonbasuoD MOjaq paqu3sap sr £lle31uon3ala sarnsol3srp puz sa3pou aAjaoai Ol ]uasu03 Jno£ MeJpqljM pu€ teuuoJ iadvd UT arnsolos TP puc sa3r lou ain IIU aAjaoai ol uo}sl3ap moX JO sn uuoju! ]snui noK /noH ']euuoJ radrd UT KIuo sarnsol3srp pIle sa3Tlou paJTnbaJ aATaoai Ol ]ueM noK ra}J€aJaqt ley 1 sn TIal puc puTUI rno£ aSurq3 aInt) Kue 3g £euI noK '£ljR31UOU3ala sn UIorJ sarnsol3s TP puz sao! lou aAjaoaJ ol apToap noK 11 3uasu03 rno£ 8ulxterpq lIM ,uolaq paqp9sap aJnpa30rd aq 1 BuTMolloJ Aq sn tUOJJ saldoo iadvd IIons JO AnAllap }sanbaJ ,QuI nox 'aaJ aS€d-rad oo'o$ = pa8Jeq3 aq 11 IM no,C 'noX ol a3yJO rno UIorJ s]uauInoop ljons Kw JO saTdoo jaded noK puas OI sn roJ qs IM noK JT 'amp ljons laIJV 'no£ ol }uas ]sly are sluaurnoop IIons JaIJr (snp OE £ljFnsn) auID JO poTJad paIjur11 e roJ lun030F rasn u8TSnoo CI inoK q8noiq1 noK ol puas aM s]uaumoop £ue luIId pIle peoIU/wop ol KIlllqe allI aAeq IIjM noK uratsAs u8TSn30(J arp JO Jasn pazpoqlnF ue an noK se guol s€ 'saTdoo ljons rod 'sn Aq noK ol £lle3luon3ala alqeln m apuuI io papTAOJd prooaJ Aug JO £doo iaded e sn UIOJJ )sanbar £eui noK 'arup £ue lv sald03 raded guIHaD ]uauIr130p SIIP JO UIOnOq aqI ]€ uo]]nq laargr it atp gupta Ito Aq ]uatuaarSe ino£ ULIyU03 aseald 'suoplpuoo puc suua1 asaq3 ol aar8F pue u040ejs4es Jno£ Ol Klleoluon3ala uoll€uuojuT STIjl ss933e uea noK JI pue '£lq8noJot{ I pue £llnjaw3 MOjaq uopeuuojuT alp pem asFald ']un033v Jasn ssaJdxa (ugTSn90a) ouI 'u8rsnoo(.I ino£ q8non{I £lle3Tuonoala saJnsol3sTP pIle saojlou ljons noK ol gUjpjAOid JOJ suorFpuoo pu€ sulla] alj3 ue MOjaq paqp3sa Cl 'sainsolosTP JO sa3T lou ual IT&w up)no noK ol aprAord ol /nFl Aq paJ}nbar aq £eur (£UFdtUOD JO sn 'a/w) uolua CI JO KIjo 'arup ol aup word THflSOI asia THfIIVNOIS aNV aHO Jm )iNOH13ala iauuIHS cujlen '+q6uqLueH AIslm 'seLuna iojluuor ')q61iqweH AIslm :o) pooi6e soIjled md co:69:e ZLOZ/ LZ/Z :uo pa}eaio ainsol9sla ain)eu61S puc pi09aU 9luoiloa13 How to contact City of Denton: You may contact us to let us know of your changes as to how we may contact you electronically, to request paper copies of certain information from us, and to withdraw your prior consent to receive notices and disclosures electronically as follows: To contact us by email send messages to: purchasing@cityofdenton.com To advise City of Denton of your new e-mail address To let us know of a change in your e-mail address where we should send notices and disclosures electronically to you, you must send an email message to us at melissa.kraft@cityofdenton.com and in the body of such request you must state: your previous e-mail address, your new e-mail address. We do not require any other information from you to change your email address.. In addition, you must notify DocuSign, Inc to arrange for your new email address to be reflected in your DocuSign account by following the process for changing e-mail in DocuSign. To request paper copies from City of Denton To request delivery from us of paper copies of the notices and disclosures previously provided by us to you electronically, you must send us an e-mail to purchasing @cityofdenton.com and in the body of such request you must state your e-mail address, full name, US Postal address, and telephone number. We will bill you for any fees at that time, if any. To withdraw your consent with City of Denton To inform us that you no longer want to receive future notices and disclosures in electronic format you may: i. decline to sign a document from within your DocuSign account, and on the subsequent page, select the check-box indicating you wish to withdraw your consent, or you may; ii. send us an e-mail to purchasing@cityofdenton.com and in the body of such request you must state your e-mail, full name, IS Postal Address, telephone number, and account number. We do not need any other information from you to withdraw consent.. The consequences of your withdrawing consent for online documents will be that transactions may take a longer time to process. . Required hardware and software Operating Systems Browsers 7for SENDERS Browsers (for SIGNERS) Windows2000? or WindowsXP? Internet Explorer 6.0? or above mlet Explorer 6.0?, Mozilla FireFox 1.0 NetScape 7.2 (or above) Access to a valid email account x Email Screen Resolution Enabled Security Settings •Allow per session cookies •Users accessing the internet behind a Proxy Server must enable Hmp 1.1 settings via roxy connectlon #8 These minimum requirements are subject to change. If these requirements change, we will provide you with an email message at the email address we have on file for you at that time providing you with the revised hardware and software requirements, at which time you will have the right to withdraw your consent. noK qH,n d}qsuopelar £UI JO asinoo arp Submp u03ua('I JO KIjo Aq aur ol alqul Te AU apeuI JO papTAOJd aq o) paJTnbar ale ]uRI sluauInoop JaHlo puz 's}uauIa8pajMOuq3e 'suor}€zuoqlne 'sarnsoTosrp 'saoUou lle sueaur 3}uonoala q8noJql £laAjsnjOxa UIOJJ aATaoaJ ol luasuoo I'aAoqR paqposap se IIO IuaC JO K)TO £JT lou Issalun JO IIIun © pIle :ssaooe pIle a3uaJajar aJnlnJ JOJ 'II tund uea I aJar{/u a9eld e o I aJnsoI3s TP atp puas JO ams JO aJnsol3sTP aHI Jaded uo IU bId uea I e PW !]uauIn30p saHflS01 Dsia aunlVN9is aNV Gao)aH DINOUI DHa dO IdIa DTd 3iNOX£)ala Ol INHSNO) 3juoJ]oaIg SIIP peal pUB ssa33B uea I • : IVIiI uuyu03 1 'xoq ,aargv I, all 1 8urloaqo Ka ,uoIaq umlnq laargr it allI SuTqoTl3 Aq MOU>1 sn laI asrald 'aAoq€ paq}nsap suoplpu03 pIle suiJa] allI uo teuuoJ oluon3ala ut £laAjsnI3xa saJnsol9s ip pUR saor lou gUI Anon o1 3uasuoo noK JT 'laguna -ssa30e pue a3uaJajai ain ItU rno£ JOJ 31 a AUS JO Jaded uo tund Ol alqe aq 111/n noK aJay,u ssaippe ue Ol ]uasu03 pue ainsoI3s TP SjIP IFeuI-a ol alqe alaM noK IRIP io ssaooe pIle aouarajaJ unInJ ino£ roJ aged STIjl a Aes £lleoluoD3aTa lo iaded uo lund ol aIq€ maM oslr noK leq) pue aJnsoIOS TP OTuon3ala SjIP pFaJ o) alqe mam noK l8ql £JuaA asRald 'noK ol 9pjAord IIjM aM )€q1 saJnsol3sTP pue sa3Tlou 3luonoala iaqlo ol wlunrs aq 111/n youjM '£ITeoruoq3ala uoTleuuojuT STIjl ssa03F u€3 noK leq) sn ol uuTJuoo ol £lle3luor)a3Ia SIeNa)eur aAjaaar ol )u3su03 pile ssa33e rno£ 8ulgpajMOUj3v